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Abstract 
 Fetal alcohol spectrum disorders (FASD) refers to the neurological, developmental, 
and behavioural abnormalities arising from in utero ethanol exposure. These abnormities 
included attention deficit, anxiety, and learning and memory impairment persisting into 
adulthood. The molecular mechanisms of such persistent behavioural changes remain 
unknown and are an area of intense research. In this thesis, mice were exposed to ethanol 
during the third trimester equivalent, the peak of synaptic development. Following this 
exposure, genome-wide epigenetic and gene expression and changes in the hippocampus 
were assessed in adult (70 day old) mice.  
 In the first experiment, genome-wide trimethylation of histone H3 at histone H3 
lysine 4 (H3K4me3) and lysine 27 (H3K27me3) were assessed using chromatin 
immunoprecipitation (ChIP) microarray (ChIP-chip). Cell-cell signalling genes were 
enriched for changes in both methylations. It included the protocadherin (Pcdh) genes, which 
confer neuronal identity and may be important for synaptic development. Changes in 
methylation also occurred at imprinted genes and lipid-metabolism genes    
 The second experiment assessed DNA methylation using methylated DNA 
immunoprecipitation (MeDIP) microarray (MeDIP-chip). The screen identified genes 
involved in peroxisome biogenesis, which metabolize lipids and generate free-radicals. This 
was also true when the histone and DNA methylation changes were considered together. 
Combined analysis of affected genes from each experiment implicated free-radical 
scavenging genes. Identification of this novel interplay between epigenetic and oxidative 
stress genes may provide insight into diagnostic or therapeutic interventions. In general, the 
results support a role of epigenetic mechanisms in long-term FASD phenotypes. 
  Finally, the third experiment examined gene expression and miRNA microarrays 
identified 59 and 60 differentially expressed genes and miRNAs between ethanol-exposed 
and control mice. These genes primarily affect free radical scavenging genes. Differential 
expression of five genes in this pathway was confirmed with droplet digital PCR (ddPCR), 
including the transcription factor Tcf7l2 and the apoptosis regulator Casp3. The affected 
genes also included other oxidative stress proteins, olfactory receptors, and biosynthetic 
enzymes that may contribute to FASD-related abnormalities.  
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 Introduction 
 Fetal Alcohol Spectrum Disorders (FASD)  
1.1.1 A Limited Definition 
Fetal alcohol spectrum disorders (FASD) is a non-diagnostic umbrella term 
encompassing several conditions caused by prenatal alcohol exposure (PAE). It includes 
fetal alcohol syndrome (FAS), partial FAS (pFAS), alcohol-related neurodevelopmental 
disorder (ARND) and alcohol-related birth defects (ARBD) (Chudley et al., 2005). These 
disorders are characterized by neurological, developmental and behavioural 
abnormalities. Birth defects in children of alcoholic parents were first described in 1968 
(Lemoine et al., 1968). The specific diagnostic criteria associated with the condition, and 
the term FAS were described in 1973 (Jones et al., 1973). These include four 
components: 1) characteristic facial dysmorphia (smooth philtrum, thin upper lip, almond 
shaped eyes) 2) impaired prenatal and/or postnatal growth, 3) central nervous system 
(CNS) or neurobehavioural disorders, 4) known exposure to alcohol (ethanol) in utero. 
The term fetal alcohol effects (FAE) was soon created to encompass individuals who 
presented only some FAS criteria, presumably from differing timing and dosage of 
ethanol (Clarren and Smith, 1978). FAE was later delineated to specific conditions: 
ARND and ARBD as well as segregating FAS from pFAS (Stratton et al., 1996). Each 
requires confirmed maternal ethanol consumption. pFAS is defined by facial dysmorphia, 
and one of the other FAS criteria. ARBD is defined by presence of congenital 
malformations. ARND is defined by presence of either CNS or behavioural abnormalities 
(Stratton et al., 1996).  
The behavioural phenotypes associated with FASD are diverse, and highly 
detrimental to those affected. A behavioural phenotype is defined as “a characteristic 
pattern of motor, cognitive, linguistic and social observations that is consistently 
associated with a biological disorder” (O’Brien and Yule, 1995). Attention deficit, 
hyperactivity, impaired executive function, learning and memory, social skills, are 
observed in children with FASD (Sokol et al., 2003). Not one of these features is unique 
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to FASD, nor is any combination of them. Further, many of these features can be present 
in FASD individuals, but not be the result of PAE. This makes differentiation of FASD 
from other disorders very challenging. For example, FASD is often misdiagnosed as 
attention deficit hyperactivity disorder (ADHD) (Peadon and Elliott, 2010). ADHD also 
has high comorbidity with FASD adding further complexity (Rasmussen et al., 2010). 
FASD is distinguished primarily by known maternal ethanol exposure. Stigma and shame 
associated with drinking while pregnant makes these self-reported metrics unreliable 
(Sokol et al., 2003). PAE is believed to impact brain development creating cognitive 
deficits as “primary disabilities” leading to behavioral outcomes as “secondary 
disabilities” (Streissguth et al., 2004).  
While the definitions of the FASD component disorders allow for phenotypic 
classification, they do not provide any mechanistic or etiological insight. It is unknown 
what dosage or developmental timing of ethanol exposure lead to which FASD 
conditions. It is clear that the behavioural aberrations are caused by ethanol, but the 
intervening molecular and cellular mechanisms are unclear. As such, the central 
questions in FASD research concern characterizing molecular and cellular changes.  
1.1.2 Statistics  
FASD is the most common cause of developmental disability in the Western 
world (May et al., 2009). The general estimate of FAS prevalence across Canada is 
approximately 1 per 1000 live births while the estimate for FASD is 10 per 1000 live 
births  (Public Health Agency of Canada., 2003). Incidence rates vary greatly, and are 
highly community-specific. Certain First Nations communities for example are at 
substantially elevated risk. FASD prevalence in an isolated First Nations community in 
British Columbia was estimated at 190 per 1000 live births (Robinson et al., 1987). The 
incidence of FAS in northeastern Manitoba was estimated at 7.2 per 1000 live births 
(Williams et al., 1999). A study of another Manitoba First Nations community estimated 
an incidence of FAS and pFAS of 55-101 per 1000 lives births (Square, 1997).  
Despite societal efforts to raise awareness about the risks, many women still 
consume alcohol during pregnancy. Approximately 14% of women among the general 
Canadian population (McCourt and Public Health Agency of Canada., 2005) and as high 
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as 50% and 60% in isolated northern communities consume alcohol regularly while 
pregnant  (Dow-Clarke et al., 1994; Muckle et al., 2011). In a study of drinking patterns 
in Inuit women in Quebec, more 19% of women who drank during pregnancy engaged in 
binge drinking, defined as drinking bringing the blood alcohol concentration (BAC) to 
0.08 grams percent or above (Fortin et al., 2015).  
The cost of FASD in Canada in 2013 was conservatively estimated to be between 
$1.3 billion and $2.3 billion (Popova et al., 2015). The largest contributing factor was the 
cost of productivity losses due to disability and premature mortality, accounting for 42% 
of the total cost. Second at 30% was the cost of corrections, including all interactions 
with the criminal justice system. Indeed, FASD individuals are at substantially elevated 
risk involvement with the criminal justice system (Fast et al., 1999). Third was the cost of 
health care at 10% (Popova et al., 2015). The authors of these studies point out that these 
estimates include only individuals diagnosed with FASD conditions, and as such 
undiagnosed or misdiagnosed individuals may be driving the costs much higher.  
1.1.3 Ethanol Metabolism  
In adults, ethanol is metabolised in the liver by alcohol dehydrogenase (ADH) to 
acetaldehyde which is converted to acetate by aldehyde dehydrogenase (ALDH). The 
mitochondrial form of ADH (ADH2) is responsible for most acetaldehyde oxidation in 
the body (Licinio and Wong, 2002). The equilibrium constant of ADH actually strongly 
favors reduction of acetaldehyde to ethanol. ALDH however irreversible converts 
acetaldehyde to acetate, which is what drives ethanol oxidation (Bosron and Li, 1987).  
This also means that acetaldehyde is normally found at very low levels, which is 
important since it exerts many of the detrimental effects commonly attributed to ethanol 
(Tong et al., 2011). Ethanol can also be metabolized to acetaldehyde by catalase found in 
peroxisomes and CYP2E1 found in microsomes (Haorah et al., 2008). ADH is not 
expressed in sufficient levels in fetal liver to break down ethanol. CYP2E1 and other 
cytochromes metabolize ethanol at much slower rates (Hines and McCarver, 2002). 
These enzymes produce oxygen free radicals as part of their enzymatic action which are 
believed to contribute to ethanol teratogenicity (Haorah et al., 2008). Further, this means 
that ethanol remains present in the fetus much longer than the maternal bloodstream. 
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ALDH2 is produced by fetal liver, but not until late in gestation in mice (Sanchis and 
Guerri, 1986). This means that acetaldehyde is not readily metabolized; due to its 
instability this leads to free radical formation and cellular damage (Tong et al., 2011). 
Since ethanol can cross the blood brain barrier, these effects all occur in the developing 
fetal brain (Muralidharan et al., 2013).  
1.1.4 Role of Genetic Variation  
The diversity of phenotypic outcomes from similar ethanol exposures suggests 
that genetic factors may modulate the teratogenic effects of ethanol. Siblings of children 
with FAS have a higher risk of FAS, 170 per 1000 live births among older sibs and 771 
per 1000 live births in younger sibs (Abel, 1988). Monozygotic twins have a higher 
concordance rate for FAS diagnosis than dizygotic twins (Streissguth and Dehaene, 
1993). Several studies have examined the role of polymorphisms in ethanol metabolism 
enzymes. ADH2 has several non-synonymous, common polymorphisms that alter the rate 
of ethanol oxidation. ADH2*3 has two amino acid changes (Arg47 and Cys369) leading 
to a greatly increased ethanol turnover rate, 80 times other variants (Licinio and Wong, 
2002). The ADH2*3 allele was shown to have a protective effect when the mother had at 
least one copy (Jacobson et al., 2006). When present in the fetus, ADH2*3 was 
associated with reduced risk of low birth weight (Arfsten et al., 2004). Another variant 
with increased enzyme kinetics, ADH2*2, was associated with decreased FAS presence 
(Viljoen et al., 2001). Genetic variation also appears to play a role in the drinking 
behaviour of pregnant women. ADH2*2 was associated with reduced alcohol 
consumption during pregnancy (Zuccolo et al., 2009). ALDH polymorphisms are known 
to be important in alcohol preference in risk for alcoholism in adults (Quertemont, 2004); 
however, no studies have implicated these variants in FASD risk. Variants of CYP2E1 
have also not been assessed in FASD and very little in alcoholism risk either. While 
genetic factors play a role in risk, the mechanisms of FASD etiology encompass many 
more molecular pathways.  
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 Understanding FASD: Animal Models   
It is difficult to assess the action of ethanol on a cellular level in humans. As such, 
animal models of PAE have been developed to gain insight into the molecular actions of 
ethanol. There are several key advantages to animal models. First, all animal models 
provide access to all tissues at many timepoints. In FASD, access to brain tissue of 
ethanol exposed fetuses during development is key (Patten et al., 2014). Further, given 
the clear importance of genetic background, use of genetically inbred stains allows 
researchers to control for genetic effects (Nestler and Hyman, 2010). Animal models 
usually have sequenced genomes with genetic tools available to characterize genomic and 
transcriptional changes. Many animals have well documented behavioural tests to assess 
changes in disease-relevant behaviours. Animal models also allow for replication using 
many animals to increase statistical power. Specific to FASD, the developmental timing 
and dosage of ethanol can be precisely controlled.  
The most logical choice for a model of FASD would seem to be non-human 
primates. Primates are close evolutionary relatives of humans, have similar gestational 
development, and have complex social behaviours which could be assessed for ethanol 
responsiveness (Patten et al., 2014). In practice, there have been very few studies of 
FASD done in primates. Primates have very long gestational times compared to other 
model organisms, and are also much longer lived, making experiments time consuming 
(Schneider et al., 2011). Ethical approval can also be challenging, and the number of 
animals raised is usually quite low, limiting statistical power. Experiments in these 
models report growth restriction as well as various behavioural aberrations including 
learning and memory deficits and tactile aversion (Clarren and Astley, 1992; Clarren et 
al., 1992; Schneider et al., 2001, 2008).  
Rodents are the most popular model organism in FASD research, with rats and 
mice being the most common. Rats and mice have a short gestation period (21 days), 
large litters, and complex behaviour with a battery of tests available. Mice are the most 
common animal model of human disease in general, due to ease of care, ease of genetic 
manipulation, and similarity to human development and physiology (Patten et al., 2014). 
Rats are larger, generally allowing easier study of physiology compared to mice and more 
tissue for molecular analyses. Rats also have more sophisticated behaviour than mice, 
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with more behavioural tests available. Both are used in genetic, biochemical, 
physiological, and behavioural studies of FASD. In mice, the C57BL/6J (B6) inbred 
laboratory strain has become the most common. B6 mice have a long history of use in 
ethanol research, in part because they voluntarily consume more ethanol solution than all 
other strains (Rodgers, 1966). In response to ethanol during development, they have a 
high amount of fetal malformations compared to other strains (Boehm et al., 1997).  
Some research has taken place in guinea pigs. Guinea pigs have an advantage 
over other rodent models of FASD: their gestation is much more similar to humans. All 
three trimester equivalents of brain development occur in utero for guinea pigs, whereas 
in mice and rats the third trimester equivalent brain development occurs postnatally 
(Dobbing and Sands, 1979; Dringenberg et al., 2001). Drawbacks of guinea pigs include 
longer gestation time (three times that of mice and rats), smaller litter size, and non-
exploratory behavioural tendencies that make behavioural tests difficult (Dringenberg et 
al., 2001). PAE models in other model organisms have been developed, including 
Caenorhabditis elegans (Davis et al., 2008), Drosophila (McClure et al., 2011), Xenapus 
laevis (Nakatsuji, 1983), zebrafish (Marrs et al., 2010), chickens (Smith, 2008), and 
sheep (Cudd et al., 2001) (for review see Patten et al., 2014). The diverse strengths of 
these models allow for examinations of FASD etiology at various biological levels.  
The creation of specific FASD models must balance dosage and timing of ethanol 
exposure. Dosage/duration of ethanol exposure is key, as it determines which 
developmental processes are be affected. CNS development begins at gestational day 
(GD) 7 in mice, equivalent to the first trimester in humans (Rice and Barone, 2010). 
Neurulation initiates CNS formation, after which neurons proliferate, migrate outward, 
and differentiate into mature neurons during trimester two (Rice and Barone, 2010). After 
differentiation, neurons undergo synaptogenesis and maturation in trimester three. 
Ethanol will disrupt each of these processes if it is administered at that time. The dosage 
of ethanol is related to the timing; usually either moderate over a longer time (mimicking 
human BAC levels) or high and episodic to maximize effects. ethanol exposure time 
point: early gestation, late gestation, or post-natal (in mice and rats). Ethanol exposure at 
these various timepoints has markedly different molecular and behavioral outcomes 
(Kleiber et al., 2014; Mantha, Kleiber, & Singh, 2013; Miller, 2006; Patten, Fontaine, & 
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Christie, 2014; Wozniak et al., 2004). In addition to dosage and timing, the vehicle of 
exposure is also variable. The primary methods used are gavage, injection, consumption 
(drinking or food), and inhalation (Kelly et al., 2009). Finally, the endpoint will 
determine what type of effects are studied: acute vs. long-term. Along these various 
dimensions, FASD rodent models are created and adjusted quite often; however, several 
specific models have been consistently employed. The Singh laboratory has developed 
and employed the continuous preference drinking model, trimester 1- and 2- equivalent 
injections, and postnatal trimester three-equivalent injections (Mantha et al., 2013).  
1.2.1 Trimester Three Binge Model: Synaptogenesis  
Post-natal day (PND) 7 is a particularly important developmental timepoint in 
mice. It is the peak of a rapid brain growth period termed “the brain growth spurt” and 
synaptogenesis (Dobbing and Sands, 1979). Synaptogenesis refers to the establishment 
and maturation of synaptic connections in the brain (Rice and Barone, 2000). In humans, 
it peaks near birth, and but continues at low levels into adulthood (Dobbing and Sands, 
1979; Rice and Barone, 2000). In mice and rats, it occurs in the first two postnatal weeks. 
Exposure of mice to a high dose of ethanol at this time can be considered a model of 
binge drinking behaviour in humans. However, PND 7 binge model has been refined to 
cause BAC levels peaking at 500 mg/dl, which is would induce unconsciousness in 
humans (Ikonomidou et al., 2000). Injection of ethanol twice on PND 7 spaced 2 hours 
apart has a maximal effect on maintaining BAC: over 200 mg/dl for 15 hours 
(Ikonomidou et al., 2000). As such, this model is viewed as a tool clearly delineate the 
effects of a high dose of ethanol at this key timepoint, and not necessarily accurately 
model FASD in humans. Other laboratories have shown that injection of ethanol on PND 
7 causes widespread apoptotic neurodegeneration in the hippocampus and prefrontal 
cortex and learning and memory impairment (Goodlett and Johnson, 1997; Ikonomidou 
et al., 2000; Olney et al., 2002; Zimmerberg et al., 1991). The Singh laboratory has 
introduced a model wherein pups are exposed to ethanol on PND 4 and 7. PND 4,7 
exposure is intended to affect both the initiation and peak of synaptogenesis. 
PND 4,7 mice demonstrate consistent FASD-relevant phenotypes. These mice 
show delayed development, hyperactivity, and impaired learning and memory. PND 4,7 
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mice are generally morphologically normal, but show delayed developmental milestones 
(Mantha et al., 2013). These mice show reduced time exploring an open field, which is 
associated with increased anxiety-related behaviours (Carola et al., 2002; Kleiber et al., 
2013). They also display increased home cage activity, indicating hyperactivity (Mantha 
et al., 2013). PND 4,7 mice have particularly strong impairment on the Barnes maze 
memory task. The Barnes maze is a circular table with one escape hole and many block 
holes around its periphery (Barnes, 1979). A mouse is place on the board in given four 
attempts per day for one week to find the exit hole. Mice eventually learn the location of 
the hole based on spatial cues; latency to the target hole decreases over the week. PND 
4,7 mice show highly reduced latency to the target hole across multiple testing days 
compared to controls. Further, the greater statistical differences were identified than that 
of trimesters one, two, or binge models indicating particularly strong impairment 
(Mantha et al., 2013). Further, after one week, the mice were tested again to assess 
memory, and were delayed in finding the target hole compared to controls (Mantha et al., 
2013). The PND 4,7 model thus provides an effective system to model FASD learning 
and memory impairment in mice, and should provide utility in studying molecular 
changes underling such aberrations.  
 Actions of Ethanol During Trimester Three 
Exposure of mice and rats to ethanol during the first postnatal week is associated 
with dramatic changes in brain structure and function. Synaptogenesis is the formation 
and maturation of synapses. Synapses are small gaps that function as junctions between 
neurons. They facilitate neuron-to-neuron communication via neurotransmitters (Cohen-
Cory, 2002). Synapses permit and regulate neuronal communication throughout the brain, 
and thus are critical in regulation of nearly all brain processes (Cohen-Cory, 2002). 
During synaptogenesis, many more synaptic connections than are ultimately needed are 
formed initially. Necessary connections are reinforced while unnecessary connections are 
removed in a process known as synaptic pruning (D’Amelio et al., 2012). Similarly, 
unnecessary neurons are removed during this time through apoptosis (programmed cell 
death). Selection of these neurons is regulated by synaptic NMDA and GABAA receptors 
(Olney, 2004). NMDA receptor activation promotes neuronal survival while GABAA 
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receptors promote apoptosis. Ethanol acts as both an NMDA antagonist and GABAA 
agonist, triggering widespread neuronal apoptosis during the synaptogenesis period 
(D’Amelio et al., 2012; Ikonomidou et al., 2000; Olney et al., 2002). This process occurs 
in nearly all brain regions, but is particularly prevalent in the hippocampus, prefrontal 
cortex, and cerebellum (Ikonomidou et al., 2000; Olney et al., 2002; Wozniak et al., 
2004). Loss of neurons in these key brain regions is believed to account, in part, for the 
behavioural phenotypes associated with FASD.  
In addition to apoptosis, ethanol causes neurodegeneration via activating the 
immune response in the brain. The immune system of the brain utilizes microglia: 
macrophage cells that respond to and remove damaged neurons by phagocytosis. 
Surveillant microglia are important for guiding neuronal development by regulating 
glutamatergic receptors and maturation and synaptic transmission (Dheen et al., 2007). 
Upon receiving environmental cues, these surveying microglia can transition to an 
activated state, characterized by production of pro-inflammatory factors and reactive 
oxygen species (ROS). These lead to neuronal death during development (Dheen et al., 
2007).  Ethanol triggers microglia activation, resulting in neuron death during the first 
postnatal week in mice (Drew and Kane, 2014). Ethanol also triggers ROS production as 
a result of its metabolism, further precipitating microglia activation and neuronal death 
(Brocardo et al., 2011). In addition, ethanol causes a loss of microglia, reducing their 
ability to carry out their maintenance functions later in life (Dheen et al., 2007). 
1.3.1 Role of Hippocampus  
1.3.1.1 Structure and Function  
The hippocampal complex refers to the hippocampus proper and dentate gyrus. 
The hippocampal formation includes the hippocampal complex, subiculum, 
presubiculum, parasubisculum, and entorhinal cortex (Canto et al., 2008; Schultz and 
Engelhardt, 2014). Its structure is conserved across mammals, and has analogous regions 
in other vertebrates (Insausti, 1993). The hippocampus proper is divided into the CA1, 
CA2, and CA3 regions. The hippocampus is similar to other cortical regions in that it has 
large, pyramid-shaped projection neurons and smaller interneurons (Schultz and 
Engelhardt, 2014). It is unique in the brain due to the largely unidirectional passage of 
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information through intra hippocampal circuits, highly distributed three-dimensional 
organization of connections, and organization of neurons into layers (Amaral et al., 2007; 
Schultz and Engelhardt, 2014). The hippocampus receives highly processed sensory 
information from numerous other regions. Information travels from the entorhinal cortex 
up through the subiculum into the hippocampus proper then out through the dentate 
gyrus. The predominate hippocampal cell type is glutamatergic excitatory pyramidal 
neurons. These neurons differ in morphology and transcriptional profiles through the 
hippocampus, which is what differentiates the CA1, CA2, and CA3 regions (Schultz and 
Engelhardt, 2014). The dentate gyrus contains dentate granule neurons which project out 
of the hippocampus (Amaral et al., 2007). Granule neurons and pyramidal neurons are 
highly laminated into distinct layers (Andersen et al., 1971). Hippocampal structure is 
very similar between rodents and humans, but there are subtle differences. The 
hippocampus occupies a much larger relative proportion of the mouse brain (Insausti, 
1993). Hippocampus neurogenesis begins on GD15.5 in mice, and is one of two brain 
regions that continues neurogenesis into adulthood (Insausti, 1993). At PND 7, the 
hippocampus is undergoing neurogenesis and synaptogenesis, making it exceptionally 
vulnerable to ethanol exposure.   
The hippocampus plays a major role in the formation of new memories and 
visual/spatial memory. In mice and humans, damage to the hippocampus results in 
profound difficulties forming new memories (Cho et al., 1999; Morris et al., 1982; 
Squire, 2009) and difficulties with spatial, but not other learning (Cho et al., 1999; Olton 
et al., 1978). The unique neuronal architecture of the hippocampus is believed to play a 
major role in processing of sensory information to form new memories. Long-term 
potentiation (LTP) is a mechanism believed to mediate memory formation in the 
hippocampus. LTP refers to an increase in strength of a synaptic connection following 
neuronal activation, lasting for hours or days (Bliss and Lomo, 1973; Lynch, 2004). By 
changing synaptic strength, neuronal pathways are believed to store information (i.e. 
memories) (Lynch, 2004). The precise mechanisms by which this occurs remain an area 
of intense research. LTP is known to be accomplished in part by changes in neuronal 
gene expression. Chemical or genetic impairment of LTP results in impaired learning and 
memory in mice (Muñoz et al., 2016; Subbanna and Basavarajappa, 2014) 
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1.3.1.2 Vulnerability to Ethanol  
The hippocampus is particularly vulnerable to the effects of ethanol exposure 
during development. Ethanol-induced neuronal apoptosis during synaptogenesis occurs at 
relatively high levels in the hippocampus (Ikonomidou, 2000). Mice exposed to ethanol 
in the first postnatal week display reductions in neuronal number (Gil-Mohapel et al., 
2010), adult neurogenesis (Bonthius and West, 1991; Gil-Mohapel et al., 2010) synaptic 
efficacy (Bellinger et al., 1999), and dendritic spine density (Abel et al., 1983) in 
adolescence and into adulthood. Mice exposed to ethanol on PND 7 also show spatial 
learning and memory impairment, similar to mice with hippocampal lesions (Cho et al., 
1999; Mantha et al., 2013). Children with FAS show similar spatial deficits (Hamilton et 
al., 2003; Uecker and Nadel, 1996, 1998), even though differences in hippocampal 
structure are inconsistent (Spadoni et al., 2007). Data on non-hippocampal memory such 
as object and verbal memory are inconsistent between studies (Mattson et al., 1996; 
Smith and Milner, 1989; Uecker and Nadel, 1998). 
 Actions of Ethanol at the Molecular Level 
1.4.1 Gene Expression Studies  
Many of the changes ethanol exerts on the brain may occur via changes in gene 
expression. Gene expression changes are involved in ethanol-induced neuronal apoptosis. 
The genes Bax and Casp3 are required for apoptosis, which are upregulated by ethanol 
(Nowoslawski et al., 2005). Blockage of upregulation of these genes prevents ethanol-
induced neurotoxicity and behavioural changes (Sadrian et al., 2012). Exposure of 
embryos to ethanol early in gestation results in dysregulation of cell proliferation, 
differentiation, and apoptosis related genes (Hard et al., 2005). Ethanol can also cause 
changes in transcription in immune response and inflammation genes, which can be 
blocked by drugs that alter gene expression (Drew et al., 2015). PAE mice with induced 
inflammation show distinct expression profiles in the hippocampus, failing to activate 
genes and regulators involved in the immune response (Lussier et al., 2015).  
Previous work in our laboratory has examined gene expression changes in four 
mouse models of FASD. In the PND 4,7 mice, within two hours of exposure, there was 
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dysregulation of apoptosis, lipid metabolism, and neurogenesis genes (Kleiber et al., 
2014b). In adult mice, genes involved in glutamate signalling, neurological diseases, and 
cell-cell signalling were differentially expressed (Mantha et al., 2013). For a complete 
introduction to gene expression, FASD, and previous results see Chapter 2. The 
mechanisms which maintain gene expression changes into adulthood in these mice 
remain unknown; however, epigenetic mechanisms are a strong candidate.  
1.4.2 Epigenetics  
Modern epigenetics is typically defined as a heritable change in chromosome 
conformation without a change in DNA sequence (Berger et al., 2009). Various chemical 
modifications to chromatin structure can promote the condensation or relaxation of its 
structure, leading to repression or activation of gene expression, respectively. Covalent 
modifications of histone proteins and methylation of DNA cytosine residues are the two 
most studied mechanisms. For a complete introduction to histone modification and DNA 
methylation, see Chapters 3 and 4 respectively. There are dozens of histone modifications 
which are associated with open or closed chromatin at various genomic locations (Barski 
et al., 2007). DNA methylation is associated with chromatin condensation and stable 
repression of gene expression (Medvedeva et al., 2014). Both modification types are 
stable through cell division, allowing long-term control over gene expression. There is 
complex cross-talk between histone modification and DNA methylation which cooperate 
to coordinate complex transcriptional responses (Cedar and Bergman, 2009; Schultz et 
al., 2002). Despite their longevity, epigenetic marks are also reversible, and highly 
sensitive to environmental perturbation, including by ethanol exposure (Rosenfeld, 2010). 
Ethanol may act though epigenetic mechanisms to affect gene expression changes. 
Indeed, histone modification and DNA methylation are sensitive to ethanol (Chapters 3, 
4; Kleiber et al., 2014a; Liu et al., 2009; Shukla et al., 2008). Despite interest in 
epigenetics in FASD, few studies have examined multiple epigenetic marks 
simultaneously. Given the coordination of DNA methylation and histone modification, 
examining both may provide broader insights into the effects of ethanol.   
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Hypothesis 
Neonatal ethanol exposure promotes epigenetic and gene expression changes in the 
hippocampus in a mouse model of FASD. 
Objectives  
1. To assess all mouse genes and their promoters in adult mouse hippocampus 
exposed to ethanol on postnatal days 4 & 7 and identify changes in:  
a. two histone modifications, H3K4me3 and H3K27me3, using chromatin 
immunoprecipitation (ChIP) coupled to the Roche NimbleGen MM9 Meth 
2.1M CpG plus Promoter array.  
b. DNA cytosine methylation using methylated DNA immunoprecipitation 
(MeDIP) coupled to the Roche NimbleGen MM9 Meth 2.1M CpG plus 
Promoter array.  
c. gene and miRNA expression and using the Affymetrix GeneChip® Mouse 
Gene 1.0 ST array and Affymetrix miRNA 2.0 array, respectively.  
2. To characterize genes and pathways affected by epigenetic and gene expression 
changes.  
3. To confirm changes at specific genes using: 
a. ChIP-real-time PCR (ChIP-qPCR) for histone modification changes. 
b. sodium bisulfite pyrosequencing for DNA methylation changes.  
c. qPCR and droplet digital PCR (ddPCR) for gene expression changes.  
 
Thesis Organization:  
 The results of this thesis are organized into three chapters. Chapter 2 describes 
histone modification changes in response to early ethanol exposure. Chapter 3 describes 
DNA methylation changes as well as their relationship to histone medication changes 
from Chapter 2. Chapter 4 describes gene expression changes and their relationship to 
results from Chapters 2 and 3.  
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 Effects of Neonatal Ethanol Exposure on  
Hippocampal Histone Modification 
 Overview  
Histone modifications have not been well researched in FASD. In this chapter, 
histone H3 lysine 4 trimethylation (H3K4me3) and H3 lysine 27 trimethylation 
(H3K27me3) were assessed using ChIP-chip in the hippocampus of 70 day-old mice 
exposed to ethanol as neonates. The results identified regions of differential histone 
methylation (RDHMs) and genes proximal to them. These genes were used in pathway 
analysis to identify impacted biological processes. The top pathway for the genes having 
both methylation changes was protocadherin-guided synaptic development. There was an 
RDHM in the protocadherin gamma gene cluster which contains a putative CTCF motif. 
There were also putative CTCF motifs in two regions of differential H3K27me3 
methylation the imprinted Snrpn/Ube3a region. Finally, there was a substantial 
occurrence of lipid metabolism pathways in H3K4me3 affected genes suggesting a novel 
interaction of lipid metabolism and epigenetics. These results are the first assessment of 
genome-wide changes in histone modification in FASD.  
 Introduction  
2.2.1 Post-translational Histone Modifications 
 The role of histone modifications in transcription was inferred following the 
crystal structure of the nucleosome (Luger et al., 1997). The crystal structure showed that 
the highly basic N-terminal tails of the histones extend from the nucleosome. The authors 
postulated modification to these tails that could alter the intra-histone interactions and 
interaction of the octamer with the DNA. Indeed, it is now clear that histone 
modifications affect nucleosome stability via several mechanisms. To view the role of 
such histone modifications in cellular events was formally described in the histone code 
hypothesis (Turner, 1993). The hypothesis postulates that each histone modification 
codes for a specific chromatin conformation. The different modifications would then 
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form a combinatorial pattern which could heritably affect gene expression (Turner, 
2000). In recent years the rigidity of the histone code hypothesis has been relaxed. Some 
view histone modifications as more of a “language” (Oliver and Denu, 2011). The same 
modifications can have different meanings in the context of nearby modifications, and are 
not strictly associated with any chromatin state. There are also multiple modifications on 
the same histone tail creating combinatorial complexity which is difficult to assay and 
evaluate. As such, correlation mapping of each modification on its own is problematic for 
grasping the full complexity of chromatin.  
 At least twelve histone modifications have been reported to over 60 different 
amino acid residues. These include methylation of lysines and arginines, phosphorylation 
of serine and threonine, acetylation of lysine, ubiquitylation, sumoylation, ADP-
ribosylation, propionylation, butyrylation and crotonylation as well as arginine 
citrullination, proline isomerization, and N-terminal formylation (Kouzarides, 2007). The 
tails of histone H3 and H4 undergo the most modifications. While all the histone tails are 
required for higher order chromatin structure (Allan et al., 1982), the H3 and H4 tails are 
individually sufficient for nucleosome oligomerization (Gordon et al., 2005). This 
indicates that while the tails work cooperatively, there is a greater contribution of H3 and 
H4 to chromatin structure. Because histones and especially histone modification vary 
greatly between species, this section will focus on mammalian histones only. The 
nomenclature used here is “histone-residue-modification-number” (if applicable), where 
modifications are shortened from acetylation to ac, methylation to me, and 
phosphorylation to ph, for example histone H3 lysine 4 trimethylation is H3K4me3. 
2.2.2 Histone Methylation  
Histone methylation occurs at lysine and arginine residues on histone tails. Like 
acetylation, lysine methylation predominantly occurs on histone H3 and to a lesser degree 
on H4. An additional layer of complexity exists for lysine methylation, as the ε-amino 
group of lysine residues can be mono-, di-, or tri-methylated. Different methylation states 
of the same lysine reside can show unique genomic localization and carry out differing 
functional roles. Since histone methylation does not affect the nucleosome charge, it must 
carry out its effects on chromatin structure indirectly via effector proteins (Taverna et al., 
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2007; Voigt and Reinberg, 2011). Many domains recognize histone lysine methylation 
including chromo, PHD, tudor, WD40, and MBT domains among others (Yun et al., 
2011). Further, histone H3 lysine 4 tri-methylation (H3K4me3) enhances transcription 
via recruitment of the PHD domain-containing TAF3 subunit of the TFIID complex 
(Lauberth et al., 2013). TFIID is the first protein to bind to chromatin during RNA 
polymerase II pre-initiation complex formation (Dynlacht et al., 1991). Many of these 
domains are present in multi-protein complexes that can bind and modify other marks.  
Specific histone methylations are linked to nearly every chromatin state and are 
very consistent between mammalian cell types (Barski et al., 2007; Zhou et al., 2011b). 
Two in particular—H3K4me3 and H3K27me3—are commonly assessed in the context of 
gene expression. H3K4me3 is often concomitant with transcription at transcriptional 
initiation sites (Santos-Rosa et al., 2002; Schneider et al., 2004). H3K4me3 is often 
viewed as the on/off switch of transcription (Dong et al., 2012). However, the true roles 
of chromatin marks are clearly much more complex as transcription can occur in the 
absence of H3K4me3 (Hödl and Basler, 2012). Further, H3K4me3 can mark poised 
genes together with H3K27me3 termed bivalent domains (Bernstein et al., 2006). These 
domains are believed to keep developmental genes poised for rapid activation while 
maintaining repression (Voigt, Tee, & Reinberg, 2013). In somatic cells, H3K27 
methylations, are linked with facultatively and constitutively repressed genes (Barski et 
al., 2007). H3K27me3 is linked more tightly with repressed TSSs, while the mono- and 
di-methylated forms are more dispersed (Barski et al., 2007). H3K9 methylations are also 
linked with repressed transcription; H3K9me3 is deposited over large genomic regions 
facilitating heterochromatin formation (Lehnertz et al., 2003; Soufi et al., 2012). Given 
this background, H3K4me3 and H3K27me3 were chosen for this study as they have the 
clearest known relationship with gene expression, and therefore are more likely to 
represent relevant changes.  
2.2.3 Acquisition and Propagation of Histone Marks  
Histone marks like most other epigenetic marks are mutable and responsive to the 
environment. Indeed, many studies have linked changes in gene expression in response to 
various stimuli to changes in DNA methylation and histone modification at promoters 
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(Rosenfeld, 2010). Studies such as these provide evidence that histone processes may 
mediate gene-environment interactions. However, with any change in epigenetic marks, it 
is not easy to distinguish between correlation and causation. Irrespective of their function, 
histone modifications often reflect the structure of chromatin and it remains an active 
area of research.   
For a histone modification to be passed on, it must be passed through cell 
division. It appears that some modifications can be passed on and are epigenetic in the 
classical sense, while others are not. As the DNA replication fork propagates producing 
two nascent DNA strands, the parental histones are displaced and are evenly distributed 
to the daughter strands (Alabert and Groth, 2012; Annunziato, 2005; Margueron and 
Reinberg, 2010; Probst et al., 2009). Parental H3/H4 dimers tend to stay together as 
tetramers, H2A/H2B are loaded as dimers (Jackson, 1988; Xu et al., 2010). New and 
parental tetramers are evenly distributed on average. Importantly, this means that the 
simplest conceptual model for histone modification propagation—copying of histone 
modifications within the same nucleosome—is not possible for H3 and H4 as both copies 
of each are either parental or new. The parental histones retain their post-translational 
marks (Alabert et al., 2015); the mechanism by which the modifications are copied onto 
new histones remains unclear. There are currently two models which apply to different 
modifications. For most histone modifications, new histones acquire modifications to 
become identical to the old ones. Before the next cell cycle, within 2-24 hours, the 
modifications are written on the new histones until they become identical to the parental 
histones (Alabert et al., 2015). Therefore, histone modification writing is not tightly 
coupled to replication, and oscillates with the cell cycle.  
The buffer model proposed by (Huang et al., 2013) applies to the repressive 
heterochromatin marks H3K27me and H3K9me. The buffer model protects constitutively 
silent genes from being activated by varying repressive mark levels after DNA 
replication. In general, repressive marks are found across large regions and function by 
recruiting effector proteins that shape the region to become inaccessible (Boyer et al., 
2006). As such, exact replication of each histone modification after cell division is not 
necessary for gene repression. Huang et al. (2013) propose relatively few nucleosomes 
(20-30%) must bear repressive modifications to repress transcriptional activity. 
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Therefore, the system functions as a buffer, wherein the levels of repressive marks never 
drop below the critical threshold and remain non-permissive to transcription. This model 
is supported by experimental evidence, which shows that the repressive H3K27me3 and 
H3K9me3 methylations are slowly written on new histones after replication. Further, 
even old histones acquired more H3K27me3 and H3K9me3 to reach pre-mitosis levels 
after replication (Alabert et al., 2015).  
2.2.4 Methods to Study Histone Modification  
Nearly all technologies to assess histone modification rely on chromatin 
immunoprecipitation. First devised in the 1970s, chromatin Immunoprecipitation (ChIP) 
relies on a specific antibody to pull down a protein of interest and its interacting genomic 
DNA (Jackson, 1978). In the case of histone analyses, the antibody is specific to a histone 
modification of interest. After the DNA is isolated and purified, it can be assessed using a 
number of approaches. Techniques including PCR (ChIP-qPCR), microarray (ChIP-
chip), and sequencing (ChIP-seq) are the most popular (Collas, 2010). In each case, the 
data are output in “peaks” of DNA enrichment (Wilbanks and Facciotti, 2010).  
ChIP-seq and ChIP-chip are the most common methods used to assess whole-
genome changes in histone modification, while ChIP-qPCR is popular for assessing 
specific loci. ChIP-chip has the advantage of utilizing the diversity of commercially 
available microarrays, allowing researchers control over experimental scale. In contrast, 
ChIP-seq examines the entire genome with greater resolution, and reduced signal-to-
noise ratio allowing identification of more subtle binding events (Massie and Mills, 
2012). ChIP-chip is more economical than ChIP-seq; however as sequencing 
technologies advance, the price differential is becoming less dramatic. Microarrays are 
limited in resolution compared to sequencing (Park, 2009). This is important for 
identifying protein binding sites, but is less crucial for identifying histone modification 
domains. Pinpointing individual histone binding sites is difficult with microarrays 
however.  
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2.2.5 Histones and Fetal Alcohol Spectrum Disorders 
Ethanol has long been known to be an epigenetic disruptor. Garro et al., (1991) 
found for the first time that fetuses exposed to ethanol had inhibited DNA 
methyltransferase 1 (DNMT1) activity. Further, this inhibition was attributed to the first 
metabolite of ethanol, acetaldehyde (Garro et al., 1991). Since this study, ethanol has 
been found to impact methylation pathways in other direct and indirect ways (Figure 
2.1). Ethanol inhibits folate absorption in both the intestine and kidney in part by 
downregulating the expression of its transporter reduced folate carrier 1 (RFC1) (Hamid 
and Kaur, 2005, 2007a). Reduced folate absorption impairs pyrimidine synthesis and 
therefore DNA synthesis (Figure 2.1). Further, acetaldehyde inhibits methionine 
synthase which converts homocysteine to methionine. (Halsted et al., 2002). These 
actions reduce the availability of s-adenosylmethionine (SAM) which is the primary 
substrate of methyltransferases and source of methyl groups.  
Ethanol also induces oxidative stress as a primary effect and through its 
metabolism which can alter methylation pathways. Conversion of ethanol to acetaldehyde 
and acetate produces reactive oxygen species (ROS) directly via CYP2E1 and via 
increased NADH levels (Figure 2.2). Ethanol-induced mitochondrial damage produces 
additional ROS (Hoek et al., 2002). Increased ROS has numerous damaging effects on 
macromolecules including DNA. Specifically, the hydroxyl radical causes mutations 
including base substitutions, deletions, single and DSBs (Hoek et al., 2002). Single 
stranded DNA can signal de novo DNMTs causing hyper-methylation of these regions 
(Christman et al., 1995). With respect to methylation enzymes, under oxidative 
conditions, homocysteine is converted to the ROS scavenging glutathione, depleting 
SAM and reducing methylation (Figure 2.2; Kerksick and Willoughby, 2005). Ethanol 
also impacts acetylation pathways. The metabolism of ethanol produces acetaldehyde 
followed by acetate then acetyl-CoA. Acetyl-CoA is the substrate HATs use as an acetyl 
group source (Figure 2.2).  
2.2.6 Effect of Ethanol on Histone Modification 
The first studies on histone modification and alcohol were focused on the effects 
of ethanol directly on liver cells. They provided several key insights into how histone  
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Figure 2.1 Inhibitory actions of ethanol on one-carbon metabolism. 
Dotted lines indicate indirect inhibitory actions. Ethanol indirectly inhibits the folate 
cycle (left) by its first metabolite acetaldehyde inhibiting MTR (Kenyon et al., 1998) and 
by blocking folate uptake via RFC1 by downregulating its expression (Hamid and Kaur, 
2007b). Ethanol induced oxidative stress (Figure 2.2) irreversibly inactivates MAT I and 
III in the liver (Seitz and Stickel, 2007). AHCY: adenosylhomocysteinase; DHF: 
dihydrofolate; DHFR: dihydrofolate reductase; dTMP: deoxythymidine monophosphate; 
dUMP: deoxyuridine monophosphate; G9a: also known as EHMT2: euchromatic histone-
lysine N-methyltransferase 2; MAT: methionine adenosyl transferase; 5-MTHF: 5-
methyltetrahydrofolate; 5,10-MTHF: 5,10-methylenetetrahydrofolate; MTHFR: 
methylenetetrahydrofolate reductase; MTR: methionine synthase; RFC1: reduced folate 
carrier 1; SAH: S-adenosylhomocysteine; SAM: S-adenosylmethionine; THF: 
tetrahydrofolate; TS: thymidylate synthase. Reprinted from Chater-Diehl et al., (2017) 
with permission from Elsevier (Appendix I).  
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Figure 2.2 Effects of the ethanol metabolism on epigenetic modifications. 
Slashed lines indicate reduction/impairment of that step. Dashed lines indicate simplified 
mechanism. Ethanol is metabolized to acetaldehyde, the acetate, both of which produce 
NADH which led to increased ROS production. Ethanol also induces mitochondrial 
damage which leads to further ROS production (Hoek et al., 2002). Oxidative conditions 
drive production of glutathione, deleting SAM and therefore reducing methyl-donors for 
histone (and other) methylation. Increased acetyl-CoA as a result of ethanol metabolism 
drives histone (and other protein) acetylation. Depletion of NAD+ by ethanol metabolism 
reduces the activity of NAD+-dependent sirtins, which prevents histone de-acetylation. 
Metabolism of ethanol to acetaldehyde by CYP2E1 is simplified, not shown is 
intermediate production of gem-diol and water, which convert to acetaldehyde and an 
oxygen radical (shown as ROS above). Conversion of homocysteine to glutathione is 
greatly simplified. Conversion of SAM to homocysteine is simplified (Figure 2.1). ACS: 
acetyl-CoA synthetase; ADH: alcohol dehydrogenases; ALDH: aldehyde dehydrogenase; 
CYP2E1: cytochrome P450 2E1; HAT: histone acetyltransferase; ROS: reactive oxygen 
species; SAM: S-adenosylmethionine. Reprinted from Chater-Diehl et al., (2017) with 
permission from Elsevier (Appendix I). 
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modifications respond to ethanol. These studies found that H3K9ac (and not other lysine 
acetylations) was increased in a time- and dose-dependent manner in (Kim and Shukla, 
2005; Park et al., 2003). In 2007, Pal-Bhadra et al. examined H3K9me2 and H3K4me2 in 
cultured hepatocytes. There were site-specific histone modification changes correlated 
with gene expression changes in response to ethanol (Pal-Bhadra et al., 2007). H3K9me2 
reduction and H3K4me2 increase occurred in the upregulated genes. In the 
downregulated genes, H3K9me2 increased with little H3K4me2 (Pal-Bhadra et al., 
2007).  This study showed that changes in histone modification can be correlated with 
changes in gene expression, implying that they do have functional relevance.   
 Since these early studies, 15 publications have examined histone modifications 
specifically in response to fetal ethanol exposure (Chater-Diehl et al., 2017). The first 
study of histone modifications in the brain in FASD used inhalation exposure of rat pups 
to ethanol from P2-12 (Guo et al., 2011). This study found reduced acetylated histone H3 
(AcH3) and H4 (AcH4) in cerebellum. In two studies, C57BL/6J mice were exposed to 
ethanol using a PND 7 dual injection model. Expression and activity of the HMT G9a 
mRNA, protein expression, and protein activity were increased after ethanol exposure in 
both hippocampus in neocortex (Subbanna et al., 2013, 2014). G9a catalyzes H3K27me3 
(facilitating conversion to H3K27me3) and is involved in early synaptic remodeling 
(Schaefer et al., 2009; Shinkai and Tachibana, 2011; Tachibana, 2002). PND 7 ethanol 
exposure was associated with increased H3K9me2 and H3K27me2 as well as apoptotic 
neurodegeneration. Treatment with the G9a inhibitor Bix prior to ethanol exposure 
prevented these effects (Subbanna et al., 2014; Subbanna et al., 2013). 
Two papers from Rajesh Miranda and Michael Golding’s group have examined 
the effects of gestational ethanol exposure on H3K4me3 and H3K27me3 changes at 
specific genes in the brain. Using neurospheres from fetal mice cultured in ethanol, the 
investigators found that Hox and other gene promoters had reduced H3K4me3 (Veazey, 
Carnahan, Muller, Miranda, & Golding, 2013). This study also used ChIP-qPCR of 
repetitive transposable element sequences—up to 45% of the human genome—as a proxy 
for genome-wide H3K4me3 and H3K27me3 changes (Slotkin and Martienssen, 2007). 
There was significant reduction of H3K27me3 for all investigated transposon types. 
There was also a trend toward reduction in H3K4me3 though it was non-significant 
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(Veazey et al., 2013). In a follow-up study, these authors examined how histone 
modification at specific genes changed following recovery from ethanol, and compared 
these changes to an in vivo mouse model. In general, after 3 days of ethanol exposure 
there were modest H3K4me3 changes, more pronounced H3K27me3 H3K9ac changes 
and large-scale H3K9me2 changes (Veazey et al., 2015). After a four day recovery 
period, the closed-chromatin marks (H3K27me3 and H3K9me2) became greatly enriched 
(Veazey et al., 2015). In an in vivo model, the histone modification profile of malformed 
ethanol-exposed pups correlated with the cell culture data: there was a reduction of 
H3K27me3 at more than half of the candidates, an enrichment of H3K9ac at some, and a 
dramatic increase in H3K9me2 at most (Veazey et al., 2015). The robust closed-
chromatin mark changes are interesting as H3K9 and H3K27 methylations are stable and 
heritable through development likely replicating through the buffer model, acting as true 
epigenetic marks of repressed chromatin (Chater-Diehl et al., 2017; Huang et al., 2013). 
They are thus are very strong candidates for the transmission of a lasting ethanol-induced 
signature (Veazey et al., 2015).  
 These studies have investigated several histone methylations globally and at 
specific genes very soon after ethanol exposure. Only two previous studies from the same 
group have examined histone modifications in adult rats in response to PAE. After 
exposure to ethanol from GD 7-21, the rats matured to PND 60-80 when cells from 
POMC cells in the hypothalamus were collected. There were reduced numbers of 
H3K4me2,3-positive POMC cells, increased H3K9me2-positive POMC cells, and a 
reduced H3K9ac-positive POMC (Bekdash et al., 2013; Govorko et al., 2012). To date, 
no other study has examined specific genome-wide changes in histone modifications in 
response to fetal ethanol, and very few have explored changes in adult mice.  
2.2.7 H3K4me3 and H3K27me3 Study Background  
In this chapter, H3K4me3 and H3K27me3 are assessed for changes across all 
promoters in the PND 70 mouse hippocampus in the PND 4,7 treatment model. Regions 
of differential histone modification (RDHMs) were identified for H3K4me3 and 
H3K27me3 as were genes proximal to these regions. Gene ontology and pathway 
analysis were used to identify the functional categories of these genes and the potential 
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biological impact of their differential methylation. Both the pathway analysis and 
previous work from our laboratory focused the analysis of this chapter on CCCTC-
binding factor (CTCF) and imprinted loci.  
CTCF is a highly conserved, ubiquitous protein involved in diverse processes 
such as transcriptional regulation and organization of chromatin architecture. CTCF 
creates three dimensional chromatin domains in which it promotes specific regulatory 
interactions that positively or negatively affect transcription (Ong and Corces, 2014). 
CTCF creates DNA loops at the Pcdha and Pcdhg genes, likely to bring isoform 
promoters into contact with enhancers and transcriptional machinery (Golan-Mashiach et 
al., 2012). The interactions of CTCF are dependent on specific patterns of DNA 
methylation within its binding motifs (Golan-Mashiach et al., 2012; Wang et al., 2012). 
In this chapter, CTCF binding motifs in RDHMs are identified and characterized.  
CTCF is critical for regulating genomic imprinting. Genomic imprinting refers to 
the expression of genes in a parent-of-origin-specific manner (Bartolomei and Tilghman, 
1997). The regulation of gene expression is accomplished with methylation and 
repression of one parental copy of the locus (the imprinted allele) while the other is 
demethylated and expressed (Morgan et al., 2005). These patterns are established early in 
development and are critical for normal cellular function, with aberrations leading to a 
host of genetic disorders (Butler, 2009). CTCF has numerous functions at imprinting loci, 
including binding to methylated DNA and preventing enhancer-promoter interactions and 
repressing gene expression (Holwerda and de Laat, 2013). In this chapter, the relationship 
between histone methylation, CTCF, and imprinted loci are explored in the context of 
FASD.  
Objectives  
1. To assess all mouse genes and their promoters in adult mouse hippocampus 
exposed to ethanol on postnatal days 4 & 7 and identify changes in H3K4me3 and 
H3K27me3 
2. To identify genes and pathways proximal to changes in H3K4me3, H3K27me3, 
and both.  
3. To confirm specific changes with ChIP-qPCR  
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 Materials and Methods  
2.3.1 Mouse Care 
Protocols were approved by the Animal Use Subcommittee (AUS) at the 
University of Western Ontario, London, Ontario, Canada (Appendix A). C57BL/6J (B6) 
mice were originally obtained from Jackson Laboratories (Bar Harbor, MA) and a 
population was subsequently maintained at the Animal Care Facility at the University of 
Western Ontario. Mice were housed in standard shoe-box sized cages and given access to 
water and food (Lab-Diet® 5P00 ProLab® RMH 3000 (St. Louis, MO)) ad libitum. 
Environmental conditions were maintained at a temperature range of 19-22ºC, a humidity 
range of 40%-60% and a 14/10-hour light/dark cycle. 25 female mice age 12-18 weeks 
were separated into individual cages and mated with males of approximately the same 
age. The male was removed once the female was visibly pregnant. The day of birth was 
PND zero.  
Sex and weight-matched littermate pups were divided into two groups: ethanol-
treated and saline control. Pups were given two subcutaneous dorsal injections at 9 am 
and 11 am on both PND 4 and PND 7 using 30 gauge BD PrecisionGlide™ needles. 
Ethanol-treated mice were injected with 2.5 g/kg of ethanol in 0.15 M NaCl 
(Ikonomidou, 2000). This protocol produces blood alcohol concentrations above the toxic 
threshold of 200 mg/dl for over eight hours (Wozniak et al., 2004). Control mice were 
injected with 0.15 M saline. Pups were weaned on PND 21 and housed in cages of two to 
four same-sex littermates. Male mice were used for all subsequent analyses (n=18). Mice 
were sacrificed on PND 70 via carbon dioxide asphyxiation followed by cervical 
dislocation. The hippocampus was dissected out (Spijker, 2011), snap-frozen in liquid 
nitrogen, and stored at -80°C. Mice were divided among gene expression, DNA 
methylation, and histone modification experiments (Table 2.1). Treatment groups 
(control vs. ethanol-exposed) always contained littermates for each microarray 
comparison. Mice from the same litter were not repeated in the same microarray 
experiment. The same litters were represented in each microarray experiment.  
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Table 2.1 Allocation of mouse litters within and between microarray studies†.  
Histone methylation  
Array 1 Array 2 Array 3 
E5.2 C5.4 E10.4 C10.6 E11.3 C11.4 
E12.5 C12.1 E16.5 C16.4 E17.3 C17.4 
E19.1 C19.2 E19.5 C19.6 E20.5 C20.6 
Gene/miRNA expression and DNA methylation  
Array 1 Array 2 Array 3 
E5.1 C5.3 E10.3 C10.5 E11.1 C11.2 
E12.4 C12.2 E16.3 C16.2 E17.1 C17.2 
E19.4 C19.4 E19.7 C19.8 E20.3 C20.4 
†Each alphanumeric code refers to a single mouse. The first letter refers to ethanol-
exposed (E) or control (C); the number after the letter refers to the litter number; the 
number after the period refers to the individual mouse. Each for each individual array, the 
three samples were pooled together. Mice used for the DNA methylation microarray 
experiment are in italics, which were not pooled with any other samples.   
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2.3.2 Chromatin Immunoprecipitation Microarray (ChIP-chip) 
2.3.2.1 Chromatin Immunoprecipitation   
Hippocampal tissue samples were thawed on ice then treated with 1% 
formaldehyde for five minutes and sonicated with the truChIPTM Tissue Prep Kit for SDS 
Chromatin Shearing (Covaris) and the Covaris® S2 Sonicator (Woburn, MA, USA) 
according to the manufacturer’s protocol. The EpiQuik™ Tissue Chromatin 
Immunoprecipitation Kit (Epigentek) was used to perform ChIP. After sonication, 
samples were divided and immunoprecipitated with ChIP-grade polyclonal antibodies 
anti-H3K4me3 (Epigentek cat # A-4033) and anti-H3K27me3 (Millipore cat #07-499). 
Two microarray experiments were performed, one for each methylation state using the 
same chromatin sample from the same mice for each. Immunoprecipitated samples were 
sent to ArrayStar Inc. (Rockville, MD, USA). ArrayStar performed whole-genome 
amplification, target preparation DNA labelling, array hybridization, scanning, and data 
summarization.  
2.3.2.2 Whole Genome Amplification (WGA) and DNA Labelling  
The enriched DNA was amplified using a WGA kit from Sigma-Aldrich (the 
GenomePlex® Complete Whole Genome Amplification (WGA2) kit). The amplified 
DNA samples were then purified with QIAquick PCR purification kit (Qiagen). The 
NimbleGen Dual-Color DNA Labeling Kit was used according to the manufacturer’s 
NimbleGen ChIP-on-chip protocol (Nimblegen Systems, Inc., Madison, WI, USA). One 
μg of DNA from each sample was incubated for 10 min at 98°C with 1 OD of Cy5-9mer 
primer (IP sample) or Cy3-9mer primer (input sample). Then, 100 pmol of 
deoxynucleoside triphosphates and 100U of the Klenow fragment (New England Biolabs, 
USA) was added and incubated at 37°C for 2 hours. The reaction was stopped by adding 
0.1 volume of 0.5 M EDTA. The labelled DNA was purified by isopropanol/ethanol 
precipitation.  
2.3.2.3 Microarray Hybridization 
Microarrays were hybridized at 42°C for four hours with 4μg of Cy3/5 labelled 
DNA in Nimblegen hybridization buffer/ hybridization component A in a hybridization 
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chamber (Nimblegen Systems, Inc., Madison, WI, USA). Washing was performed after 
hybridization using the Nimblegen Wash Buffer kit (Nimblegen Systems, Inc., Madison, 
WI, USA). For array hybridization, Roche NimbleGen's Mouse ChIP-chip 2.1M Deluxe 
Promoter Array was used. Samples were pooled in triplicate and hybridized to three 
arrays for each treatment; i.e. 9 ethanol-treated mice on three arrays were compared to 9 
litter-matched controls on three arrays. Scanning was performed with the Axon GenePix 
4000B microarray scanner. Raw data were extracted as pair files by NimbleScan 
software. The files were uploaded to GEO (Series record GSE61488).  
2.3.2.4 Microarray analysis  
The .pair files were analyzed utilizing the tiling workflow provided in Partek 
Genomics Suite® version 6.6 (St. Louis, Missouri, USA). Nimblegen .pair files 
(representing the 635 nm and 532 nm scans) for each sample were normalized using the 
default methods of normalization in the tiling workflow in Partek. The default method 
includes adjustments for probe sequence, background correction, quantile normalization, 
and Log (base 2) transformation. In addition, to ensure quality, Principal Components 
Analysis (PCA) was performed. Files were annotated against the mm9 mouse genome 
build and enriched regions were detected using a one-way ANOVA to compare 
enrichment between the ethanol-exposed and control groups: three ethanol-exposed 
mouse arrays contrasted to the three matched control mouse arrays. The enriched regions 
settings were set at a minimum p-value of 0.01 and the number of probes to call a region 
was set at a minimum of five. The Model-based Analysis of Tiling-arrays (MAT) 
algorithm was used to detect enriched regions [64]. The MAT algorithm is designed to 
detect enriched regions in tiling ChIP-chip experiments, and provides a score for the 
degree of enrichment between experimental samples or groups of samples. A list of 
regions with MAT scores and corresponding p-values was the output. These regions with 
differential histone methylation (RDHMs) were scored to overlap with RefSeq (2014-01-
03 version) genes when they were present in the gene body or within 5000 bp upstream 
or 3000 bp downstream of the transcriptional start site. The list of gene names 
overlapping RDHMs with a MAT p-value<0.001 were generated. A false discovery rate 
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(FDR) q-value < 0.05 was used to assess multiple testing error. No RDHMs passed this 
threshold.  
The list of gene names from Partek were submitted as text files to Ingenuity 
Pathway Analysis (Ingenuity Systems Inc, CA, USA), Partek Pathway (Fishers Exact 
Test), and Enrichr to determine overrepresented genes using gene ontology (GO) 
analysis. A cut-off of p<0.05 was used to determine significant pathways for all software 
programs. 
2.3.3 CTCF Motif Prediction   
To determine putative CTCF sites in the identified RDHMs, the online CTCFBS 
database was used (Zentner and Henikoff, 2013). RDHM sequences were extracted from 
the UCSC genome browser. Five additional nucleotides were extracted at the 5’ and 3’ 
ends of the RDHM to capture for CTCF sequences that may only partially overlap in the 
RDHM. The sequences were submitted to CTCFBS’s prediction tool. The position 
weight matrices (PWM) score associated with each predicted CTCF site was used to 
identify significant predictions; a cut-off of PWM > 3 was used to identify matches as 
recommended by the CTCFBSDB creators.  
2.3.4 ChIP-qPCR 
ChIP was performed on independent biological samples. Mice were treated with 
ethanol or saline and hippocampus was isolated as described above. Five ethanol-exposed 
and five control mice were generated. ChIP was performed against H3K27me3 as 
described above. Input DNA was compared against H3K27me3 enrichment and normal 
mouse IgG (background control) enrichment using SYBR green-based real time PCR. 
qPCR was performed using SsoAdvanced™ Universal SYBR® Green Supermix 
(BioRad) according the manufacture’s protocol on the CFX Connect™ Real-Time PCR 
Detection System (BioRad). Primer sequences were as follows: Snrpn forward 
TCCACATCCTTGTCAGCATC, reverse TCAAAAATTCAGGTGACAGCA; 
Snord 1 forward AGATTGCTTTTGGCCATCC, reverse 
GCCTGAGAACTTTTCACCAGA; Snord 3 forward CCACCTTGTCATGAGATTGC, 
reverse GAGATCAAAGCAGGGATGGA; Ipw forward 
CCACCTTGTCATGAGATTGC reverse GAGATCAAAGCAGGGATGGA; 
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PCDHb5/a9 forward TTTTCCCAAGTGGCAGAGAC, reverse 
AACTCTGTCTCCCTTGAACTGC. The efficiency of each primer pair was calculated 
using a standard curve. The Pcdhb5/a9 primers did not fall within the acceptable 90-
110% efficiency and were not pursued further. After amplification, the raw Ct values 
were corrected based on reaction efficiency. Enrichment was calculated as % enrichment 
= 100% x efficiency^(input Ct-K3K27me3 Ct) and  reported as average percent 
H3K27me3 enrichment ± standard error. Significant differences were assessed using a 
Paired Samples t-Test. 
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 Results  
2.4.1 Distribution of Histone Modification Changes  
To define significant regions of differential histone modification (RDHMs), a 
Model-based Analysis of Tiling-arrays (MAT) score p-value cut-off of p<0.001 was 
used. At this significance level, there were 625 unique H3K4me3 RDHMs and 165 
unique H3K27me3 RDHMs (Figure 2.3). For H3K4me3, 29% (181) of RDHMs had a 
negative MAT score indicating increased methylation (Figure 2.4); for H3K27me3, 16% 
(26) of RDHMs had a negative MAT score (Figure 2.4). Thirteen regions had a change 
in both H3K4me3 and H3K27me3.   
The RDHMs were unevenly distributed across chromosomes (Figure 2.5). For 
H3K4me3, chromosomes 7 and 11 had the most RDHMs. Most chromosomes mirrored 
the positive MAT/negative MAT ratio of the genome overall i.e. they had more RDHMs 
with more negative MAT scores than positive; however, chromosomes 11-15 did not. 
Each of these had more positive MAT RDHMs, with chromosome 14 having all positive 
MAT RDHMs (Figure 2.5). For H3K27me3, chromosomes 2, 7, and 11 had the most 
RDHMs (Figure 2.5). Most chromosomes displayed the same positive MAT/negative 
MAT ratio of the genome overall. i.e. they had more RDHMs with more positive MAT 
scores than negative. An exception was chromosome 18 which had much more negative 
than positive (Figure 2.5).  
Since the experiment employed a promoter microarray, chromosomes with more 
genes were interrogated more often. The RDMHs per chromosome were therefore 
corrected based on gene density (Figure 2.6). Chromosomes 7 and 11 are very gene-
dense, and as such their enrichment was somewhat normalized. Nevertheless, 
chromosome 11 along with 15 and 18 had the most H3K4me3 RDHMs per gene. 
Chromosome 15 also had the most H3K27me3 RDHMs per gene (Figure 2.6). 
Chromosome 3 and the X chromosome were depleted of RDHMs of both methylations. A 
linear regression of the number of genes per chromosome vs. the number of RDHMs 
found R2 values of 0.51 for H3K4me3 and 0.30 for H3K27me3 (Appendix C). These 
values indicate a modest correlation between these two variables, suggesting other factors 
account for a substantial portion of the variation in RDHM distribution.  
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Figure 2.3 Genomic overview of regions of differential H3K4me3 and H3K27me3.  
Negative MAT score (red) indicates increased methylation, positive (blue) indicates 
decreased methylation. Track A shows H3K4me3 regions of differential histone 
modification (RDHMs) p<0.001; track B shows H3K27me3 RDHMs p<0.001. 
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Figure 2.4 H3K4me3 and H3K27me3 regions with differential histone methylation 
(RDHMs) and proximal genes. 
Venn diagrams show numbers of unique A) RDHMs and B) genes identified at MAT 
score p-value cut-off of p<0.001 (two-way ANOVA).  
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Figure 2.5 Distribution of regions with differential histone methylation (RDHMs) 
across chromosomes. 
Bars show the number of RDHMs present on each chromosome at MAT p<0.001. Black 
denotes RDHMs with a positive MAT score indicating depleted methylation, while white 
denotes RDHMs with a negative MAT score indicating enriched methylation.  
44 
 
 
Figure 2.6 Distribution of regions with differential histone methylation (RDHMs) 
across chromosomes corrected for gene density. 
The number of RDHMs on each chromosome was divided by the total number of genes 
(from build mm10) on each chromosome.   
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2.4.2 Ontology of Genes Proximal to Histone Modification 
Changes  
A list of genes potentially affected by RDHMs was next assembled. Genes were 
included in the list if their promoter (defined as -5000 to 0 bp relative to the 
transcriptional start site), or gene body contained at least one RDHM. For H3K4me3, 
61% of RDHMs lay in gene promoters while 39% lay in gene bodies (including introns). 
For H3K27me3, 68% of RDHMs lay in gene promoters, while 32% lay in gene bodies. 
There were 797 genes proximal to H3K4me3 RDHMs, 227 genes proximal to 
H3K27me3 RDHMs, and 33 genes proximal to both (Figure 2.4). 
To identify genetic systems affected by H3K4me3 changes in the PND 4,7 FASD 
model, gene ontology (GO) analysis was performed. The list of 797 genes proximal to a 
H3K4me3 RDHM was used for GO analysis using Enrichr (Chen et al., 2013) (Table 
2.2). Enricher determined biological processes, cellular components, molecular functions 
overrepresented in the gene list. The top affected biological processes for this gene set 
was “Cell-cell adhesion via plasma-membrane adhesion molecules”. The penultimate 
affected biological process was also related to cell-cell adhesion (Table 2.2). Three of the 
top ten biological processes were also related to the nervous system, and two were related 
to kinase signaling (Table 2.2). The top affected cellular component was “Ionotropic 
glutamate receptor complex”, with five other entries related to neurons, three of which 
were synapse-specific (Table 2.2). Other components included cytosolic and 
cytoskeleton proteins. The top affected molecular function was “Calcium ion binding”. 
Nine of the top ten entries were related to substrate binding, including phosphoprotein, 
phosphorylated amino acid, Ras GTPase, Rab GTPase binding. The other was “Receptor 
signaling complex scaffold activity” (Table 2.2). In summary, the GO analysis implicates 
synaptic, cell adhesion, and signal transduction genes as affected by H3K4me3 changes.  
The list of 227 genes proximal to a H3K27me3 RDHM was used for GO analysis 
using Enrichr (Chen et al., 2013) (Table 2.3). Similar to the H3K4me3 genes, the top 
affected biological process was “Homophilic cell adhesion via plasma membrane 
adhesion molecules”, and the second and third processes were also cell-cell   
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Table 2.2 Gene ontology (GO) analysis of genes with regions of differential 
H3K4me3 in their promoter†. 
GO biological process  
   GO term p-value 
Cell-cell adhesion via plasma-membrane adhesion molecules 
(GO:0098742) 
1.49E-09 
Cell-cell adhesion (GO:0098609) 1.66E-09 
Nervous system development (GO:0007399) 0.003 
Negative regulation of growth (GO:0045926) 0.0033 
Regulation of neuron differentiation (GO:0045664) 0.0036 
Sympathetic nervous system development (GO:0048485) 0.0042 
Regulation of stress-activated MAPK cascade (GO:0032872) 0.0042 
Cellular response to organonitrogen compound (GO:0071417) 0.0043 
Regulation of stress-activated protein kinase signaling cascade 
(GO:0070302) 
0.0044 
   GO cellular component 
Ionotropic glutamate receptor complex (GO:0008328) 0.002 
Spectrin-associated cytoskeleton (GO:0014731) 0.0045 
Synaptic membrane (GO:0097060) 0.0056 
Postsynaptic membrane (GO:0045211) 0.0078 
Transcription factor complex (GO:0005667) 0.011 
Cell body (GO:0044297) 0.012 
Neuronal cell body (GO:0043025) 0.023 
Axon (GO:0030424) 0.023 
Cytosol (GO:0005829) 0.027 
Synapse part (GO:0044456) 0.028 
   GO molecular function  
Calcium ion binding (GO:0005509) 0.00012 
Phosphoprotein binding (GO:0051219) 0.00091 
Receptor signaling complex scaffold activity (GO:0030159) 0.007 
Protein phosphorylated amino acid binding (GO:0045309) 0.0081 
Vinculin binding (GO:0017166) 0.011 
Ras GTPase binding (GO:0017016) 0.011 
SH3 domain binding (GO:0017124) 0.013 
Rab GTPase binding (GO:0017137) 0.013 
Gamma-catenin binding (GO:0045295) 0.013 
GTPase binding (GO:0051020) 0.015 
†The top ten GO terms are shown where the number of entries exceeds ten. GO 
identification numbers are shown for each term. p-values for each entry are shown 
(Fisher’s exact test). 
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Table 2.3 Gene ontology (GO) analysis of genes with regions of differential 
H3K27me3 in their promoter†. 
GO biological process 
   GO term p-value 
Homophilic cell adhesion via plasma membrane adhesion molecules 
(GO:0007156) 
9.48E-10 
Cell-cell adhesion via plasma-membrane adhesion molecules 
(GO:0098742) 
2.52E-08 
Cell-cell adhesion (GO:0098609) 2.67E-08 
Mammary gland development (GO:0030879) 6.15E-05 
Neuron fate specification (GO:0048665) 0.0015 
Proximal/distal pattern formation (GO:0009954) 0.0018 
Negative regulation of cell aging (GO:0090344) 0.0056 
Insulin-like growth factor receptor signaling pathway (GO:0048009) 0.0084 
Fibril organization (GO:0097435) 0.0084 
Mitochondrial calcium ion homeostasis (GO:0051560) 0.0095 
   GO cellular component 
Microfibril (GO:0001527) 0.0032 
Fibril (GO:0043205) 0.006 
Intermediate filament cytoskeleton (GO:0045111) 0.011 
Integral component of mitochondrial membrane (GO:0032592) 0.038 
Golgi apparatus (GO:0005794) 0.043 
   GO molecular function 
Calcium ion binding (GO:0005509) 0.00011 
Pre-mRNA binding (GO:0036002) 0.0071 
Ankyrin binding (GO:0030506) 0.016 
Extracellular matrix structural constituent (GO:0005201) 0.023 
Core promoter sequence-specific DNA binding (GO:0001046) 0.025 
Galactosyltransferase activity (GO:0008378) 0.038 
Oxygen binding (GO:0019825) 0.044 
†Top 10 GO processes are shown where number of entries exceeds 10. GO identification 
numbers are shown for each term. p-values for each entry are shown (Fisher’s exact test).  
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adhesion related (Table 2.3). FASD-relevant biological processes include “Neuron fate 
specification” and “Insulin-like growth factor receptor signaling pathway”. The top two 
affected cellular components were “Microfibril” and “Fibril” with several other structural 
components implicated (Table 2.3). The affected biological functions did not show any 
trends, several binding activies were implicated including “Calcium ion binding”, “pre-
mRNA binding”, and “Oxygen binding” (Table 2.3).  
2.4.3 Pathways Affected by Histone Methylation Changes  
The set of enriched H3K4me3 genes was also submitted to three separate pathway 
suites: Ingenuity Pathway Analysis (IPA), Partek Pathway, and Enrichr. The most 
common process identified by each software suite was fatty acid metabolism, with 10 
pathways identified across the three software platforms (Table 2.4). The top lipid-related 
IPA network identified was “Endocrine System Development and Function, Lipid 
Metabolism, Small Molecule Biochemistry” (Figure 2.7). IPA canonical pathways 
identified include “Fatty acid β-oxidation”, “Sphingomyelin metabolism”, and “Fatty 
acid metabolism” (Table 2.4). Patek pathway and Enrichr also identified “Sphingolipid 
metabolism”. The individual genes present in the H3K4me3 list driving the identification 
of these pathways include β-oxidation enzymes (Acsl4, Acsl6), lipases (Pnpla2, Lipe), 
sialidases (Neu1, Neu2), sphingomyelinases (Smpd4, Smpd3), pre-angiotensinogens (Agt) 
and oxidoreductases (Ecsit). Importantly, there is little redundancy in the genes identified 
between these pathways, indicating diversity of affected lipid genes that cannot be 
captured by one software alone. Other pathways identified include cell morphology, 
development, and survival IPA networks, and cancer signaling pathways identified by 
both IPA and Partek pathway (Table 2.4). 
Unlike H3K4me3, the alterations in H3K27me3 methylation following ethanol 
exposure appear to affect relatively few networks (Table 2.5). Predominantly, they affect 
processes such as endocrine system development and function, molecular transport and 
protein synthesis.  The canonical pathways identified by IPA are enriched for 
biosynthetic processes including eumelanin, myo-inositol, and proline biosynthesis. 
Partek pathway analysis also identified two pathways, “Tyrosine metabolism” and  
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Table 2.4 Pathways identified from each software suite in the genes in proximity to 
H3K4me3 changes†.  
Pathway name  p-value  
    IPA network/pathway 
Carbohydrate Metabolism, Molecular Transport, Small Molecule 
Biochemistry 
10E-63 
Hematological System Development and Function, Tissue Morphology, 
Cell Death and Survival 
10E-49 
Humoral Immune Response, Protein Synthesis, Cellular Function and 
Maintenance 
10E-31 
 
Endocrine System Disorders, Gastrointestinal Disease, Immunological 
Disease 
10E-25 
Endocrine System Development and Function, Lipid Metabolism, Small 
Molecule Biochemistry 
10E-24 
Cellular Development, Cellular Growth and Proliferation, Cancer 10E-24 
Cell Morphology, Connective Tissue Development and Function, Cellular 
Development 
10E-23 
Energy Production, Lipid Metabolism, Small Molecule Biochemistry 10E-22 
Endocrine System Development and Function, Carbohydrate Metabolism, 
Molecular Transport 
10E-20 
Cellular Growth and Proliferation, Cell Morphology, Cellular Assembly 
and Organization 
10E-20 
Embryonic Development, Organismal Development, Gene Expression 10E-18 
Cellular Movement, Immune Cell Trafficking, Hematological System 
Development and Function 
10E-17 
Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry 10E-14 
     IPA canonical 
Regulation of cellular mechanics by calpain protease  0.0039 
Fatty acid β-oxidation  0.0044 
Amyotrophic lateral sclerosis signaling  0.0088 
Bladder cancer signaling  0.013 
Thyroid cancer signaling  0.014 
Giloma invasiveness signaling  0.016 
Non-small cell lung cancer signalling  0.029 
Sphingomyelin metabolism  0.032 
Estrogen biosynthesis  0.035 
Spliceosomal cycle  0.038 
FGF signaling  0.040 
TREM1 signaling  0.045 
FAK signaling  0.048 
     Partek Pathway 
Pathways in cancer 0.034 
Fatty acid metabolism  0.035 
Sphingolipid metabolism  0.040 
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    Enrichr KEGG 
MAPK Signaling pathway  0.041 
Sphingolipid metabolism 0.046 
†p-values provided for each pathway are shown (Fishers exact test). Lists of genes present 
in each pathway are found in Appendix D.  
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Figure 2.7 Top lipid-related Ingenuity Pathway Analysis (IPA) network from 
H3K4me3 affected genes.  
The pathway is termed “Energy production, lipid metabolism, small molecule 
biochemistry”. Nodes in red indicate increased H3K4me3 while nodes in green indicate 
decreased H3K3me3 in ethanol exposed mice. Score determined in IPA was 23 
corresponding to p=10E-23 (right-tailed Fisher’s Exact Test). See Appendix B for 
symbol legend.   
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Table 2.5 Pathways identified from each software suite in the genes in proximity to 
H3K27me3 changes†. 
 Pathway name Genes in pathway and list p-value  
    IPA network/pathway 
Endocrine System 
Development and 
Function, Molecular 
Transport, Protein 
Synthesis 
Myadml2, Nphs1, Igf1, Kif5a, Ublcp1, Appl2, 
Mfap4, App, Tinagl1, Rbm39, Lingo1, Zbtb20, 
Abcg2, Tmem40, Slc39a14, Tsc2, Sh2b2, 
Sult1e1, Mif, Ccdc109b, Plec, Smad1, Retnlb, 
Eif5b, Dnm1, Itm2b, Pou3f1, Sox9 
10E-39 
 
Cancer, Skeletal and 
Muscular Disorders, 
Tissue Morphology 
Hoxd9, Hoxd10, Hoxb9, Cst12, Bcl6b, Hoxb3, 
Hoxc10, Grik3, Lhx5, Epha3, Disp2, Rgs19, 
Mb, Rpl10a, Rasa2, Phf1, Cd300e, Ccl6, 
B3gnt3, Scnn1b, Muc4, Tmbim1, S1pr2 
10E-30 
Cellular Function and 
Maintenance, 
Inflammatory Response, 
Hematological System 
Development  
Mir195, Mir497b, Mir376c, H2-DMa, Tbx4, 
Mir196a-2, Mir375, Pycr1, Rassf1, Tusc2, 
Calb2, Icosl, Atp2b3, Fzr1, Gtf2h4, Apol6, 
Nthl1, Psg28, Slc8a1, Cabin1, Zfhx3, Lrch1 
10E-28 
 
Organismal Survival, 
Gene Expression, 
Endocrine System 
Development and 
Function 
Hoxa7, Mir337, Mir543, Mir667, Sall3, Asap1, 
Prdx4, Csnk1a1, Naf1, Dnajc6, Prh1, Rhof, 
Snrk, Dmrta2, Casz1, Macf1, Astn2, Dnal4, 
Ap1b1, Matk, Flii, Ctnnd2 
10E-28 
     IPA canonical  
Eumelanin Biosynthesis Mif 0.037 
Myo-inositol 
Biosynthesis 
Impa1 0.037 
Proline Biosynthesis I Pycr1 0.037 
     Partek Pathway 
Tyrosine Metabolism Mettl2, Mif 0.031 
Aldosterone-regulated 
sodium reabsorption  
Igf1, Scnn1b 0.036 
    Enrichr KEGG 
MTOR signalling 
pathway 
Igf1, Tsc2, Eif5b, Ulk4 0.033 
†p-values for each pathway are shown (Fisher’s exact test).  
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“Aldosterone-regulated sodium reabsorption” while Enrichr KEGG identified only 
“MTOR signaling” (Table 2.5). 
2.4.4 Genes and Pathways Affected by Both H3K4me3 and 
H3K27me3 Changes 
Genes affected by changes in both H3K4me3 and H3K27me3 following alcohol 
exposure were next examined. This list constituted 33 genes (p<0.001; Appendix E). Six 
of these regions had reciprocal changes in H3K4me3 and H3K27me3, meaning the 
changes were in opposite directions. Similar to both of the individual H3K4me3 and 
H3K27me3 gene lists, there was enrichment of cell-cell adhesion ontologies, representing 
the top three biological processes (Table 2.6). Implicated cellular components included 
many dendrite and synapse-related categories such as “Dendrite cytoplasm”, “Cell 
projection cytoplasm” and “Presynaptic membrane” (Table 2.6). The top molecular 
function was “Calcium ion binding”, with “Oxidoreductase activity” and “Glutamate 
receptor” also implicated (Table 2.6).  
Many of the Partek and IPA canonical pathways identified included very few 
genes, often only one (Table 2.7). However, the top IPA network contained 12 genes, 
termed “Cell-to-cell signaling and interaction, cellular assembly and organization, 
nervous system development and function” (Figure 2.8). This pathway represents the 
proteins that interact to organize synaptic networks during brain development. This gene 
network contains at least five “hub genes” MYC, TP53, TNF, Rad21 and CTCF which are 
transcription factors. Of special interest to these results is the CTCF (CCCTC-binding 
factor) gene involved in the regulation of protocadherins. CTCF is a master 
transcriptional regulator involved in establishing and maintaining specific chromatin 
environments (Ong and Corces, 2014). Fourteen of the 33 genes in the shared 
H3K4me3/H3K27me3 list were Pcdh genes (Appendix C). There are 11 RDHMs that 
affect these 14 Pcdh genes, five of these have changes in both H3K4me3 and H3K27. 
One particular RDHM overlaps with all 14 affected genes (Figure 2.9). Confirmation this 
RDHM with ChIP-qPCR was attempted; however, suitably efficient primers could not be 
designed to target the region. All RDHMs had a negative MAT score, indicating 
increased trimethylation in these regions at both H3K4me3 and H3K27me3. 
54 
 
Table 2.6 Gene ontology (GO) analysis of genes with both H3K4me3 and H3K27me3 
RDHMs in their promoter. 
GO biological process 
   GO term p-value 
Homophilic cell adhesion via plasma membrane adhesion molecules 
(GO:0007156) 
1.80E-20 
Cell-cell adhesion via plasma-membrane adhesion molecules 
(GO:0098742) 
6.60E-19 
Cell-cell adhesion (GO:0098609) 7.04E-19 
Regulation of mitochondrial membrane potential (GO:0051881) 0.0013 
Regulation of membrane potential (GO:0042391) 0.0088 
Proline biosynthetic process (GO:0006561) 0.014 
Positive regulation of mitochondrial fission (GO:0090141) 0.016 
Positive regulation of protein homooligomerization (GO:0032464) 0.016 
Negative regulation of interleukin-17 production (GO:0032700) 0.018 
Killing of cells in other organism involved in symbiotic interaction 
(GO:0051883) 
0.018 
   GO cellular component  
Dendrite cytoplasm (GO:0032839) 0.013 
Cell projection cytoplasm (GO:0032838) 0.013 
Terminal bouton (GO:0043195) 0.036 
Presynaptic membrane (GO:0042734) 0.040 
Perikaryon (GO:0043204) 0.044 
Intermediate filament cytoskeleton (GO:0045111) 0.050 
Ionotropic glutamate receptor complex (GO:0008328) 0.044 
   GO molecular function  
Calcium ion binding (GO:0005509) 5.95E-12 
Extracellular-glutamate-gated ion channel activity (GO:0005234) 0.031 
FMN binding (GO:0010181) 0.026 
Ionotropic glutamate receptor activity (GO:0004970) 0.032 
Oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor 
(GO:0016653) 
0.021 
Oxidoreductase activity, acting on the CH-NH group of donors, NAD or 
NADP as acceptor (GO:0016646) 
0.032 
Glutamate receptor activity (GO:0008066) 0.045 
Oxidoreductase activity, acting on the CH-NH group of donors 
(GO:0016645) 
0.047 
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Table 2.7 Pathways identified from each software suite in the genes in proximity to 
both H3K4me3 and H3K27me3 changes. 
 Pathway name Genes in pathway and list p-value  
   IPA  
Cell-To-Cell Signaling and Interaction, 
Cellular Assembly and Organization, 
Nervous System Development and Function 
Fbxl16, Flii, Pebp4, Hoxa7, 
Pycr1, Pcdhga4, Pcdhgb5, 
Pcdhga7, Pcdhgb2, Pcdhga9, 
Pcdhgb1, Rassf1 
10E-23 
Cell Death and Survival, Cancer, Infectious 
Disease 
Tusc2 0.013 
Immunological Disease, Infectious Disease, 
Cell Morphology 
H2-DMa 0.04 
   IPA canonical  
Proline biosynthesis I Pycr1 0.02 
   Partek  
Asthma Rassf, Pycr1, H2-DMa 0.017 
Intestinal immune network for IgA 
production 
Rassf 0.030 
Bladder cancer Rassf1 0.031 
Inflammatory bowel disease (IBD) Rassf1 0.032 
Arginine and proline metabolism Pycr1 0.033 
Staphylococcus aureus infection Rassf1 0.033 
Graft-versus-host disease Rassf1 0.033 
Allograft rejection Rassf1 0.034 
Type I diabetes mellitus Pycr1 0.039 
Autoimmune thyroid disease H2-DMa 0.039 
Non-small cell lung cancer Rassf1 0.039 
Biosynthesis of amino acids Pycr1 0.041 
    KEGG  
Bladder cancer Rassf1 0.018 
Arginine and proline metabolism Pycr1 0.021 
Non-small cell lung cancer Rassf1 0.025 
Biosynthesis of amino acids Pycr1 0.031 
Glutamatergic synapse Rassf1 0.048 
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Figure 2.8 Top Ingenuity Pathway Analysis (IPA) network for genes sharing both 
H3K4me3 and H3K27me3 RDHMs.  
The pathway is termed “Cell-To-Cell Signaling and Interaction, Cellular Assembly and 
Organization, Nervous System Development and Function”. Nodes outlined in blue 
represent proteins whose genes bear both H3K4me3 and H3K27me3 changes; functional 
relationships with these proteins are highlighted in light blue. Red circle highlights CTCF 
regulation of Pcdh genes.IPA pathway score 23 corresponding to p=10E-23 (right-tailed 
Fisher Exact Test). See Appendix B for symbol legend.   
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Figure 2.9 Location of region of differential H3K4me3 & H3K27me3 containing 
putative CTCF binding motif in the mouse Pcdhg gene cluster. 
Total expanded DNA sequence shows the DMR, while the underlined region shows the 
putative CTCF binding motif. This DMR was enriched for H3K4me3 and H3K27me3 in 
ethanol-exposed mice (H3K4me3 MAT score = -11.2, p= 9.36E-5.; H3K27me3 MAT 
score = -14.1, p= 4.8E-4, CTCF position weight matrices score = 3.31) 
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2.4.5 Protocadherin-Proximal CTCF Motifs Show Altered 
H3K4me3 and H3K27me3 
Due to the implication of Pcdh genes and CTCF in the shared 
H3K4me4/H3K27me3 gene list, CTCF motif analysis was performed on the RDHM 
sequences using the CTCF prediction tool on the CTCFBS database 2.0. There were 150 
out of 625 (24%) H3K4me3 RDHMs which contained a putative CTCF binding motif. 
For the H3K27me3 RDHMs, 46 out of 166 (28%) contained a putative CTCFbinding 
motif. Further, CTCF was identified as a top upstream regulator for both the H3K4me3 
and H3K27me3 genes by IPA and Enrichr, respectively. 
The 11 specific RDHMs affecting the Pcdh genes were assessed for putative 
CTCF sites. One of the RDHMs contained a putative CTCF site (H3K4me3 MAT score = 
-11.2, p= 9.36E-5.; H3K27me3 MAT score = -14.1, p= 4.8E-4, CTCF PWM score = 
3.31). This RDHM overlapped with the gene bodies of all 14 Pcdh genes identified, and 
is situated just after the first exon of Pcdhgb5 (Figure 2.9). The TAAACTGCC sequence 
contained within the 20 bp RDHM is a predicted M2 CTCF binding motif (Schmidt et al., 
2012). This particular sequence at this position is somewhat conserved in rat, and absent 
in humans.  
2.4.6 H3K27me3 Reduction at Snrpn/Ube3a CTCF Sites 
CTCF also controls the expression of many imprinted genes. Given our 
laboratory’s previous findings regarding CTCF binding sites in the Snrpn/Ube3a 
imprinted region (Laufer et al., 2013), histone methylation changes in potential CTCF 
binding motifs in this region were assessed. There were five RDHMs in the Snrpn/Ube3a 
region, two of which had significant predicted CTCF binding motifs (Figure 2.10). One 
was a reduction of H3K27me3 in ethanol-treated mice 2.5 kb upstream of the Snrpn 
transcriptional start site (H3K27me3 MAT score=1.5, p=0.001, CTCF position weight 
matrices score=3.23). The other was a reduction in H3K27me3 1.2 kb upstream of the 
Snord116 first transcriptional start site (H3K27me3 MAT score=3.1, p=0.0004, CTCF 
PWM score=7.6). These CTCF motifs were in the correct orientation with respect to their 
gene promoters. One is a predicted M2 motif upstream of the Snrpn gene, the other is a  
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Figure 2.10 Location of region of differential H3K27me3 in mouse Snrpn/Ube3a 
locus. 
RDHMs are shown as vertical black lines. RDHMs containing a putative CTCF binding 
site are expanded to sequence view, with the CTCF motif underlined. The RDHM 
upstream of Snrpn was depleted of H3K27me3 in ethanol-exposed mice (MAT score = 
1.5, p = 0.002, CTCF position weight matrices score = 3.23). The RDHM upstream of 
Snord116 was also depleted of H3K27me3 in ethanol-exposed mice (MAT score = 3.1, p 
= 0.0004, CTCF position weight matrices score = 7.6).  
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predicted LM7 motif (Xie et al., 2007) upstream of the Snord116 promoter. There were 
no H3K4me3 changes in the region.  
Confirmation of all the RDHMs in Figure 2.10 were attempted with ChIP-qPCR 
(Figure 2.11). The Snrpn RDHM showed 2.55 ± 0.69 fold H3K27me3 enrichment in 
ethanol-exposed mice vs. 2.88 ± 1.13 in control mice (p=0.42, Paired Samples t-Test). 
The more 5’ region upstream of Snord116 showed 3.18 ± 1.26 fold H3K27me3 
enrichment in ethanol-exposed mice vs 3.90 ± 0.85 in control mice (p=0.34, Paired 
Samples t-Test). The region more proximal to Snord116 showed 3.03 ± 0.92 fold 
H3K27me3 enrichment in ethanol-exposed mice vs. 4.18 ± 1.93 in control mice (p=0.32, 
Paired Samples t-Test). The RDHM upstream of IPW showed 2.53 ± 0.35 fold 
H3K27me3 enrichment in ethanol-exposed mice vs. 4.30 ± 0.22 in control mice (p=0.26, 
Paired Samples t-test). Primers could not be designed to target the RDHM upstream of 
Ube3a.  
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Figure 2.11 Attempted chromatin immunoprecipitation-real-time PCR 
confirmations of H3K27me3 RDHMs in the Snrpn/Ube3a locus. 
ChIP against each region was performed in independent biological samples (n=5 ethanol, 
n=5 control) i.e. different mice than the ChIP-chip array. Enrichment for each sample was 
assessed using qPCR and compared to its IgG control using % enrichment = 100% × 
efficiency^(input Ct - H3K27me3 Ct). Data shown are average percent H3K27me3 
enrichment ± standard error. Significance was assessed using a Paired Samples t-Test; no 
region was significantly enriched between ethanol and control groups.  
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 Discussion  
2.5.1 Gene Ontology Analysis Implicates Synaptic Development 
Genes 
GO analysis of each of the H3K4me3, H3K27me3, and shared 
H3K4me3/H3K27me3 gene lists implicate synaptic development genes. The H3K4me3 
gene list was enriched for cell-cell adhesion genes, nervous system development genes, 
and synaptic genes (Table 2.2). Similarly, GO analysis of the H3K27me3 gene list 
showed enrichment of cell-cell adhesion genes, and neuron development genes (Table 
2.3). In the shared gene list, the top three GO biological processes were cell-cell adhesion 
related (Table 2.6). The top implicated cellular components included many dendrite and 
synapse-related categories.  
Taken together, the GO analyses of each gene list suggest that nervous system 
development and cell-cell adhesion genes are disproportionately proximal to H3K4me3 
and H3K27me3 changes in this model. The development of synapses during the neonatal 
period in mice is guided by communication via cell-cell adhesion molecules, including 
protocadherins (Cohen-Cory, 2002); the presence of these genes in each list likely drive 
the implication of synaptic GO categories (Discussed in section 2.5.3 below). Disruption 
of synaptogenesis by ethanol can lead to improper synapse formation, interfering with 
synaptic transmission, potentiation, and plasticity in adulthood (Mameli et al., 2005; 
Olney et al., 2002; Puglia and Valenzuela, 2010). Dysregulation in the expression of cell-
cell communication and synaptic development GO categories at PND 70 was reported 
previously in our laboratory in this model (Kleiber et al., 2013). In this previous work and 
this thesis, these alterations to synaptic development genes persist long after exposure to 
ethanol. Such changes may represent the presence of a different pool of cells in the brain 
following PND 4,7 ethanol-induced apoptosis, differential expression/methylation of 
genes in remaining cell, or a combination of both (Kleiber et al., 2014). In any case, these 
changes may represent a residual footprint of ethanol exposure.  
2.5.2 H3K4me3 Changes Affect Lipid Pathways   
The most striking feature of the pathways affected in the H3K4me3 genes is the 
abundance of lipid metabolism pathways (Table 2.4). There were 10 pathways involving 
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lipids identified across the three software platforms. Figure 2.7 shows the top lipid-
related pathway. The hub of this network is leptin, a peptide hormone that is the master 
regulator of hunger and adipocyte function. Failure of leptin to cross the blood-brain 
implicates leptin in neurological disorders such as Alzheimer’s (Lee, 2011). Other 
important hub genes are the β-oxidation enzymes ACOX1 and BDNF, implicated in a 
host of neurodevelopmental and processes and pathologies. There were several individual 
genes identified as having proximal H3K4me3 driving lipid pathway identification. 
These include the genes encoding the β-oxidation enzymes Acsl4 and Acsl6, lipases 
Pnpla2 and Lipe, sialidases Neu1 and Neu2, sphingomyelinases Smpd4 and Smpd3, pre-
angiotensinogen Agt and oxidoreductase Ecsit (Table 2.4). Acsl6 was upregulated in an 
embryonic model of FASD (Zhou et al., 2011a). Pnpla2 expression was reduced in adult 
mice exposed to fetal ethanol (Christensen et al., 2015).  
Alteration of lipid metabolism is a feature of FASD. Prenatal ethanol exposure 
causes changes in cholesterol in the adult mouse brain (Barcelo-Coblijn et al., 2013). 
Prenatal ethanol exposure also causes changes to the entire phospholipid profile in the 
hippocampus (Wen and Kim, 2004). Neonatal ethanol exposure during the third trimester 
equivalent is characterized by widespread apoptosis involving Bax and caspase-3 
activation. β-oxidation of fatty acids also produces reactive oxygen species (ROS). The 
ACOX enzyme (present in the top network shown in Figure 2.7) catalyzes the first step 
of β-oxidation in the brain and is a major source of ROS (Trompier et al., 2014). Fetal 
alcohol exposure causes lipid peroxidation in the brain after ethanol exposure which can 
persist to adulthood (Brocardo et al., 2016; Petkov et al., 1992; Smith et al., 2005). 
Supplementation with omega-3 fatty acids can prevent oxidative damage and 
hippocampal synaptic changes caused by prenatal ethanol exposure (Patten et al., 2013a, 
2013b). This thesis is the first report of an interaction of histone modification and lipid 
metabolism in ethanol-exposed hippocampus, the region implicated in learning and 
memory deficits.  
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2.5.3 Enrichment of Protocadherin Genes for H3K4me3 & 
H3K27me3 Changes   
The simultaneous changes in H3K4me3 and H3K27me3 are proximal to genes in 
the network “Cell-to-cell signaling and interaction, cellular assembly and organization, 
nervous system development and function” (Figure 2.8). This is the gene network 
responsible for shaping cell-to-cell communication in the brain—synaptogenesis—during 
development. The peak of synaptogenesis occurs on PND 7 in mice (Dobbing and Sands, 
1979). Several RDHM-proximal genes in the top pathway were protocadherin (Pcdh) 
genes which are crucial for synaptogenesis. Pcdh genes are clusters of related genes that 
are believed to be responsible for establishing specific connections between neurons in 
vertebrate brain development by generating single-neuron diversity (Thu et al., 2014). 
The Pcdhg genes are necessary for neurite self-avoidance (Lefebvre et al., 2012). PCDH 
proteins allow neurons to determine if they are self-synapsing, or synapsing with another 
neuron. Neurites can then use this diversity to form the complex web of synaptic 
connections during trimester three. Most Pcdh genes are organized into three genomic 
clusters which are conserved across species. The Pcdha, Pcdhb and Pcdhg gene clusters 
are located in tandem on human chromosome 5, and mouse chromosome 18. Pcdha and 
Pcdhg  have alternative first exons and are regulated by complex hierarchical chromatin 
looping (Tasic et al., 2002; Wang et al., 2002). This leads to proteins with differing 
extracellular domains, and constant cytoplasmic domains generating neuronal 
individuality and guiding synaptic interactions.  
The Pcdh genes are regulated in part by CCCTC-binding factor (CTCF). CTCF 
creates three dimensional chromatin domains, and promotes specific regulatory 
interactions that positively or negatively affect transcription (Ong and Corces, 2014). The 
relationship of CTCF with histone modification is complex, and differs based on the 
genomic context. Little is known about the relationship between H3K4me3 and CTCF. 
H3K27me3 is enriched at CTCF binding sites, and may play a functional role in its 
binding at some loci (Handoko et al., 2011). CTCF can also recruit the PRC2 complex 
which trimethylates H3K27me3 (Li et al., 2012). CTCF acts as an insulator to the 
repressive H3K27me3 mark and thereby promotes gene expression. Loss of CTCF can 
thus lead to inappropriate gene silencing at such loci (Witcher and Emerson, 2009). All of 
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the H3K4me3 and H3K27me3 RDHMs in the Pcdh loci identified here were increases in 
methylation (Appendix E). These gains of H3K27me3 may be correlated with enhanced 
CTCF binding, disrupting regulation of the region. Increased histone methylation and 
enhanced CTCF binding in response to early ethanol exposure is consistent with DNA 
methylation data.  
Two recent studies—one from our laboratory—associate increased DNA 
methylation at Pcdh loci with FASD in humans. Laufer et al., (2015) found that there was 
increased DNA methylation in the Pcdhg cluster in children with FAS. A similar study 
design with a larger sample size found again increases in DNA methylation in the Pcdhb 
and Pcdhg cluster in children with FASD (Portales-Casamar et al., 2016). These two 
studies point to Pcdh loci as candidate epigenetic biomarkers of FASD. Together with the 
data presented in this thesis, a clear picture emerges suggesting protocadherin genes as 
strong candidates for FASD etiology.   
2.5.4 H3K27me3 Changes Affect Imprinted Loci  
Previous work from our laboratory implicated DNA methylation changes at 
CTCF sites in imprinted loci. Therefore, such sites were assessed for histone methylation 
changes. The Snrpn-Ube3a locus expresses a neuron-specific polycistronic transcript that 
includes two clusters of snoRNAs (Le Meur et al., 2005). The function of this transcript 
is not clear; however its timing and dosage are critical, with alterations leading to 
neurodevelopmental disorders (Leung et al., 2009). There were putative CTCF sites at 
two of five H3K27me3 RDHMs in the Snrpn/Ube3a imprinted region. One site was 
upstream of Snrpn and the other is upstream of Snord116 (Figure 2.10). A reduction of 
methylation in H3K27me3 at CTCF sites could have a number of explanations. It is 
likely that the H3K27me3 change itself was a result of altered one-carbon metabolism by 
ethanol, which would then affect CTCF binding. It is also possible that ethanol-induced 
changes in CTCF binding occurred, which precipitated H3K27me3 reduction, but a 
mechanism for this is not clear. As described in the previous section, H3K27me3 may be 
involved in the formation of CTCF DNA loops. Therefore, the reduction of H3K27me3 
at CTCF motifs found at the Snrpn/Ube3a locus here may correlate with reduced CTCF 
binding and a loss of looping and gene expression. It is known that a loss of CTCF at 
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imprinted loci is associated with loss of insulator function, and thus deregulation of 
imprinted genes (Kanduri et al., 2002; Szabo et al., 2004).  
Confirmation of each of the RDHMs in the region was attempted (Figure 2.11). 
The differences in enrichment between the ethanol-exposed and control groups were not 
statistically significant. Each of the regions did trend toward the expected difference, that 
is a decrease in H3K27me3 enrichment in ethanol-exposed mice. It is possible that 
increased sample size would bring these regions toward significance. It should also be 
noted that these confirmation ChIP-qPCR experiments were done in independent 
biological samples, i.e. different mice that the ChIP-Chip assessment. Replication 
between biological groups can be a challenge in ethanol research due to the 
heterogeneous nature of the effects of ethanol.  
The results of this section are supported by previous work from our laboratory 
which found several ethanol-induced DNA methylation changes at imprinted regions 
including CTCF sites. There was an increase in DNA methylation at CTCF sites in the 
imprinting control region (ICR) of H19 and Igf2 (H19/Igf2) in response to fetal ethanol 
exposure (Laufer et al., 2013). Others have also found changes in this particular CTCF 
site in FASD including differential DNA methylation in FASD placental tissue (Haycock, 
2009) and in sperm of alcohol-consuming fathers (Knezovich and Ramsay, 2012). At the 
Snrpn/Ube3a locus specifically, our laboratory has shown increased expression of 
ncRNA in FASD individuals (Laufer et al., 2015). Other research has found methylation 
changes in the Ube3a gene in a model of FASD (Liu et al., 2009). 
2.5.5 Conclusion  
In this chapter, genes and pathways affected by histone methylation changes in 
response to early ethanol exposure are described. Lipid metabolism genes were 
predominantly proximal to H3K4me3 changes, which is consistent this results from the 
gene expression and DNA methylation chapters of this thesis. A putative CTCF motif in 
one of the Pcdhg promoters was found to have increased levels of H3K4me3 and 
H3K27me3. Confirmation this change by ChIP-qPCR was attempted; however efficient 
primers could not be designed for the region. Alteration of the epigenetic state of this 
motif could affect the regulation of the entire region given that loss of CTCF is associated 
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with reduced Pcdh expression dendritic arborisation (Hirayama et al., 2012). The 
methylation changes may be remnants of earlier dysregulation, perhaps from the 
synaptogenesis period. This observation may relate to learning and memory deficits in 
FASD since these processes are dependent on synaptic structure and plasticity in the 
hippocampus (Bliss and Collingridge, 1993; Whitlock et al., 2006). Indeed, our 
laboratory has previously shown that this mouse model has impaired learning and 
memory into adulthood (Mantha et al., 2014) and that many CTCF sites show altered 
DNA methylation in whole-brain tissue (Laufer et al., 2013). The potential for epigenetic 
deregulation of Pcdh genes to underlie this phenotype is also evident in changes in gene 
expression and DNA methylation (Laufer et al., 2013). Such long lasting effects are 
viewed as stable; they may account for cellular changes underling learning and memory 
deficits in FASD. Finally, reduction in H3K27me3 across the Snrpn/Ube3A locus was 
identified. These changes were not confirmed, but trended towards a reduction. Again, 
this loss of methylation may represent footprint of earlier ethanol exposure.  
The results of this section represent a timepoint in a small portion of the 
hippocampal epigenome in response to ethanol. Based on the known effects of ethanol on 
lipid metabolism, oxidative stress, methylation pathways, etc. hypotheses can be 
generated regarding the origins of these histone methylation changes. The results of this 
chapter suggest that altered one-carbon metabolism affects H3K4me3 and H3K27me3 
soon after ethanol exposure which are maintained to PND 70. Further work 
characterizing the histone methylation of the identified regions and their expression is 
needed at earlier timepoints.  
Footnote 
 A modified version of this chapter has been published (Chater-Diehl et al., 2017).  
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Effects of Neonatal Ethanol Exposure on  
Hippocampal DNA Methylation 
 Outline  
Ethanol impairs one-carbon metabolic pathways from which methyl groups are 
derived. Ethanol-induced changes in gene expression may lead to altered brain function 
and behaviour. Previous work has implicated DNA methylation changes in models of 
FASD, but none have examined long-term changes in the hippocampus. In this chapter, 
hundreds of changes in DNA methylation were identified using methylated DNA 
immunoprecipitation microarray in PND 70 mice exposed to ethanol as neonates. 
Changes occurred in genes related to lysosomes, peroxisomes, and cell structure. 
Differential methylation in the peroxisome gene Acaa1 was confirmed with sodium 
bisulfite pyrosequencing. Also in this chapter, the DNA methylation results and histone 
modification results are analyzed together. The combined analysis strengthened the 
implication of peroxisome genes, and also implicated novel processes not found in 
individual analyses including cardiovascular pathways and notch signalling. These data 
suggest a novel interplay between oxidative stress and epigenetic methylation in the 
ethanol exposed hippocampus.  
 Introduction  
3.2.1 DNA Cytosine Methylation  
Methylation of cytosine nucleotides in DNA is a well characterized modification 
regulating chromatin structure and gene expression through development. 5-methyl-
cytosine (5mC) was first described in 1948, with its chemical makeup inferred from its 
chromatography separation pattern from cytosine (Hotchkiss, 1948). It was several 
decades until the function of 5mC (often referred to as simply DNA methylation) was 
determined. Studies in the late 70’s and early 80’s found that DNA methylation was 
involved with local gene expression at developmental genes and regulating cell 
differentiation (Compere and Palmiter, 1981; Holliday and Pugh, 1975).  After intensive 
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investigation, it has become clear that DNA methylation is principally a negative 
regulator of gene expression in mammals. DNA methylation in gene promoters is 
associated local gene repression and is stable over cellular differentiation once 
established (Medvedeva et al., 2014).  
Cytosine methylation occurs predominately at CpG dinucleotides in mammals, 
which are almost always methylated (Deaton and Bird, 2011). 5mC has a high mutagenic 
potential, as it is easily deaminated to thymine (Coulondre et al., 1978). As such, CpG 
sites are evolutionarily constrained, and are depleted through the most eukaryotic 
genomes (Bird, 1980). However, there are concentrations of CpG sites often found within 
gene promoters which can be heavily demethylated called CpG islands (Bird et al., 1985). 
CpG islands are routinely defined as a region at least 200 bp long with greater than 50% 
GC content, and an observed-to-expected CpG ratio greater than 60% (Gardiner-Garden 
and Frommer, 1987). Methylation of CpG islands is associated with the repression of 
nearby (both up- and down-stream) genes (Deaton and Bird, 2011).  
3.2.2 Regulation of DNA Methylation  
DNA methylation patterns are established by complex protein interactions which 
catalyze methylation at the appropriate time and genomic location. De novo CpG 
methylation is established by the DNMT3A and DNMT3B enzymes which can methylate 
unmodified CpG sites (Okano et al., 1998). CpG sites are a simple genetic palindrome, 
the same 5’ to 3’ sequence on each strand. This structure is exploited by the maintenance 
DNA methyltransferase DNMT1 to maintain DNA methylation after cell division. The 
hemi-methylated CpG site in each daughter cell is recognized by DNMT1, which then 
catalyzes the addition of a methyl group to the unmethylated strand. In this way, 
methylation information is preserved through cell division. DNMT3A and DNMT3B are 
highly active during embryonic development, during which time they establish patterns 
which direct stem cell differentiation and ultimately provide somatic cell identity 
(Seisenberger et al., 2012). DNA methylation is erased during gamete production 
(Messerschmidt et al., 2014). During gametogenesis, there is an initial wave of 
demethylation, followed by another after fertilization (Geiman and Muegge, 2009; Smith 
and Meissner, 2013). This active demethylation is believed to be achieved by recently 
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discovered DNA demethylases called TET proteins (Kohli and Zhang, 2013). De novo 
methyltransferases and TET proteins are highly active during embryogenesis and early 
development, but are then inactive in most adult tissues (Okano et al., 1999). DNMT1 
remains active at low levels (Ratnam et al., 2002). In conjunction with DNA methylation 
data, this suggest that DNA methylation is stable in most somatic tissues.  
Once DNA methylation patterns are established, they must be translated into 
signals to direct chromatin-based processes such as transcription. DNA methylation can 
achieve repressive effects on transcription and promote condensed chromatin by either 
promoting negative factor binding or blocking positive factor binding. There are several 
classes of proteins that fill the former role. The MBD, SRA, Kaiso and Kaiso-like protein 
domains are the major groups that bind to methyl-CpG sites (Defossez and Stancheva, 
2011). These domains are components of proteins which form large multi-protein 
complexes containing other domains that affect chromatin structure and/or transcription. 
For example, the H3K9 methylase SETDB1 contains an MBD domain suggesting that 
DNA methylation can drive the deposition of H3K9me (Schultz et al., 2002). H3K9me 
directs chromatin condensation, prohibiting gene expression (Audergon et al., 2015). 
Similarly, histone deacetylation is observed at 5mC-containing promoters, suggesting 
DNA methylation carries out gene repression in part through blocking open-chromatin 
marks (Cedar and Bergman, 2009). There are many such examples suggesting complex 
crosstalk between DNA methylation and other chromatin modifications. The presence of 
DNA methylation in specific DNA motifs may also occlude the binding of positive 
transcription factors, repressing transcription (Spruijt and Vermeulen, 2014).  Initially, 
this was imagined to be the primary mechanism by which DNA methylation modulated 
gene expression. Recent data suggest that it is rare however, restricted to specific 
examples at particular genes (Medvedeva et al., 2014).  
3.2.3 Functions of DNA Methylation  
3.2.3.1 Unique Role in the Adult Brain  
DNA methylation is relatively stable once established, supported by the 
downregulation of de novo DNA methyltransferases in most adult tissues. In the brain 
however, this pattern does not hold true. De novo DNMTs are expressed in post-mitotic 
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neurons in the mammalian brain (Feng et al., 2005; Goto et al., 1994). Pharmacological 
inhibition or deletion of DNMT3A and DNMT3B in the hippocampus results in impaired 
synaptic plasticity and long-term potentiation (LTP) (Muñoz et al., 2016). These 
processes are key to many brain functions including learning and memory. Specific 
studies indicate that methylation is increased at some genes and decreased at others in 
response to neuronal activation (Lubin et al., 2008; Miller and Sweatt, 2007; Miller et al., 
2010). This suggests that the blockage of DNMT3A and DNMT3B in neurons impairs 
synaptic plasticity via disrupting the balance between the memory activating and 
repressing genes (Zovkic et al., 2013).  
The DNA demethylating TET enzymes are believed to play an important role in 
maintaining a 5mC balance in the brain. The TET enzymes produce several intermediate 
modifications of cytosine during demethylation: 5-hydroxymethylcytosine, 5-
formylcytosine, and 5-carboxylcytosine (Ito et al., 2011). 5-hydroxymethylcytosine 
(5hmC) is enriched in the brain, specifically at genes involved in synaptic function 
(Khare et al., 2012). Whether it is functioning as a unique epigenetic mark or is simply a 
step in demethylation remains unclear. Some researchers hypothesize that 5hmC blocks 
repressive 5mC-binding proteins and thus promotes transcription (Branco et al., 2011). 
Some believe that during evolution the mammalian brain co-opted epigenetic 
mechanisms which evolved to govern development, and tweaked them to accomplish 
complex neurological functions.  
Non-CpG cytosine methylation is also enriched in the brain. CpH (H=A, C, or 
T) methylation is enriched in regions of low CpG density, reduced at protein binding 
sites, and is negatively correlated with gene expression (Guo et al., 2014). CpH 
methylation can be recognized by the same reader proteins as CpG methylation, such as 
the MBD-containing MeCP2 implying that it may also repress gene expression (Guo et 
al., 2014). CpH methylation is established by de novo methyltransferases in mature 
neurons, suggesting it is involved in higher neuronal functions (Guo et al., 2014). More 
research is needed to understand the role of this methylation subtype. 
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3.2.3.2 Control of Gene Expression 
CpGs islands are one of the organizational paradigms by which DNA methylation 
regulates gene expression. CpG islands are a vertebrate-specific phenomenon where in 
CpG sites are concentrated near a gene or genes. They are at least 200 bp long, but 1000 
bp on average. Approximately 70% of genes are associated with a CpG island, 
(Illingworth et al., 2010; Saxonov et al., 2006). CpG islands are sites of transcriptional 
initiation, with about half localized over TSSs (Macleod et al., 1998). Interestingly, many 
CpG islands are not associated with known gene TSSs; however, many such sites have 
proved to be previously unknown genes (Macleod et al., 1998). Indeed, many CpG 
islands not associated with genes have been shown to overlap with non-coding RNA 
TSSs (Guttman et al., 2009). H3K4me3 is a hallmark of CpG islands and is necessary but 
not sufficient for transcription to occur, as it is present even at inactive genes (Guenther 
et al., 2007). CpG density alone correlates with H3K4me3 levels (Thomson et al., 2010). 
Methylated CpG islands are associated with local gene repression; however, DNA 
methylation often occurs after repression via histone modifications (Okamoto and Heard, 
2009). Therefore, methylation of CpG islands may act to stably lock genes in a repressed 
state. Examples from specific genes show that methylation of non-CpG-island promoters 
cause similar changes to histones and repress gene expression (Han et al., 2011). 
DNA methylation at enhancers is more complex. Enhancers tend to be CpG poor, 
and incompletely methylated (Jones, 2012). Since TET proteins are also present at 
enhancers during embryonic development, active DNA demethylation in may occur at 
these loci (Lu et al., 2014). Indeed, whole-genome 5hmC analyses have shown that TET-
mediated demethylation occurs mainly at enhancers during development (Lu et al., 2014) 
and is also prevalent in the adult brain (Tognini et al., 2015). Current research in this field 
is testing the hypothesis that DNA demethylation and 5hmC at enhancers controls gene 
expression in response to neuronal stimulation, long-term potentiation, and learning 
(Tognini et al., 2015). 
3.2.3.3 Genomic Imprinting  
A key function of DNA methylation is regulating genomic imprinting. Genomic 
imprinting refers to the expression of genes in a parent-of-origin-specific manner (Smith 
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and Meissner, 2013). Depending on the locus, the maternal or paternal allele can be 
imprinted. The imprinted allele is methylated and not expressed, while the other is 
unmethylated and expressed. Often, differential methylation occurs at imprinting control 
regions (ICRs) which direct the expression of several proximal imprinted genes 
(Bartolomei and Tilghman, 1997). These patterns are established during germline 
development and are maintained through epigenomic reprograming that occurs during 
fertilization (Bartolomei and Tilghman, 1997). Only a small number of genes are 
imprinted; the total number is estimated to be a few hundred in mice and humans (Ishida 
and Moore, 2013). Imprinting is specific to eutherian mammals, and has evolved 
independently in flowering plants (Scott and Spielman, 2006). Mutations and other 
molecular aberrations at imprinted loci cause many genetic diseases in humans (Butler, 
2009). The non-disease functions of genomic imprinting are not clear. It seems 
disadvantageous to only express one copy of any gene in a diploid organism. The most 
widely accepted theory of imprinting function is the kinship theory (Moore and Haig, 
1991). It postulates that the paternal expressed genes promote maximal fetal growth, with 
no regard for maternal health. The maternal expressed genes promote optimal fetal 
growth, balanced with maternal health (Moore and Haig, 1991). DNA methylation is a 
key mechanism by which this parent-of-origin expression is achieved.  
3.2.4 DNA Methylation Analysis Methods  
There are many methods to assess DNA methylation, and most fall into two 
categories: enrichment-based or bisulfite-based. Enrichment-based techniques rely on a 
protein to pull down methylated genomic DNA. The methylated DNA can then be 
characterized by gene-specific methods such as qPCR, or genome-wide methods such as 
microarrays and sequencing. Global analysis methods are also possible, in which the 
amount of DNA enrichment between samples is simply compared. Global methods are 
inexpensive and quick, by provide no genomic location information. Methylated DNA 
immunoprecipitation (MeDIP) and MBD capture are specific enrichment methods. 
MeDIP uses an antibody against 5mC (Jacinto et al., 2008), while MBD capture uses 
beads coated with MBD to pull down 5mC. MBD capture is more sensitive to regions 
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with high CpG density while MeDIP is more sensitive to regions with low CpG density 
(Nair et al., 2011).  
Bisulfite-based techniques use sodium bisulfite to chemically modify all 
unmethylated cytosines to uracils. Following PCR amplification, these uracils are read as 
thymines, but the methylated cytosine remain cytosines. The converted DNA can then be 
sequenced using any region-specific or whole-genome technology. Comparison to the 
reference genome can thus identify C-to-T transitions as unmethylated sites. Microarrays 
which are specific to the converted and uncovered sequences are also used (Li and 
Tollefsbol, 2011). Enrichment approaches have the advantage of not damaging DNA as 
bisulfite does. Further, 5hmC is also insensitive to bisulfite conversion, meaning bisulfite 
sequencing is unable to distinguish 5mC from 5hmC. The resolution of bisulfite is much 
greater than enrichment techniques, allowing identification of single-base methylation 
differences (Li and Tollefsbol, 2011). Enrichment techniques also greatly reduce the total 
DNA sample amount, requiring a whole-genome application step that can introduce 
biases against CpG regions (Robinson et al., 2010). Whole-genome bisulfite sequencing 
is also very expensive, and often provides more information than the experiment 
necessitates. Enrichment of CpG dense regions using enzymatic digestion at CCGG sites 
reduces the total DNA to be sequenced dramatically, reducing cost per sample by 10 
times (Gu et al., 2011). The diversity of methods available allows researchers to tailor the 
technique to their experimental question.  
3.2.5 DNA Methylation and FASD 
DNA methylation is believed to be a key component of numerous disease 
etiologies, including FASD. Aberration of DNA methylation is associated with many 
human diseases. In particular, diseases involving errors in cellular differentiation such as 
cancers often involve altered DNA methylation (Robertson and Wolffe, 2000). 
Imprinting disorders are also caused by genetic or epigenetic changes at imprinting loci. 
Repeat expansion disorders involve DNA methylation, as the expanded region is often 
methylated leading to silencing (Robertson and Wolffe, 2000). Given the important role 
of DNA methylation in neurological function, it is unsurprising that numerous 
neurodevelopmental and neurodegenerative disorders are associated with changes in 
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DNA methylation (Lu et al., 2013). Identifying a causative role for DNA methylation in 
these disorders is very difficult compared with growth disorders. Nevertheless, DNA 
methylation at disease-relevant genes is associated with dozens of human neurological 
disorders (Lu et al., 2013). As the interest in DNA methylation in neurological disorders 
increased through the 1990s, research was initiated into the role of DNA methylation in 
FASD.  
DNA methylation was suspected to be particularly relevant in FASD due to the 
molecular actions of ethanol. DNA methyltransferases rely on one-carbon metabolic 
pathways to transfer a methyl group onto cytosine. Briefly, DNMTs transfer the methyl 
group from the methyl donor SAM. The first metabolite ethanol, acetaldehyde, exerts 
several inhibitory effects on SAM availability. Acetaldehyde prevents the uptake of 
folate, a precursor of SAM (Hamid and Kaur, 2007). Acetaldehyde also directly inhibits 
methionine adenosyl transferase and methionine synthase which produce SAM and its 
precursor methionine respectively (Kenyon et al., 1998; Seitz and Stickel, 2007). Much 
of this information emerged from studies of adult alcohol-induced liver disease, which 
has since been associated with changes in DNA methylation (Shukla et al., 2008). These 
effects have also been observed in in vivo FASD models. Garro et al. (1991) provided the 
first implication of DNA methylation in FASD. Exposure of mouse fetuses to ethanol 
from GD9-11 resulted in DNA hypomethylation. Nuclei from ethanol-exposed fetuses 
had lower levels of DNMT activity even when exposed to excess SAM, suggesting 
irreversible enzyme activation (Garro et al., 1991). Furthermore, DNA methylation 
provides a molecular mechanism for gene-by-environment interactions: environmental 
changes can potentially affect gene expression via DNA methylation which is dependent 
on environmental sources of carbon (Baccarelli and Bollati, 2009). Combined with 
emerging studies on the importance of DNA methylation in neurological disease, these 
data provided the theoretical basis for exploration of the role of 5mC in FASD.  
DNA methylation has become a popular research area in FASD. Interestingly, 
histone modifications were initially more studied in FASD through the late 1990’s and 
early 2000s. At this time this thesis was undertaken in 2011, there had been only three 
studies of DNA methylation in FASD models. The first was the aforementioned study by 
Garro et al. (1991) which found global DNA hypomethylation in mouse fetuses following 
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acute exposure to a high dose of ethanol from GD 9-11. Haycock and Ramsay (2009) 
assessed the H19 imprinted domain using bisulfite sequencing of mouse embryos 
exposed to ethanol during preimplantation (GD 1.5-2.5). When assessed at GD 10.5, the 
authors found no DNA methylation changes in the embryos (Haycock and Ramsay, 
2009). There was a reduction in methylation at the paternal alleles in ethanol-exposed 
placentae. The third study was the most comprehensive, and has driven much of the 
interest in the role of DNA methylation in FASD. Using whole-embryo culture, Liu et al. 
(2009) investigated the effects of ethanol exposure on DNA methylation and gene 
expression during neurulation. Using MeDIP-chip, the authors compared DNA 
methylation in embryos that developed or did not develop neural tube deficits in response 
to ethanol exposure. There was a 10-fold increase in the number of genes with increased 
methylation on chromosomes 7, 10, and X (Liu et al., 2009). DNA methylation changes 
were enriched in imprinted genes and olfactory genes, with notable examples of 
developmental and chromatin-regulating genes (Liu et al., 2009). There were 84 genes 
differentially expressed and differentially methylated. The results from these studies 
provide evidence that ethanol may exert its neurotoxic effects at least in part through 
epigenetic changes in gene expression.  
Since the initiation of this thesis, there have been numerous other studies 
investigating DNA methylation following various exposure paradigms in various tissues. 
Rat pups exposed to ethanol from PND 2-10 showed global hypomethylation in the 
hippocampus and prefrontal cortex (Otero et al., 2012). In another study, the promoter of 
Pomc (a gene involved in neuronal control of stress and metabolism) showed reduced 
methylation at PND 60 following GD 7-21 ethanol exposure. Pomc expression was also 
reduced (Govorko et al., 2012). Interestingly, this effect was passed to the F2 and F3 
male offspring of ethanol exposed mice. This study provided the first evidence that 
ethanol-induced epigenetic changes could be passed transgenerationally. In another 
study, mice exposed to ethanol from GD 7-16 showed altered 5mC and 5hmC levels in 
hippocampus at PND 7 which were correlated with delayed hippocampal development 
(Chen et al., 2013). Other studies have attempted to understand the mechanisms of 
ethanol-induced DNA methylation changes. Blockage of the apoptosis-inducing factor 
Caspase 3 prevented ethanol-induced reduction in DNMT1 and DNMT3A proteins and 
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DNA methylation in the hippocampus. This suggests that DNA methylation changes 
occur downstream of apoptosis in response to ethanol.  
Our laboratory has also assessed DNA methylation in other models of FASD. 
Using the CPD model, we found that adult mice show genome-wide changes in DNA 
methylation in the whole-brain. These changes were enriched at imprinted genes and 
genes regulated by CTCF (Laufer et al., 2013).  When these data were compared to 
human children with FAS, we found that both the mouse brain and human buccal cells 
had enrichment of DNA methylation changes at protocadherins, glutamatergic synapses, 
and hippo signaling genes (Laufer et al., 2015). Another group also found decreased 
methylation at protocadherins genes in children with FASD, suggesting this may serve as 
a biomarker for FASD (Portales-Casamar et al., 2016).  
3.2.6 DNA Methylation Study Design  
Previous studies have not assessed genome-wide DNA methylation changes in 
adult mice exposed to ethanol during development. Studies have focused on the 
hippocampus, but most have examined short-term responses to ethanol exposure (Chen et 
al., 2013; Liu et al., 2009; Otero et al., 2012). The effects of DNA methylation in the 
adult brain have only been assessed by one other group, which only investigated a single 
gene (Govorko et al., 2012). Given that FASD is associated with lifelong changes in 
behaviour (Among and Women, 2010) our laboratory has focused on studying molecular 
changes in the young adult brain. In terms of tissue of interest, our laboratory and others 
have focused on the hippocampus. As reviewed in Chapter 1, the hippocampus is highly 
vulnerable to ethanol-induced neurotoxicity (Gil-Mohapel et al., 2010), and is the brain 
region associated with spatial learning and memory which are disrupted in FASD 
(Among and Women, 2010). DNA methylation also plays a dynamic role in learning in 
the hippocampus. For these reasons, the experiments of this thesis were designed to 
assess DNA methylation in the hippocampus of adult mice exposed to ethanol during 
PND4-7. Given the nature of the experimental question, MeDIP-chip was selected with 
confirmations by a completely different technology, bisulfite pyrosequencing. MeDIP 
was coupled to a promoter microarray to restrict analysis to only regions relevant to gene 
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expression, and reduce costs. Given the crosstalk between DNA methylation and histone 
modifications, the genes and pathways affected by both were also considered.  
Objectives  
1. To assess all mouse genes and their promoters in PND 70 mouse hippocampus 
exposed to ethanol on postnatal days 4 & 7 and identify changes in DNA 
methylation. 
2. To identify genes proximal to changes in DNA methylation, and pathways 
affected. 
3. To confirm specific changes with ChIP-qPCR.  
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 Materials and Methods  
3.3.1 Mouse Care 
For full mouse care protocol, see Chapter 2, section 2.3.1. In brief, all protocols 
were approved by the Animal Use Subcommittee (AUS) at the University of Western 
Ontario, London, Ontario, Canada. The day of birth was termed post-natal day (PND) 
zero. Sex and weight-matched littermate pups were divided into two groups: ethanol-
treated and saline control mice. Pups were given two subcutaneous dorsal injections on 
both PND 4 and PND 7. Ethanol-treated mice were injected with 2.5 g/kg of ethanol in 
0.15 M NaCl (Ikonomidou et al., 2000). Control mice were injected with 0.15 M saline 
only. Male mice were used for all subsequent analyses (n=18). Mice were sacrificed on 
PD 70 via carbon dioxide asphyxiation. The hippocampus was dissected out (Spijker, 
2011), snap-frozen in liquid nitrogen, and stored at -80°C for no longer than 30 days until 
formaldehyde fixation. The mice used in this chapter were the same used for the RNA 
analysis in Chapter 2 (Table 2.1) The experimental design of this Chapter differs, in that 
three individual mice were used for three separate microarrays per treatment group, i.e. 
three biological replicates were not pooled together as in Chapter 2. The biological 
sample used for each microarray in this section was used on one of the microarrays from 
Chapter 2 (Table 2.1).  
3.3.2 MeDIP-Chip 
3.3.2.1 Genomic DNA Fragmentation  
Genomic DNA (gDNA) was quantified and quality assessed by NanoDrop ND-
1000. Genomic DNA of each sample was sonicated to ~200 – 1000 bp with a Bioruptor 
sonicator (Diagenode) on “Low” mode for 10 cycles of 30 seconds “ON” & 30 seconds 
“OFF”. The gDNA and each sheared DNA were analyzed with agarose gel 
electrophoresis.  
3.3.2.2 Methyl-Cytosine Immunoprecipitation 
1 μg of sonicated genomic DNA was used for immunoprecipitation using a mouse 
monoclonal anti-5-mC antibody (Diagenode). For this, DNA was heat-denatured at 94°C 
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for 10 min, rapidly cooled on ice, and immunoprecipitated with 1 μL primary antibody 
overnight at 4°C with rocking agitation in 400 μL immunoprecipitation buffer (0.5% 
BSA in PBS). To recover the immunoprecipitated DNA fragments, 200 μL of anti-mouse 
IgG magnetic beads was added and incubated for an additional 2 hours at 4°C with 
agitation. After immunoprecipitation, five immunoprecipitation washes were performed 
with ice-cold immunoprecipitation buffer. Washed beads were resuspended in TE buffer 
with 0.25% SDS and 0.25 mg/mL proteinase K for 2 hours at 65°C and then allowed to 
cool down to room temperature. MeDIP DNA were purified using Qiagen MinElute 
columns (Qiagen). 
3.3.2.3 Whole Genome Amplification (WGA) 
The MeDIP-enriched DNA was amplified using a WGA kit from Sigma-Aldrich 
(GenomePlex® Complete Whole Genome Amplification (WGA2) kit) following the 
manufacturer’s protocol. The amplified DNA samples were then purified with QIAquick 
PCR purification kit (Qiagen) following the manufacture’s protocol. 
3.3.2.4 Real-time PCR Assessment of Fold-Enrichment  
The purpose of the qPCR experiment is to verify that the MeDIP DNA has been 
enriched for methylated fragments and depleted for unmethylated fragments (Butcher and 
Beck, 2010). This experiment was performed by ArrayStar Inc. The primers for 
specifically methylated regions (the positive control, Tsh2b promoter) and unmethylated 
regions (the negative control, Gapdh promoter) were used to assess the enrichment level 
of these two regions in both input (sonicated DNA) and MeDIP-enriched DNA (Butcher 
and Beck, 2010). All six samples showed expected enrichment. An enrichment value for 
two samples could not be calculated due to complete lack of amplification in the IgG 
negative control. All samples can be considered quantitatively above the background 
signal (noise) for both. The PCR primer sequences were: Tsh2b 101 bp 
F:5’CTCTCCTTGCGGCATCTCT3’ R:5’GCGGTAAAGGGTGCTACTATT3’. Gapdh 
161 bp F:5’GCCCTTGAGCTAGGACTGGATAA3’ 
R:5’CCTGGCACTGCACAAGAAGATG3’.  
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3.3.2.5 DNA Labelling and Array Hybridization 
The purified DNA was quantified using a NanoDrop ND-1000. For DNA 
labelling, the NimbleGen Dual-Color DNA Labeling Kit was used according to the 
manufacturer’s guideline detailed in the NimbleGen MeDIP-chip protocol (NimbleGen 
Systems, Inc., Madison, WI, USA). 1 μg DNA of each sample was incubated for 10 min 
at 98°C with 1 OD of Cy5-9mer primer (IP sample) or Cy3-9mer primer (Input sample). 
Then, 100 pmol of deoxynucleoside triphosphates and 100U of the Klenow fragment 
(New England Biolabs, USA) were added and the mix incubated at 37°C for 2 hours. The 
reaction was stopped by adding 0.1 volume of 0.5 M EDTA, and the labeled DNA was 
purified by isopropanol / ethanol precipitation. Microarrays were hybridized at 42°C 
during 16 to 20h with Cy3/5 labelled DNA in NimbleGen hybridization buffer/ 
hybridization component A in a hybridization chamber (Hybridization System - 
NimbleGen Systems, Inc., Madison, WI, USA). Following hybridization, washing was 
performed using the NimbleGen Wash Buffer kit (NimbleGen Systems, Inc., Madison, 
WI, USA). For array hybridization, Roche NimbleGen's MM9 Meth 2.1M CpG plus 
Promoter array was used. 
3.3.2.6 Data Extraction and Normalization  
Raw data were extracted as pair files by NimbleScan software. ArrayStar 
performed Median-centering, quantile normalization, and linear smoothing by 
Bioconductor packages Ringo, limma, and MEDME. After normalization, a normalized 
log2-ratio data (*_ratio.gff file) was created for each sample. From the normalized log2-
ratio data, a sliding-window peak-finding algorithm provided by NimbleScan v2.5 
(Roche-NimbleGen) was applied to find the enriched peaks with specified parameters 
(sliding window width: 750 bp; mini probes per peak: 2; p-value minimum cut-off: 2; 
maximum spacing between nearby probes within peak: 500 bp). Raw and normalized 
data files were uploaded to GEO.  
3.3.2.7 MEDME Analysis  
To accurately quantify CpG methylation levels, MEDME (modeling experimental 
data with MeDIP enrichment) was used to improve the evaluation and interpretation of 
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MeDIP derived DNA methylation estimates. MEDME relies on generating a fully 
methylated gDNA sample for comparison. To generate the fully methylated profiles, 
DNA from each sample was pooled and treated with CpG methyltransferase (M.SssI, 
NEB) to add methyl-groups to all cytosine residues within CpG di-nucleotides, in order 
to obtain fully methylated genomic DNA. Raw data for fully methylated sample and test 
samples were median-centered and quantile normalized using Bioconductor packages 
Ringo and limma. Then MEDME was performed to calculate probe AMS and RMS. In 
the fully methylated DNA MeDIP experimental dataset, the weighted count of 
methylated CpG di-nucleotides in the 1 kb window centered at each probe is calculable 
by genomic CpG in the window, as every CpG is expected to be methylated. 
The MEDME protocol utilizes the absolute methylation score (AMS) as the 
indicator of DNA methylation, which is decided by the weighted count of methylated 
CpG di-nucleotides in a 1 kb window centered at each probe. The AMS is verified to be a 
more accurate and sensitive indicator of DNA methylation than log-Ratio. The MEDME 
method also provides a relative methylation score (RMS) that normalizes AMS with 
respect to the total number of CpGs represented by CpGw. Differentially methylated 
probes between ethanol-exposed and control groups were identified using AMS by Paired 
Samples t-Test. And probes with p-value<0.05 and ABS (AMS_dif)>8 were selected and 
used to find AMS DMRs. The RMS is more useful when comparing regions with 
different CpG densities. Since this study is only comparing the same region across 
samples, AMS was used in characterization and analysis. After probe AMS and RMS 
were obtained from analyzing the MeDIP-chip data by MEDME, a further analysis of 
identification of DMRs (differentially methylated regions) was performed to identify 
significantly differentially methylated regions. An FDR q-value < 0.05 was used to 
determine multiple testing error; no DMRs survived this threshold.   
3.3.2.8 Sodium Bisulfite Pyrosequencing  
 The same DNA samples used for MeDIP-chip were used for sodium bisulfite 
pyrosequencing (n=3 control and n=3 ethanol). EpigenDx Inc. performed pyro-
sequencing on the PSQ96 HS System (Qiagen) following the manufacturer’s instructions, 
using custom assays and a gradient of controls with known methylation levels. This 
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allowed for the quantiﬁcation of the absolute percent methylation (Lim et al., 2014) of 
each CpG at specific loci using QCpG software (Qiagen). The absolute percent 
methylation at each assayed cytosine was averaged among ethanol-exposed (n=3) and 
control (n=3) samples and compared using a Paired Samples t-Test. The custom primers 
assayed CpGs at the following positions (mm10): Acaa1: chr9:119342321, 
chr9:119342332, chr9:119342352, chr9:119342366, chr9:119342378, chr9:119342386; 
Pxmp1: 110285970, chr5110285964, chr5110285959, chr5110285948, chr5110285944, 
chr5110285940, chr5110285908, chr5110285878; Pex6: chr17:46706646, 
chr17:46706654, chr17:46706661, chr17:46706672, chr17:46706678, chr17:46706691, 
chr17:46706698, chr17:46706715; Mafg: chr11:120625270, chr11:120625264, 
chr11:120625261, chr11:120625225, chr11:120625205, chr11:120625131; Tcf7l2: 
chr19:55745017, chr19:55745023.  
3.3.3 8-OHdG ELISA 
To assess oxidative damage to hippocampal DNA in PND 70 mice, 8-hydroxy-2' -
deoxyguanosine (8-OHdG) levels were assessed. The Colorometric EpiQuik 8-OHdG 
DNA Damage Quantification Direct Kit (Epigentek) was used according to the 
manufacturer’s protocol. The same DNA samples from the six ethanol-exposed and six 
control mice used for MeDIP-chip were used (Chapter 2, Table 2.1). Florescence levels 
were quantified by the Epoch 2 Microplate Spectrophotometer (BioTek). A standard 
curve was generated from provided 8-OHdG standards. Individual 8-OHdG values for 
each sample were calculated using Equation 1. Once 8-OHdG (ng) was calculated, 
technical replicates for each sample (3) were averaged, then compared to input DNA 
levels to obtain the percentage of 8-OHdG for each sample.    
 
8 − 𝑂𝐻𝑑𝐺 (𝑛𝑔) =
𝑆𝑎𝑚𝑝𝑙𝑒 𝑂𝐷 − 𝑁𝐶 𝑂𝐷
𝑠𝑙𝑜𝑝𝑒
 
Equation 1. Quantity of 8-OHdG. 
93 
 
OD refers to optical density determined by the instrument, NC refers to negative control, 
slope refers to the slope of the line obtained by plotting OD vs. 8-OHdG concentration 
for each standard.   
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 Results  
3.4.1 Distribution of Differentially Methylated Regions  
MeDIP-chip identified thousands of differentially methylated regions (DMRs) 
across the mouse genome in response to ethanol exposure. DMRs are genomic regions 
containing several differentially methylated cytosines. Two algorithms were used to 
generate DMRs, absolute methylation score (AMS) and relative methylation score 
(RMS). AMS is derived by the weighted count of methylated CpG di-nucleotides in a 1 
kb window centered at each probe. RMS is simply the AMS score that normalized with 
respect to the total number of CpGs in the region. Each algorithm produced different 
DMRs, though there was overlap (Table 3.1). The AMS produced mostly DMRs with 
increased methylation in response to ethanol, the RMS DMRs were nearly equally 
increases and decreases. These trends in direction of methylation change remained 
constant as the significance level of the AMS was increased (Figure 3.1; Figure 3.2). 
There were more AMS DMRs than RMS DMRs. AMS identified changes in CpG 
islands, while RMS did not, likely due the high CpG density of the regions. RMS is 
intended to compare the relative methylation of different regions within the same sample. 
Since this experiment only compared the same genomic regions between different 
samples, AMS score alone was used for the remainder of the analysis.  
The AMS DMRs were distributed relatively evenly across the genome (Figure 
3.3). Chromosomes 7 and 11 had the most DMRs, while 18 and 19 and Y had the fewest, 
with none on the Y chromosome. All chromosomes showed a similar distribution of 
increased and decreased AMS scores: each had more increases than decreases indicating 
hypermethylation (Figure 3.3). Since the experiment employed a promoter microarray, 
chromosomes with more genes were interrogated more often. The DMRs per 
chromosome were therefore corrected based on gene density (Figure 3.4). Despite being 
relatively gene dense, chromosome 11 had the highest number of DMRs per gene. 
Chromosome 6 had the lowest DMRs per gene, but the distribution was relatively even 
across chromosomes. Indeed, a linear regression of number of genes vs. number of 
DMRs found an R2 value of 0.86 indicating a strong correlation (Appendix C). Thus, 
most of the variation in DMRs across chromosomes is attributed the number of genes on 
the chromosome.  
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Table 3.1 Characteristics of differentially methylated regions (DMRs) identified by 
methylated DNA immunoprecipitation microarray (MeDIP-chip)†. 
  Number of DMRs (% 
increased methylation) 
 
Location p-value cut 
off 
AMS RMS Number of Identical 
DMRs  
Promoter p<0.05 10599 
(82.2%) 
7738 (55%)  3773 (43.6%↑↑, 
8.4%↓↓, 47.8% differ) 
Promoter p<0.01 4640 (82.3%) 2766 (52%) 582 (48.6%↑↑, 
10.1%↓↓, 46.4 differ) 
Promoter  p<0.001 733 (83.3%) 435 (47%) 18 (27.7%↑↑, 5.6%↓↓, 
66.7% differ) 
CpG island p<0.05 1112 (91.7%) 0 N/A 
CpG island p<0.01 549 (93.2%) 0 N/A 
CpG island p<0.001 100 (92%) 0 N/A 
miRNA 
promoter 
p<0.05 292 (66.1%) 238 (47.9%) 3 (66.6%↑↑, 33.3%↓↓) 
miRNA 
promoter 
p<0.01 126 (65.1%) 63 (52.3%) 0 
miRNA 
promoter 
p<0.001 16 (87.5%) 3 (66.6%) 0 
†Lists of DMRs for each genomic location (as identified by Array-star analysis) were 
generated for three p-values. The number of DMRs in these lists for both absolute 
methylation score (AMS) and relative methylation score (RMS) algorithms are shown. 
The number of identical DMRs, i.e. those having are the same start and end points, is 
shown. The agreement of the direction of methylation change (up “↑” or down “↓”) for 
the identical DMRs is shown.  
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Figure 3.1 Differentially methylated regions (DMRs) identified by absolute 
methylation score (AMS) at increasing stringency levels. 
Track A shows genomic locations of DMRs with AMS p-value<0.05; Track B shows 
genomic locations of DMRs with AMS p-value<0.01; Track C shows genomic locations 
of DMRs with AMS p-value<0.001. Colours denote the direction and magnitude of the 
AMS score of each DMR.  
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Figure 3.2 Differentially methylated regions (DMRs) identified by relative 
methylation score (RMS) at increasing stringency levels. 
Track A shows genomic locations of DMRs with RMS p-value<0.05; Track B shows 
genomic locations of DMRs with RMS p-value<0.01; Track C shows genomic locations 
of DMRs with RMS p-value<0.001. Colours denote the direction and magnitude of the 
RMS score of each DMR.  
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Figure 3.3 Distribution of differentially methylated regions (DMRs) across 
chromosomes. 
Bars show the number of DMRs present on each chromosome at an AMS p<0.001. Black 
denotes positive AMS score, indicating increased methylation, while white denotes 
negative AMS score indicating reduced methylation.  
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Figure 3.4 Distribution of differentially methylated regions (DMRs) across 
chromosomes corrected for gene density. 
The number of DMRs on each chromosome was divided by the total number of genes 
(from build mm10) on each chromosome.   
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3.4.2 Ontology of Genes Proximal to DNA Methylation Changes  
To identify genetic systems affected by DNA methylation changes in the PND 4,7 
FASD model, gene ontology (GO) analysis was performed. A list of 689 genes in 
proximity to the 733 DMRs (AMS p<0.001) was generated for gene ontology and 
pathway analysis. The DMR was required to lay within 5000 bp upstream of the 
transcriptional start site of the gene, or the gene body. Genes were also implicated if a 
DMR occurred in a CpG island known to correlate with expression of the gene. These 
genes were submitted to gene ontology software. The top two affected biological 
processes were related to myeloid cell differentiation (Table 3.2). Several other processes 
were related to cell growth and development. Three of the top ten biological processes 
were related to hormone response (Table 3.2). Also notable were “Negative regulation of 
lipid biosynthetic process” and “Regulation of neuron projection development”. The top 
ten cellular components were all related to cellular structure or membrane components 
(Table 3.2). The top affected component was “Basement membrane” with various other 
membranes and components implicated (Table 3.2). The top three affected molecular 
functions were hormone, estrogen, and growth factor binding (Table 3.2). Other 
receptors were implicated including neuropeptide, nuclear hormone, and tumor necrosis 
factor, and notch binding. 
3.4.3 Pathways Affected by DNA Methylation Changes  
The list of 689 genes proximal to DMRs was also submitted to three separate 
pathway suites: Ingenuity Pathway Analysis (IPA), Partek Pathway, and Enrichr (Table 
3.3).  The top IPA pathway was “Cellular Movement, Cell Death and Survival, Cellular 
Development” (Figure 3.5). In total five pathways were identified by IPA, each related to 
cell growth and development, or cell death (Table 3.3). Partek pathway identified five 
pathways, the top being “Hematopoietic cell lineage”. Enrichr identified two pathways, 
which were the same as two identified by Partek pathway: “Peroxisome” and 
“Lysosome”. Due to “Peroxisome” being identified by both software suites, and  
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Table 3.2 Gene ontology (GO) analysis of genes with differentially methylated 
regions (DMRs) in their promoter†. 
GO term p-value 
   GO biological processes  
Myeloid leukocyte differentiation (GO:0002573) 0.0004 
Myeloid cell differentiation (GO:0030099) 0.0004 
Cellular response to thyroid hormone stimulus (GO:0097067) 0.0008 
Positive regulation of cell fate commitment (GO:0010455) 0.0013 
Negative regulation of lipid biosynthetic process (GO:0051055) 0.0017 
Granulocyte differentiation (GO:0030851) 0.0020 
Response to thyroid hormone (GO:0097066) 0.0020 
Positive regulation of developmental growth (GO:0048639) 0.0022 
Cellular response to hormone stimulus (GO:0032870) 0.0026 
Regulation of neuron projection development (GO:0010975) 0.0027 
   GO cellular component  
Basement membrane (GO:0005604) 0.0002 
Extracellular matrix part (GO:0044420) 0.0008 
Anchored component of membrane (GO:0031225) 0.0027 
Extrinsic component of cytoplasmic side of plasma membrane 
(GO:0031234) 
0.011 
Extracellular matrix (GO:0031012) 0.011 
Ruffle (GO:0001726) 0.021 
Cortical cytoskeleton (GO:0030863) 0.022 
Extrinsic component of plasma membrane (GO:0019897) 0.025 
Cell surface (GO:0009986) 0.027 
Exosome (RNase complex) (GO:0000178) 0.028 
   GO molecular function  
Hormone receptor binding (GO:0051427) 0.0020 
Estrogen receptor binding (GO:0030331) 0.0027 
Growth factor activity (GO:0008083) 0.0060 
Glycosaminoglycan binding (GO:0005539) 0.0076 
S100 protein binding (GO:0044548) 0.0074 
Neuropeptide receptor binding (GO:0071855) 0.011 
Sequence-specific DNA binding RNA polymerase II transcription factor 
activity (GO:0000981) 
0.013 
Nuclear hormone receptor binding (GO:0035257) 0.013 
Tumor necrosis factor receptor superfamily binding (GO:0032813) 0.013 
Notch binding (GO:0005112) 0.015 
†Top 10 GO processes are shown where number of entries exceeds 10.   
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Table 3.3 Pathways significantly enriched with differentially methylated genes†. 
Network name  p-value 
   IPA  
Cellular Movement, Cell Death and Survival, Cellular Development 10E-130 
Cell Cycle, Cellular Development, Cellular Growth and Proliferation 10E-50 
Inflammatory Response, Cellular Movement, Immune Cell Trafficking 10E-50 
Organismal Development, Tissue Development, Embryonic Development 10E-43 
Cell Death and Survival, Cellular Development, Cellular Growth and 
Proliferation 
10E-35 
    Partek pathway  
Hematopoietic cell lineage 0.0003 
Peroxisome 0.0006 
Jak-STAT signaling pathway 0.0006 
Lysosome  0.003 
Taurine and hypotaurine metabolism 0.009 
   Enrichr KEGG  
Peroxisome 0.024 
Lysosome 0.026 
†p-values for each entry are shown (Fisher’s exact test). For list of genes in each pathway, 
see Appendix G. 
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Figure 3.5 Top affected IPA pathway for genes proximal to a differentially 
methylated region (DMR). 
Pathway is titled “Cellular Movement, Cell Death and Survival, Cellular Development” 
(IPA score 130). Red indicates proteins which have increased DNA methylation proximal 
to their encoding gene, green indicates decreased methylation. For full legend of symbols 
used, see Appendix B. 
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identified in the histone analysis, the Partek Peroxisome pathway was selected for further 
analysis (Figure 3.6). 
3.4.4 Combined DNA & Histone Methylation Analysis 
To examine genes proximal to ether DNA methylation or histone modification 
changes, a combined gene list of genes with either a DMR or an RDHM in their 
promoter/gene body was created. There was minimal overlap between lists, and no single 
gene contained a DMR, H3K4me3 RDHM, and H3K27me3 RDHM (Figure 3.7). The 
direction of each change in ethanol-exposed mice was standardised between the marks by 
listing genes with changes predicted to increase gene expression as +1 (i.e. loss of DNA 
methylation, loss of H3K27me3, gain of H3K4me3) and changes predicted to decrease 
gene expression as -1 (i.e. gain of DNA methylation, gain of H3K27me3, loss of 
H3K4me3). Conflicting gains/losses were scored as 0 (22 genes total). The DMR/RDHM 
p-value cut off was kept at p<0.001. The list comprised 1589 genes.  
3.4.5 Combined Gene Ontology and Pathway Analyses  
The combined list was submitted to GO and pathway analysis software. GO 
analysis of the combined list identified some, but not all of the same processes as the 
DNA methylation or histone modification lists alone. The top affected biological 
processes were both cell-cell adhesion related (Table 3.4), which was also true for the 
H3K4me3, H3K27me3, and shared histone methylation GO analyses (Chapter 2). The 
next to top processes were “Regulation of neuron differentiation”—which was not 
implicated in any of the individual GO analyses—and “Regulation of neuron projection 
development”—which was only implicated in the DNA methylation GO analysis (Table 
3.4; Table 3.2; Chapter 2).  Also of note was “Nervous system development” which was 
also implicated in H3K4me3 GO analysis (Table 3.4; Chapter 2). “Myeloid cell 
differentiation” was also implicated; this was the top hit for the DNA methylation GO 
analysis but was not implicated in the histone analyses (Table 3.4; Table 3.2). “CD4-
positive, alpha-beta T cell activation” was implicated, but was not in any of the individual 
lists (Table 3.4). 
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Figure 3.6 Top Partek pathway for genes proximal to differentially methylated 
regions (DMRs).   
Pathway is titled “Peroxisome biogenesis”. Proteins whose encoding genes are proximal 
to an increase in methylation are shown in red, decreases are shown in green. 
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Figure 3.7 Combined gene list characterization, genes proximal to either a DNA 
methylation (5mC), H3K4me3, or H3K27me3 change. 
The number of genes proximal to each methylation change are shown in each circle. 
Genes proximal to multiple changes, regardless of the direction of those changes, are 
shown in overlapping regions. 
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Table 3.4 Gene ontology (GO) analysis of genes proximal to a differential 
methylated region (DMR) or region of differential histone modification (RDHM)†. 
GO term p-value 
   GO biological processes 
Cell-cell adhesion via plasma-membrane molecules (GO:0098742) 5.26E-06 
Cell-cell adhesion (GO:0098609) 5.81E-06 
Regulation of neuron differentiation (GO:0045664) 5.63E-05 
Regulation of neuron projection development (GO:0010975) 0.00012 
Myeloid cell differentiation (GO:0030099) 0.00034 
Regulation of cell projection organization (GO:0031344) 0.00047 
Erythrocyte differentiation (GO:0030218) 0.00050 
Nervous system development (GO:0007399) 0.00051 
CD4-positive, alpha-beta T cell activation (GO:0035710) 0.00062 
Mammary gland development (GO:0030879) 0.0011 
   GO cellular component  
Basement membrane (GO:0005604) 0.0019 
Extracellular matrix part (GO:0044420) 0.0026 
Transcription factor complex (GO:0005667) 0.0033 
Synapse (GO:0045202) 0.005 
Extracellular matrix (GO:0031012) 0.0092 
Ionotropic glutamate receptor complex (GO:0008328) 0.011 
Axon (GO:0030424) 0.012 
STAGA complex (GO:0030914) 0.02 
Synaptic membrane (GO:0097060) 0.021 
Ruffle (GO:0001726) 0.027 
   GO molecular functions 
Calcium ion binding (GO:0005509) 0.00061 
Estrogen receptor binding (GO:0030331) 0.0021 
Calmodulin binding (GO:0005516) 0.0047 
Growth factor activity (GO:0008083) 0.0058 
Integrin binding (GO:0005178) 0.01 
Protein tyrosine kinase activity (GO:0004713) 0.011 
S100 protein binding (GO:0044548) 0.015 
Extracellular matrix structural constituent (GO:0005201) 0.015 
Hormone receptor binding (GO:0051427) 0.016 
Gamma-catenin binding (GO:0045295) 0.019 
†Top 10 GO processes are shown for each.   
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In general, the GO cellular components implicated a mix of structural components 
and neuronal/synaptic components (Table 3.4). The top two components were “Basement 
membrane” and “Extracellular matrix part”, which was also true for the DNA 
methylation GO analysis (Table 3.4;Table 3.2). “Transcription factor complex”, “Axon”, 
and synaptic components were implicated and were also present in the H3K4me3 
analysis (Table 3.4; Chapter 2). “Ionotropic glutamate receptor complex” was implicated 
and was also present in the H3K4me3 and shared lists (Table 3.4; Chapter 2). “STAGA 
complex” was implicated, but was not in any of the individual analyses (Table 3.4). The 
top molecular function was “Calcium ion binding” which was also true for all three 
histone lists (Table 3.4; Chapter 2). “Estrogen receptor binding” as well as several other 
receptor binding functions were implicated and also present in the DNA analysis (Table 
3.4; Table 3.2). The third to top function was “Calmodulin binding” and the fifth was 
“Integrin binding” neither of which were implicated in any of the other lists (Table 3.4).  
The combined list was submitted to three pathway analysis software suites (Table 
3.5). IPA implicated 22 total pathways; the top pathway was “Embryonic Development, 
Organismal Development, Cellular Development” (Figure 3.8). This pathway was not 
identified in any of the individual analyses. Four of the top six pathways were related to 
hematological/cardiovascular development and function (Table 3.5). Six pathways 
involved cell-to-cell signaling and interaction. Cell-to-cell signalling pathways were 
implicated in the histone analyses (Chapter 2). Four pathways involved cell death and 
survival; this term was also implicated in the DNA methylation analysis (Table 3.2; 
Table 3.4). Four pathways involved nervous system development, which was also 
identified in the H3K4me3 analysis. Three pathways involving lipid metabolism were 
implicated. Three lipid metabolism pathways were also implicated in the H3K4me3 
analysis (Chapter 2). Partek pathway identified four pathways enriched for genes in the 
combined DNA methylation and histone modification list (Table 3.4). The top affected 
pathway was “Peroxisome biogenesis” (Figure 3.9). The same pathway was implicated 
in the DNA methylation analysis using Partek as well as the DNA methylation KEGG 
analysis (Table 3.3). The KEGG analysis of the combined list did identify “Peroxisome”  
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Table 3.5 Pathways significantly enriched with genes proximal to DNA methylation 
or histone methylation changes†. 
Pathway name p-value 
   IPA  
Embryonic Development, Organismal Development, Cellular Development 10E-64 
Cardiac Hypertrophy, Cardiovascular Disease, Developmental Disorder 10E-56 
Humoral Immune Response, Protein Synthesis, Hematological System 
Development and Function 
10E-49 
Cellular Development, Cellular Growth and Proliferation, Hematological 
System Development and Function 
10E-41 
Skeletal and Muscular Disorders, Developmental Disorder, Hereditary 
Disorder 
10E-30 
Hematological System Development and Function, Tissue Morphology, 
Cell-To-Cell Signaling and Interaction 
10E-26 
Endocrine System Development and Function, Molecular Transport, Protein 
Synthesis 
10E-24 
Cell Death and Survival, Antimicrobial Response, Inflammatory Response 10E-23 
Cell-To-Cell Signaling and Interaction, Hematological System Development 
and Function, Immune Cell Trafficking 
10E-21 
Embryonic Development, Organismal Development, Cell-To-Cell Signaling 
and Interaction 
10E-20 
Cell-To-Cell Signaling and Interaction, Reproductive System Development 
and Function, Tissue Development 
10E-20 
Cell Death and Survival, Lipid Metabolism, Small Molecule Biochemistry 10E-20 
Cell Cycle, DNA Replication, Recombination, and Repair, Cellular 
Development 
10E-19 
Embryonic Development, Organismal Development, Cell Morphology 10E-19 
Cell Death and Survival, Cancer, Cellular Development 10E-19 
Cell-To-Cell Signaling and Interaction, Nervous System Development and 
Function, Behavior 
10E-18 
Lipid Metabolism, Small Molecule Biochemistry, Molecular Transport 10E-18 
Cell Morphology, Cell Death and Survival, Nervous System Development 
and Function 
10E-16 
Cell-To-Cell Signaling and Interaction, Nervous System Development and 
Function, Cellular Development 
10E-16 
Lipid Metabolism, Small Molecule Biochemistry, Vitamin and Mineral 
Metabolism 
10E-15 
Tissue Morphology, Embryonic Development, Organismal Development 10E-15 
Nervous System Development and Function, Cellular Development, Tissue 
Morphology 
10E-14 
   Partek Pathway  
Peroxisome  0.008 
Hematopoietic cell lineage  0.01 
Notch signalling pathway  0.032 
110 
 
ABC transporters  0.036 
  Enrichr KEGG  
Notch signaling pathway 0.040 
Bladder cancer 0.048 
†p-values for each entry are shown (Fishers exact test). For a list of genes in each 
pathway, see Appendix H. 
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Figure 3.8 Top affected Ingenuity Pathway Analysis (IPA) pathway for genes 
proximal to either a DNA methylation or histone methylation change. 
Pathway is titled “Embryonic Development, Organismal Development, Cellular 
Development” (IPA score 64). Red indicates proteins whose encoding genes are proximal 
to a DMR or RDHM which is associated with increased gene expression, green indicates 
those predicted to decrease gene expression. For full legend of symbols used, see 
Appendix B. 
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Figure 3.9 Top Partek pathway for genes proximal to either a DNA methylation or 
histone methylation change. 
Pathway is titled “Peroxisome biogenesis”. Red indicates proteins whose encoding genes 
are proximal to a DMR or RDHM which is associated with increased gene expression, 
green indicates those predicted to decrease gene expression.  
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as well, however; it a p-value of 0.070, and as this did no meet the cut-off it was not 
shown. “Notch signalling pathway” was also implicated in both the Partek and KEGG 
analyses of the combined list (Table 3.5). “Hematopoietic cell lineage” was the second 
Partek pathway, which was also identified in the DNA methylation analysis (Table 3.3; 
Table 3.5). Given the implication of peroxisomes in both analyses, oxidative damage to 
hippocampal DNA was assessed. No difference in the DNA oxidative damage marker 8-
hydroxy-2' -deoxyguanosine (8-OHdG) was found (Figure 3.10). 
3.4.5.1 DNA Methylation Confirmations 
To confirm differential methylation of cytosines in the identified DMRs, sodium 
bisulfite pyrosequencing was performed. Five DMRs were selected for confirmation 
(Table 3.6). Two genes were selected which also showed differential expression on the 
microarray: Tcf7l2 and Mafg. Three genes were selected from the “Peroxisome 
biogenesis” Partek pathway: Acaa1, Pex6, and Pxmp2. Primers were designed to target as 
many CpG cytosines in each DMR as possible (Table 3.6). There were three DMRs 
proximal to Mafg, the DMR selected for analysis was upstream of the TSS and had a 
reciprocal change in methylation relative to gene expression. One cytosine was confirmed 
to have a decrease in methylation in the region proximal to Acaa1 (Figure 3.11). This 
cytosine was located just outside of the DMR in intron 2 (Figure 3.12). There was also a 
nominally significant change in the Pex6 DMR (Figure 3.11). 
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Figure 3.10 Quantification of oxidative damage to DNA in ethanol-exposed vs. 
control mice.  
Absolute 8-OHdG levels for each sample were normalized to input DNA amount to 
obtain the 8-OHdG percentage in total DNA. Data are mean ± standard error. p=0.16 
(Paired Samples t-Test) 
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Table 3.6 Percentage methylation of CpG cytosines in gene of interest differentially 
methylated regions (DMRs) as assessed by bisulfite pyrosequencing†. 
Gene Location From 
TSS 
(bp) 
Mixing 
control 
R2 
Ethanol 
methyl-
ation 
(%) 
Ethanol 
SEM 
Control 
methyl-
ation 
(%) 
Control 
SEM 
T-test 
p-value 
Mafg chr11:120625270 8331 0.90 5.55 0.37 6.12 0.69 0.44 
 
chr11:120625261 8340 0.95 13.77 0.16 13.68 0.98 0.45 
 
chr11:120625225 8376 0.95 3.46 0.52 4.23 0.35 0.37 
 
chr11:120625205 8396 0.93 3.27 0.28 4.30 0.36 0.44 
 
chr11:120625131 8470 0.95 2.30 0.09 1.41 0.72 0.13 
Acaa1 chr9:119342321 1028 0.99 72.18 0.58 71.94 1.75 0.26 
 
chr9:119342332 1039 0.99 68.07 1.59 68.32 1.74 0.29 
 
chr9:119342352 1059 1.00 61.70 1.35 64.89 1.25 0.49 
 
chr9:119342366 1073 1.00 74.24 1.10 75.49 1.10 0.10 
 
chr9:119342378 1085 0.98 63.52 0.60 64.54 1.58 0.04 
Pex6 chr17:46706646 -4817 0.97 94.02 1.52 93.72 0.72 0.22 
 
chr17:46706661 -4802 0.99 93.74 0.31 95.33 0.90 0.06 
 
chr17:46706678 -4785 0.96 87.63 0.45 87.28 1.71 0.12 
 
chr17:46706715 -4748 0.98 98.52 0.93 98.97 0.68 0.17 
Pxmp2 chr5:110285970 217 0.97 0.00 0.00 1.37 1.37 0.21 
 
chr5:110285964 223 0.98 1.71 0.90 4.91 0.42 0.35 
 
chr5:110285959 228 0.97 0.00 0.00 0.00 0.00 N/A 
 
chr5:110285948 239 0.90 2.04 1.02 1.40 1.40 0.22 
 
chr5:110285944 243 0.95 0.00 0.00 0.00 0.00 N/A 
 
chr5:110285940 247 0.97 0.00 0.00 0.00 0.00 N/A 
 
chr5:110285908 279 0.96 0.00 0.00 0.00 0.00 N/A 
 
chr5:110285878 309 0.96 0.00 0.00 0.00 0.00 N/A 
Tcf7l2 chr19:55745017 3208 0.92 46.89 1.26 50.40 0.94 0.40 
 
chr19:55745023 3214 0.96 38.90 0.54 40.58 1.46 0.17 
†Genomic location and distance from nearest gene transcriptional start site (TSS) are 
shown for each CpG cytosine. Mixing control R2 value is shown for each location. Mean 
of n=3 samples and standard error of the mean (SEM) are shown for control and ethanol-
exposed mice. The p-value for a Paired Samples t-Test comparing these two groups is 
shown for each cytosine.   
  
116 
 
 
 
Figure 3.11 Confirmation of cytosine methylation changes in peroxisome genes. 
Percentage cytosine methylation for each was assessed for n=3 samples per group using 
pyrosequencing. Data shown are mean ± standard error. *p<0.05. 
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Figure 3.12 Location of differentially methylated CpG position in of Acaa1 gene. 
Bars denote Acaa1 exons, lines denote introns, grey bars denote untranslated regions, and 
black bars denote coding sequence. Yellow bar shows location of DMR from microarray. 
Red line shows location of 3.2% decrease in methylation at cytosine in CpG site in 
ethanol-exposed mice (Paired Samples t-Test). Not pictured an additional DMR 3.7 kb 
upstream, 1.2 kb in size.  
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 Discussion  
There were hundreds of DNA methylation changes identified using MEDIP-chip. 
Interestingly, the changes were predominantly increases in methylation. This finding 
became more pronounced as the p-value cut-off of the DMR was increased and also 
remained true regardless of the region: gene promoters, CpG islands, and miRNA 
promoters (Table 3.1). The majority of FASD methylation studies have found global 
hypomethylation after ethanol exposure, consistent with ethanol-impaired cellular 
methylation processes. The findings presented in this chapter corroborate one of the few 
studies of similar design, which found hypermethylation in the hippocampus following 
neonatal ethanol exposure in a rat model of FASD (Otero et al., 2012). The effect of 
ethanol on the methylome is not simple, with timing, dosage, and tissue/cell type offering 
dramatically different results. However, the findings may be reproducible with similar 
experimental designs. This hypermethylation may be explained be ethanol-induced 
changes in oxidative stress pathways, which also impact methyl donor metabolism 
(Wallace and Fan, 2010). It may be that this particular ethanol-exposure regime results in 
specific cellular conditions leading to DNA hypermethylation.  
The RMS algorithm, which was not used for analysis, indicated nearly equal 
increases and decreases in methylation. RMS is simply the AMS normalized to the 
number of CpG within the region. It is especially useful from comparing regions with 
different CpG densities (Pelizzola et al., 2008). As such, it was not used in this study, in 
which only the same regions are compared between treatment groups. The difference 
between these two algorithms (i.e. hypermethylation in AMS) is likely due to many 
increases in methylation occurring to relatively few CpGs in CpG dense regions. This is 
an important consideration of the AMS dataset, as it indicates numerous regions have 
increased methylation, but not all CpG cytosines in these regions are methylated.  
3.5.1 Differential Methylation of Growth and Lysosomal Genes  
Both the GO and pathway analyses of the DNA methylation data implicated 
differential methylation at cell growth and development genes. GO analysis implicated 
myeloid cell differentiation, as well as cell growth and development. Three of the top ten 
biological processes were related to hormone response (Table 3.2). There was also one 
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lipid and one neuron-related process. In line with the GO analysis, all five IPA pathways 
related to cell growth and development or cell death. Despite these pathways having 
similar names, they contain very different genes, with only seven genes occurring in 
more than one pathway (Ddx5, Polr2a, Tmem97, Egr2, Numbl, Thpo, and Cdc25c). 
Polr2a encodes the largest component of the RNA polymerase II complex. Ddx5 is 
involved in mRNA splicing. Egr2, Thpo, and Cdc25c are involved in cell cycle and cell 
growth regulation. Numbl is involved in embryonic neurogenesis.  
 “Peroxisome” and “Lysosome” were implicated by both Partek and KEGG 
pathway analysis. Though these are both similar organelles in terms of general structure, 
the genes implicating them were completely different (Table 3.3). Lysosomes are 
organelles which contain hydrolytic enzymes and are responsible for breaking down 
cellular waste. They are also involved in repair, cell signalling, and metabolism 
(Settembre et al., 2013). In the developing brain, lysosomal autophagy is believed to be a 
response to ethanol-induced neurotoxicity and oxidative stress (Chen et al., 2012). 
Interestingly, peroxisomes, which modulate oxidative stress, were also implicated in 
pathway analysis. Peroxisomes are discussed in conjunction with the combined 
methylation results below. Ap1g2, Lamp2, Ap1s1, Tcirg1, Ctsd, and Ctsb  
3.5.2 Combined Gene Ontology and Pathway Analysis  
The DNA methylation changes discussed above do not occur in isolation in the 
mouse hippocampus. The histone modification changes from Chapter 2 are present in the 
same tissue at the same time. Biologically, DNA methylation and histone modification 
cooperate and engage in complex cross-talk to regulation the chromatin environment 
(Cedar and Bergman, 2009). Therefore, a combined list of the genes proximal to either 
DNA methylation DMRs or histone modification RDHMs was created to give a more 
complete picture of the impact ethanol. In general, the GO and pathway analyses of the 
combined methylation genelist found a mix of the processes implicated by the individual 
histone and DNA methylation analyses. There were instances of emergent hits not 
present in the top ten processes of any component analysis. These processes indicate a 
modest enrichment of these genes in each list, that become more significant when the 
lists are considered cumulatively. Identifying hits such as these was the intended purpose 
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of analyzing the combined lists. As the individual lists are discussed in their respective 
chapters, this section will focus on the emergent processes and pathways.  
3.5.2.1 GO Analysis  
The penultimate GO biological process was “Regulation of neuron 
differentiation” which was not implicated in any of the individual GO analyses. “CD4-
positive, alpha-beta T cell activation” was also implicated, but not in any of the 
individual lists (Table 3.4). Differentially methylation of genes involved in neuron 
differentiation has clear relevance to FASD in the brain. The relevance of T cell genes in 
the brain is less clear, as T cells are normally prohibited from crossing the blood brain 
barrier; however they can cross under numerous pathological conditions (Takeshita and 
Ransohoff, 2012). Differential methylation of T-cell genes may also represent a more 
general epigenomic response to inflammation, which is a key component of FASD 
etiology (Drew et al., 2015).  
In general, the cellular components were a mix of structural components 
implicated from the DNA methylation gene list and cell-cell communication genes 
implicated from the histone lists. An exception was “STAGA complex” which was not in 
any of the individual analyses (Table 3.4). The STAGA complex is transcriptional co-
activator protein complex responsible for histone acetylation during transcription, DNA 
repair, and splicing (Martinez et al., 2001). STAGA genes are crucial for 
neurodevelopment and their depletion is associated with numerous neurodegenerative 
diseases (Wang and Dent, 2014). The top molecular function was “Calcium ion binding” 
which was also true for all three histone lists (Table 3.4; Chapter 2). “Estrogen receptor 
binding” as well as several other receptor binding functions were implicated and also 
present in the DNA analysis (Table 3.4; Table 3.2). The third to top GO molecular 
function was “Calmodulin binding”. Calmodulin is a calcium-binding messenger protein 
involved in mediating Ca2+ signaling cascades. Calmodulin is critical for propagating 
nerve impulses, and may also be involved in ethanol-induced neurotoxicity (Caillard et 
al., 1999; Flentke et al., 2014). Differential methylation of calmodulin binding proteins 
may represent an epigenomic response to early ethanol exposure.   
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3.5.2.2 Pathway Analysis  
IPA implicated 22 total pathways. The top pathway was “Embryonic 
Development, Organismal Development, Cellular Development” (Figure 3.6). This 
pathway was not identified in any of the individual analyses. A hub of this network is 
proinsulin, which is regulated by Tcf7l2, which was differentially expressed (Chapter 4). 
Proinsulin is the precursor of the peptide hormone insulin. Deregulation of insulin 
signalling and insulin resistance in the CNS are a key feature of FASD (Dembele et al., 
2006a; de la Monte and Wands, 2010). Four of the top six pathways were related to 
hematological/cardiovascular development and function (Table 3.3). There were very 
few cardiovascular pathways implicated in the histone or DNA methylation analyses.  
“Cellular Development, Cellular Growth and Proliferation, Hematological System 
Development and Function” was identified in this analysis, and the exact same pathway 
was identified in previous work by our laboratory in GD18 fetus (Mantha et al., 2014). 
None of the same genes were identified however. Malformations in the heart and 
cardiovascular system are a major component of FASD; congenital heart disease is 
present in in 67% of individuals with FAS (Burd et al., 2007). Changes in epigenetic 
regulation of heart genes may not be functional in the hippocampus, but if they also 
occurred in the heart they may be involved with FASD-induced heart defects. The 
implication of these pathways may arise from the presence of blood in the brain samples. 
In order to flash freeze hippocampal tissue as fast as possible to preserve RNA quality, 
the mice in this study were not perfused. This means that blood is still present in the 
vasculature of the hippocampus. Thus, some of the blood epigenome is likely represented 
in the epigenomic and transcriptomic data.  
Only one pathway—“Endocrine System Development and Function, Molecular 
Transport, Protein Synthesis Six” —was implicated in the H3K27me3 another analysis 
(Chapter 2). Many pathways had similar terms however. There were cell-to-cell 
signalling and nervous system development pathways which were also identified in the 
H3K4me3 analysis (Chapter 2). Cell death and survival pathways were also prevalent in 
the DNA methylation analysis (Table 3.3). Three pathways involving lipid metabolism 
were implicated. Three lipid metabolism pathways were also implicated in the H3K4me3 
analysis (Chapter 2). Interestingly, the top Partek pathway, “Peroxisome biogenesis” was 
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also related to lipid metabolism (Figure 3.9). The same pathway was implicated in the 
DNA methylation analysis using Partek as well as the DNA methylation KEGG analysis 
(See below for discussion).  
Notch signaling was implicated by both Partek pathway and KEGG analyses 
(Table 3.5). The same genes made up both pathway lists. Notch signaling promotes 
neurogenesis in both embryonic development and the adult brain (Imayoshi and 
Kageyama, 2011). Notch proteins are expressed in the adult brain and appear to be 
involved in learning and memory (Costa et al., 2003). There is also evidence that Notch 
signaling is dysregulated in some early developmental models of FASD (Sarmah et al., 
2016). Changes in epigenetic marks at Notch signaling genes could represent a 
maintained “footprint” of ethanol exposure (see Chapter 5). 
3.5.3 Peroxisome Biogenesis Pathway  
The top network from the Partek DNA methylation (Figure 3.6) and combined 
methylation analysis (Figure 3.9) was “Peroxisome biogenesis”. Peroxisomes are 
membrane bound organelles found in all eukaryotic cells. Their main functions are the β-
oxidation of very-long-chain fatty acids (VLCFAs) and synthesis of ether lipids such as 
plasmalogens (Trompier et al., 2014). The β-oxidation genes Acaa1a (Acetyl-CoA 
Acyltransferase 1A) and Peci were proximal to hypermethylated DMRs. Acaa1a also had 
increased H3K4me3 levels. Importantly, peroxisomes are key to the redox balance of the 
cell; both generating and scavenging free radicals (Trompier et al., 2014). The ROS-
generating Nitric Oxide Synthase, Nos2, gene was proximal to a hypermethyalted DMR 
in this study. NOS2 is also involved in neurotransmission (Vincent, 2010). Peroxisome 
production in response to oxidative stress is regulated by the Pex genes, which assemble 
peroxisome structure and guide matrix proteins inside the organelle. The Pex26 and Pex6 
genes were proximal to hypermethylated DMRs in this study. PEX26 is a peroxisome 
biogenesis factor that anchors Pex1 and Pex6 to the peroxisomal membrane, and is likely 
required for protein import (Tamura et al., 2014). Five genes (Acsl4, Acsl6, Agt, Mpv17, 
and Mpv17l2) had only histone changes, being implicated in the combined analysis but 
not the DNA methylation analysis (Table 3.4). 
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Due to the potential for oxidative damage to hippocampal cells, levels of 8-
hydroxy-2' -deoxyguanosine (8-OHdG) were assessed in the genomic DNA. 8-OHdG is 
an excellent biomarker of oxidative DNA damage, as it is directly caused by free radicals. 
Further, it has high potential for detrimental effects include G-to-T transversions, and 
inappropriate binding of DNA methylation proteins such as MBD (Valavandis et al., 
2009). There was no change in 8-OHdG in the mice used for the MeDIP analysis (Figure 
3.10). 8-OHdG is repaired by DNA repair enzymes, and thus may not have persisted to 
PND 70 if it were induced (Valavandis et al., 2009). Other oxidative damage such as lipid 
peroxidation is not repaired, and has been observed in long-term FASD models (Petkov 
et al., 1992). Thus, examination 8-OHdG much earlier or other macromolecules at PND 
70 may have identified changes in this experiment.   
Oxidative stress is a well characterized component of FASD etiology. Ethanol 
acts directly on mitochondria to produce superoxide, hydroxide, and nitric oxide radicals 
(Wu and Cederbaum, 2003). Metabolism of ethanol by cytochrome CYP2E1 produces 
oxidized products and ultimately hydroxide radial generation (Mansouri et al., 2001). 
Catalase also produces acetaldehyde from alcohol in the brain, further increasing the 
formation of ROS (Shaw, 1989). Oxidative damage can lead to blood-brain barrier 
impairment, inflammation, and increased apoptosis (Haorah et al., 2008). Interestingly, 
these are also key features of FASD etiology. Indeed, oxidative damage is observed in 
many rodent models of FASD, including lipid peroxidation, protein oxidation, and DNA 
damage (Brocardo et al., 2011). Lipid peroxidation is not often present in young animals, 
but accumulates over time into adulthood (Dembele et al., 2006b). In a Drosophila model 
of developmental ethanol exposure, changes in expression of antioxidant genes 
contributed to oxidative stress in adult flies (Logan-Garbisch et al., 2014). Further, this 
increased oxidative stress was a primary cause of developmental delay associated with 
ethanol exposure (Logan-Garbisch et al., 2014).  
Peroxisomes are being explored as a target for FASD therapies. A class of drugs 
known as PPAR (Peroxisome proliferator-activated receptor) agonists were initially 
developed to treat other disorders. PPARs are nuclear receptors that act as transcription 
factors when activated by ligand binding. PPARα is important for lipid metabolism in the 
liver; when activated by fatty acid ligands it transcribes hundreds of target genes. PPARγ 
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is activated by prostaglandins and regulates fatty acid storage and glucose metabolism. 
The PPARγ agonist pioglitazone was developed to treat diabetes (Bajaj et al., 2007). 
Several researchers later noted that pioglitazone reduced inflammation, including 
inhibition of microglia activation and cytokine production in the brain (Bernardo et al., 
2000; Petrova et al., 1999). Kane et al. (2011) found that co-administration of 
pioglitazone with ethanol prevented cultured granule cells and microglia from the toxic 
effects of ethanol (Kane et al., 2011). A subsequent in vivo study found that co-
administration of pioglitazone and ethanol from PND4-9 prevented ethanol-induced 
increases in cytokines interleukin-1β and tumor necrosis factors in the hippocampus 
(Drew et al., 2015). These studies suggest that upregulation of peroxisome (and other) 
gene expression may prevent inflammatory responses associated the brain’s response to 
FASD-induced oxidative stress.  
3.5.4 Pyrosequencing Confirmations  
CpG cytosines in five DMRs were investigated using pyrosequencing. A 3.2% 
decrease in the methylation of one CpG in the Acaa1 regulatory region was confirmed 
(Figure 3.11). As stated above, this gene is critical for the peroxisomal β-oxidation. No 
other statistically significant changes were identified, though one nominally significant 
(p=0.057) decrease in methylation occurred at one cytosine in the Pex6 DMR (Figure 
3.11). PEX6 is a membrane-associated protein which is necessary for import of 
peroxisome proteins. Mutations in both Acaa1 and Pex6 cause peroxisome biogenesis 
disorders in (Trompier et al., 2014). One possible reason for not confirming more 
methylation changes by pyrosequencing was the use of anti-methylcytosine antibody for 
the MeDIP-chip. This would allow any differences in cytosine methylation, not just CpG 
cytosines, to be identified by MeDIP analysis. Due to the limitations of bisulfite 
pyrosequencing assay design, only CpG cytosines could be assessed. Non-CpG 
methylation is highly abundant in the brain, representing 25% of all cytosine methylation 
in hippocampal dentate granule neurons (Guo et al., 2014). It is possible that the DMRs 
implicated by MeDIP-chip included many CpH cytosines methylation changes, which 
would not be assayed by pyrosequencing.  
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3.5.5 Conclusion  
This chapter describes genes and pathways affected by DNA methylation changes 
in the hippocampus in response to early ethanol exposure. These changes provide insight 
into the long-term effects of PAE on the epigenome. These genes and pathways were 
distinct from those affected by histone methylation changes. Analysis of the DNA 
methylation data with the histone data identified novel processes not found in any of the 
individual analyses. Cardiovascular pathways and notch signalling emerged as affected 
processes in the combined analysis. These processes are important to FASD etiology and 
their differential methylation in the hippocampus may be relevant. Peroxisome biogenesis 
was implicated in the DNA methylation analysis, and was the top affected pathway in the 
combined methylation analyses. Peroxisomes are key regulators of oxidative stress and 
lipid metabolism; upregulating their biogenesis is already being explored as a therapy for 
FASD.  
Footnote 
A modified version of this chapter has been published (Chater-Diehl et al., 2016). 
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Effects of Neonatal Ethanol Exposure on the 
 Hippocampal Transcriptome 
 Overview  
Gene expression changes are thought to be an important part of FASD etiology. 
PAE induces apoptosis, and numerous other changes at the cellular level; they are 
hypothesized to be involved in altered expression of important genes in response to 
ethanol. Further, small regulatory RNAs such as microRNAs (miRNAs) are believed to 
regulate the expression many genes in response to ethanol. Pervious work has 
investigated ethanol-responsive genes in various models of FASD. Prior to this thesis, no 
study has investigated long-term gene expression changes in the hippocampus in 
response to PAE. In this chapter, 59 genes and 60 miRNAs were found to be 
differentially expressed in 70-day-old mouse hippocampus after neonatal ethanol 
exposure. Gene ontology and pathway analysis found that the genes are enriched for 
several functions including oxidative stress-response, biosynthetic, and olfaction. Six 
genes from the top pathway “Free Radical Scavenging, Gene Expression, Dermatological 
Diseases and Conditions” were confirmed using droplet digital PCR. Several miRNAs 
identified have FASD-relevant regulatory functions, and many were implicated in 
pervious work. Gene expression data were also compared with the epigenetic methylation 
data from Chapters 2 and 3. Tcf7l2 was the only differentially expressed gene to have 
changes in H3K4me3, H3K27me3, and DNA methylation. Tcf7l2 may thus be a strong 
candidate gene for FASD given its role in oxidative stress amelioration, and the 
implication of peroxisome genes in the methylation analysis.  
 Introduction  
Assessment of the transcriptome allows for identification of genes which are 
responsive to a given condition. Eukaryotic protein-coding genes are transcribed from 
genomic DNA by RNA polymerase II (RNAPII) (Lee and Young, 2000). Transcription is 
regulated by numerous transcription factors and enhancer proteins that bind specifically 
to target genes (Lee and Young, 2000). The timing of these events coordinates expression 
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of target genes to necessary developmental and regulatory timepoints. Dysregulation of 
gene expression is associated with altered cellular function, and many disease conditions 
(Emilsson et al., 2008). Beyond single genes, alteration of transcriptome-wide expression 
patterns are observed in response to a variety of exposures and environmental factors 
including ethanol (Jaluria et al., 2007). Such studies assess these changes involving the 
whole transcriptome using microarrays.  
 Microarrays have become a common tool to assess the expression of a large 
subset of genes in one experiment. Developed in the 1990’s, microarrays provide 
enormous scale, allowing the entire transcriptome to be assessed simultaneously 
(Hoheisel, 2006). Microarrays permit hypothesis-free experimental design. The 
researcher does not need to have any preconceived knowledge of the experimental system 
or prior candidate genes in mind. Another main advantage of microarray analyses is the 
emergence of patterns in gene expression profiles (Khatri et al., 2012). The dysregulation 
of several genes in the same pathway may represent a meaningful biological change. 
Pathway analysis tools provide further insight into the biological impact of these groups 
of gene expression changes.  
It is often assumed that changes in mRNA expression translate into changes in 
protein abundance, and thereby affect cellular processes. However, data show only partial 
correlation between gene and protein expression levels. In mice, a study found a 
coefficient of determination of R2=0.41 between mRNA and protein expression levels for 
over 5000 genes, indicating only a moderate correlation between the two (Schwanhäusser 
et al., 2011). Many factors between mRNA and protein expression may account for this 
discrepancy. For instance, mRNAs are far less stable than proteins. Further, mRNAs are 
translated at a rate of approximately 2 per hour, whereas dozens of copies of the 
corresponding protein are produced (Schwanhäusser et al., 2011; Vogel and Marcotte, 
2012). Such factors also vary greatly between genes. Regardless of their applicability to 
protein levels, mRNA studies do make definitive statements on the available mRNA 
pool, and remain a popular tool in molecular biology.  
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4.2.1 Non-Protein-Coding RNAs 
MicroRNAs (miRNAs) are short (~26 base pair), non-protein coding RNA 
molecules that can regulate mRNAs. Like mRNAs, miRNAs are transcribed by RNAPII 
and have several similarities in their promoter motifs (Zhou et al., 2007). They are 
transcribed in stem-loop structures termed primary miRNAs (pri-miRNAs). These pri-
miRNAs can be found in protein-coding gene 3’UTRs, and can also contain up to six 
miRNA hairpin precursors (Lee et al., 2004). These are spliced out, and exported from 
the nucleus. In the cytoplasm, the RNA-induced silencing complex (RISC) processes the 
double-stranded hairpin precursor into a single-stranded mature miRNA (Rana, 2007). 
The mature miRNA can then regulate complementary mRNA by two methods: targeting 
the mRNA for degradation or preventing translation (Rana, 2007). Perfect pairing of the 
miRNA and mRNA target promotes degradation of the mRNA via endonucleolytic 
cleavage, whereas a mismatch promotes translational blockage mediated by the 
Argonaute family of proteins (Gu and Kay, 2010; Valencia-Sanchez et al., 2006). The 
latter is more common in mammalian cells. A single miRNA can target hundreds of 
mRNAs, and a single mRNA can be targeted by dozens of miRNAs. There are 
approximately 2200 miRNA genes in the in the mammalian genome, and about one third 
of the human genome is estimated to be regulated by miRNAs (Urbich et al., 2008).   
MiRNAs are important regulators of numerous development- and disease-relevant 
processes. MiRNAs are a key regulator of cellular differentiation due to their ability to 
influence expression of many genes simultaneously. Specific miRNA profiles have been 
observed in numerous cancers (Naeini and Ardekani, 2009). Targeting miRNAs has been 
suggested as a promising therapeutic strategy in cancer treatment (Cheng et al., 2014). 
MiRNAs are also important in neurological development and disease. Mammalian brains 
have a higher expression level of miRNAs than most other tissues (Babak et al., 2004). 
Several miRNAs have key regulatory roles during neurodevelopment, with alteration in 
their expression causing abnormal brain growth (Sun and Shi, 2015). They are also 
involved in complex brain functions such as learning and memory. Expression levels of 
specific miRNAs regulating signalling pathways during long-term potentiation (Wang et 
al., 2012). Many neurological diseases impact neuroplasticity, and many do so via 
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alteration in miRNA expression. Drug addiction, schizophrenia, and autism have well 
characterized associations with miRNA expression changes (Wang et al., 2012).    
4.2.2 Gene Expression Changes in FASD are Gene-Specific  
Gene expression changes have been studied in several FASD models. Gene 
expression changes are part of the mechanisms by which ethanol induces neuronal 
apoptosis (Ikonomidou, 2000). Exposure of embryos to ethanol early in gestation results 
in dysregulation of cell proliferation, differentiation, and apoptosis related genes (Hard et 
al., 2005). Ethanol can also cause changes in immune response and inflammation that are 
present at the transcript level. PAE mice with induced inflammation show distinct 
expression profiles in the hippocampus, failing to activate genes and regulators involved 
in the immune response (Lussier et al., 2015). Gene expression changes may also 
underlie morphological abnormalities in FASD. Cell growth, apoptosis, and histone 
variant genes were differentially expressed in a study of neural tube deficits following 
ethanol exposure to embryos in culture (Zhou et al., 2011). Further, expression profiles 
were specific to a neural tube phenotype, with closed and open tubes associated with 
neurotrophic/growth factor and histone variant genes respectively (Zhou et al., 2011).  
 In addition to expression profiles, there have also been studies characterizing the 
causal relationship between gene expression change and FASD phenotypes. A study 
found downregulation of sonic hedgehog (Shh) in embryonic neural crest cells associated 
with ethanol exposure in fetal chicks. Sonic hedgehog is responsible for cranio-facial 
development, with mutations causing severe facial abnormalities (Nanni et al., 1999). 
Addition of the SHH protein to ethanol-exposed chicks ablated cranio-facial deformities 
(Ahlgren et al., 2002). In another study, exposure of Xenopus embryos to ethanol resulted 
in malformation of the eye with associated changes in eye development genes (Peng et 
al., 2004). Reduction of oxidative stress via upregulation of catalase and of cytosolic and 
mitochondrial peroxiredoxin prevented the gene expression changes and malformations 
(Peng et al., 2004). In a study using mouse whole-embryo culture, many developmental 
morphology parameters (including hindbrain, midbrain, forebrain, and optic systems) 
were reduced in size by ethanol exposure. Treatment with capsaicin ameliorated most of 
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these morphogenic changes, likely via the increased antioxidant mRNA expression levels 
(Kim et al., 2008).  
MiRNA expression changes have also been associated with FASD. As in other 
neurological disorders, miRNAs differentially expressed in FASD disproportionately 
affect neurological development and function. Suppression of specific miRNAs in fetal 
neural stem cells (NSCs) and neural progenitor cells (NPCs) accounted for their 
resistance to apoptosis (Sathyan et al., 2007). Other studies have found miRNAs 
associated with cranial abnormalities (Sathyan et al., 2007). From these studies, it is clear 
that gene and miRNA expression changes can underlie the phenotypic effects of PAE. 
4.2.3 Gene Expression Changes in FASD are Pathway- and 
Network-Specific  
Pathway and network analysis are key tools for understanding how groups of 
affected genes may interact to affect a phenotype. Gene lists generated from microarray 
and sequencing experiments provide candidate genes for the phenotype. However, these 
lists do not provide mechanistic insight into the underlying biology. Reducing the gene 
list to smaller sets based on pathways reduces complexity. These pathways often provide 
more explanatory power than a single differentially expressed gene list (Khatri et al., 
2012). Many of these tools use over representation analysis (also known as enrichment 
analysis). Hundreds of biological pathways are assessed for the percentage of their 
component genes that are differentially expressed in the researcher experiment (Khatri et 
al., 2012). Using a Fisher’s exact test, the software determines the statistical significance 
of the overlap with each pathway. Partek pathway uses the well annotated list of Kyoto 
Encyclopedia of Genes and Genomes (KEGG) pathways. Ingenuity pathway analysis 
(IPA) uses a proprietary network database based on curated literature searches. Gene 
ontology analysis uses the same principle to assess enrichment of gene functions.  
4.2.4 Previous Results from the Singh Laboratory in FASD Models  
Previously, the Singh laboratory characterized gene expression changes in several 
FASD models. We have sought to identify genes responsive to PAE across various 
exposure regimes, developmental endpoints, and after mitigating or exacerbating factors. 
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Using the continuous preference drinking (CPD) model, significant gene networks were 
cellular and tissue development, free radical scavenging, lipid metabolism, and nervous 
system development in PND 70 mouse brain (Kleiber et al., 2012). This study identified 
relatively few (less than 20) differentially expressed genes with greater than a 1.2 fold 
change (p<0.05). In another study in this model, we assessed miRNA expression changes 
in addition to gene expression changes. There was an enrichment of miRNAs with roles 
in neuronal development and function, as well as an enrichment (20%) of miRNAs which 
targeted imprinted regions (Laufer et al., 2013).  
In the trimester one model of exposure, PND 60 mice showed dysregulation of 
genes involved in apoptosis, cell-cell signalling, and neurological disease (Mantha et al., 
2013). In the trimester two exposure model, short- (GD 16) and long-term (PND 70) gene 
expression changes in the whole-brain were assessed (Mantha et al., 2013).  These genes 
were enriched for apoptosis, free-radical scavenging, lipid metabolism, and neurological 
functions (Mantha et al., 2014). There were also 20 miRNAs differentially expressed in 
the PND 70 mice.  
In the trimester three PND 4,7 injection model, short (PND 7) and long (PND 60) 
gene expression changes in the whole-brain have been assessed. The short term mice 
showed dysregulation of apoptosis, lipid metabolism, and neurogenesis genes (Kleiber et 
al., 2014a). In adult mice, genes involved in glutamate signalling, neurological diseases, 
and cell-cell signalling were differentially expressed (Mantha et al., 2013). There were 
also 33 differentially expressed miRNAs at PND 60. Together, these previous whole-
brain studies have consistently implicated free radical scavenging, lipid metabolism, and 
brain development and function genes as well as several miRNAs.  
4.2.5 Gene Expression Changes in the Hippocampus  
The previous work from our laboratory used mouse whole-brain for gene 
expression microarray analysis. Gene expression patterns differ within the brain; 
approximately 50% of expressed genes are differently expressed between brain regions in 
mice and humans (Strand et al., 2007). Pooling all brain regions together will lose this 
heterogeneity. Changes in specific brain regions may also be washed out by expression in 
other regions. Furthermore, individual brain regions are associated with specific FASD-
141 
 
relevant behaviours, while the whole-brain is not associated with any single behaviour. 
For these reasons, this thesis examined a specific brain region, the hippocampus. The 
hippocampus is particularly vulnerable to the pro-apoptotic effects of ethanol 
(Ikonomidou, 2000). It is involved in the formation of new memories and visual/spatial 
memory  (Cho et al., 1999; Morris et al., 1982; Squire, 2009). Mice exposed to ethanol on 
PND 7 also show spatial learning and memory impairment, similar to mice with 
hippocampal lesions (Cho et al., 1999; Mantha et al., 2013). Children with FAS show 
similar spatial deficits (Hamilton et al., 2003; Uecker and Nadel, 1996, 1998). Changes in 
gene expression are associated with learning impairment in response to PAE (Subbanna 
and Basavarajappa, 2014). In this chapter, gene and miRNA expression changes in the 
hippocampus of PND 70 mice exposed to ethanol on PND 4 & 7 are assessed. 
Objectives  
1. To assess expression of all mouse protein coding genes and miRNAs in PND 70 
mouse hippocampus exposed to ethanol on postnatal days 4 and 7.  
2. To identify the ontology and pathway enrichment of differentially expressed 
genes.  
3. To confirm specific changes with qPCR/ddPCR. 
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 Materials and Methods 
4.3.1 Mouse Care 
For the full mouse care protocol, see Chapter 2 Materials and Methods. In brief, 
all protocols were approved by the Animal Use Subcommittee (AUS) at the University of 
Western Ontario, London, Ontario, Canada. The day of birth was termed PND zero. Sex 
and weight-matched littermate pups were divided into two groups: ethanol-treated and 
saline-injected control mice. Pups were given two subcutaneous dorsal injections on both 
PND 4 and PND 7. Ethanol-treated mice were injected with 2.5 g/kg of ethanol in 0.15 M 
NaCl (Ikonomidou et al., 2000). Control mice were injected with 0.15 M saline only. 
Male mice were used for all subsequent analyses. The mice used in this chapter included 
the same mice used for the DNA methylation analysis in Chapter 3 (n=9 control and n=9 
ethanol-exposed mice; see Table 2.1). Mice were sacrificed on PND 70 via carbon 
dioxide asphyxiation. The hippocampus was dissected out (Spijker, 2011), snap-frozen in 
liquid nitrogen, and stored at -80°C for no longer than 30 days until formaldehyde 
fixation.  
4.3.2 DNA/RNA Isolation  
 DNA and RNA were isolated with AllPrep DNA/RNA Mini Kit (Qiagen, 
Valencia, CA, USA) according to the manufacturer’s protocol. This kit allows DNA and 
RNA to be isolated from the same hippocampal sample. DNA and RNA were stored at  
-20°C and -80°C respectively.  
4.3.3 Gene and miRNA Expression Microarray  
Nine ethanol-exposed and nine control hippocampus samples were used for 
expression analysis. RNA quality was assessed using the Agilent 2100 Bioanalyzer 
(Agilent Technologies Inc., Palo Alto, CA) and the RNA 6000 Nano kit (Caliper Life 
Sciences, Mountain View, CA). RNA from three non-littermate males was then pooled 
for microarray analysis on three separate arrays per treatment group.  
 All sample labeling and GeneChip processing was performed at the London 
Regional Genomics Centre (Robarts Research Institute, London, Ontario, Canada; 
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http://www.lrgc.ca). RNA quality was assessed using the Agilent 2100 Bioanalyzer 
(Agilent Technologies Inc., Palo Alto, CA) and the RNA 6000 Nano kit (Caliper Life 
Sciences, Mountain View, CA). Single-stranded complimentary DNA (sscDNA) was 
prepared from 200 ng of total RNA as per the Ambion WT Expression Kit for Affymetrix 
GeneChip Whole Transcript WT Expression Arrays 
(http://www.ambion.com/techlib/prot/fm_4411973.pdf, Applied Biosystems, Carlsbad, 
CA) and the Affymetrix GeneChip WT Terminal Labeling kit and Hybridization User 
Manual (http://media.affymetrix.com/support/downloads/manuals/wt_term_label_ambion 
_user_manual.pdf, Affymetrix, Santa Clara, CA).  
Total RNA was first converted to cDNA, followed by in vitro transcription to 
make cRNA. 5.5 μg of single stranded cDNA was synthesized, end labeled and 
hybridized, for 16 hours at 45°C, to Mouse Gene 1.0 ST arrays (Affymetrix, Santa Clara, 
CA). One microgram of total RNA was labeled using the Flash Tag Biotin HSR kit from 
Genisphere (http://www.genisphere.com/array_detection_flashtag_biotin.html).  Samples 
were then hybridized to Affymetrix miRNA 2.0 arrays for 16 hours at 48°C. All washing 
steps were performed by a GeneChip Fluidics Station 450 and GeneChips were scanned 
with the GeneChip Scanner 3000 7G (Affymetrix, Santa Clara, CA) using Command 
Console v1.1. 
Probe level (.CEL file) data was generated using Affymetrix Command Console 
v1.1.  Probes were summarized at the miRNA and gene level using RMA (Irizarry et al., 
2003). Partek was used to determine ANOVA p-values and fold changes for genes and 
miRNAs. Species annotations were added and used to filter miRNAs. Partek Pathway 
and Ingenuity pathway analysis (IPA) were used to determine and visualize significantly 
enriched pathways (using a Fisher’s exact test). Gene list was also uploaded to Enrichr 
(Chen et al., 2013) for Gene Ontology (GO) analysis. .CEL files and log2 normalized 
files were uploaded to GEO. An FDR q-value < 0.05 was used to determine multiple 
testing error; no transcripts survived this threshold.   
4.3.4 Gene-Specific Confirmations  
 Purified RNA was converted to cDNA using the High-Capacity cDNA Reverse 
Transcription Kit (Thermo-Fisher). cDNA was diluted 10-fold and stored at -20°C until 
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use. Individual genes were investigated with TaqMan® assays (Applied Biosystems), 
assays IDs: Vipr2: Mm01238618_g1; Synpo2: Mm03809162_m1; Tcf7l2: 
Mm00501505_m1; Casp3: Mm01195085_m1, Krt8: Mm04209403_g1; L3mbtl4: 
Mm00623914_m1, Stac; Mm00450338_m1, Mafg: Mm00521961_g1, Tmem79: 
Mm00470361_m1, Defb4: Mm00731768_m1. For all assays, TATA binding protein 
(TBP) was used as a reference gene: Mm01277042_m1. Individual (i.e. not pooled) 
ethanol-exposed (n=7) and control (n=7) samples from the gene expression microarray 
were used for these analyses. Four samples from the microarray experiment (E17.1, 
C17.2, E19.7, C19.8) could not be included as they had insufficient RNA remaining for 
cDNA synthesis.  
4.3.4.1 Real-Time PCR 
For each assay, the gene of interest and Tbp reference gene were run in multiplex 
using FAM and VIC labeling respectively. Reactions were prepared using TaqMan® 
Gene Expression Master Mix (Applied Biosystems). Each sample was run in three 
technical replicates. The probe/primer pairs for each gene of interest were multiplexed 
with TBP primer/probe; 10 μl reactions were used. Gene expression levels were 
quantified using the comparative delta Ct, or delta delta Ct (ΔΔCt) method, where Ct 
refers to critical threshold when the amplification signal rises above background levels. 
ΔΔCt, relative quantity, and fold change were calculated by the StepOne software. 
DataAssist software (Applied Biosystems) was used for statistical analysis, in which 
average ΔΔCt values for each technical replicate were averaged (after removing any 
outliers), and treatment groups were compared using a Paired Samples t-Test with 
littermates paired.  
4.3.4.2 Droplet Digital PCR 
 For each assay, the gene of interest and TBP reference gene were run in multiplex 
using FAM and VIC labeling respectively. Reactions were prepared using ddPCR™ 
Supermix for Probes (BioRad), cDNA, and probes according to the manufacturer’s 
protocol. Droplets were generated from the reactions using Droplet Generation Oil for 
Probes (BioRad) on the QX100 Droplet Generator (BioRad) according to the 
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manufacturer’s protocol. Droplets were cycled on the C1000 Touch Thermal Cycler 
(BioRad) for 40 cycles, 60°C annealing temperature, 2°C/sec ramp speed. Droplets were 
read using the QX100 Droplet Reader (BioRad). Data were analyzed in QuantaSoft 
software (BioRad). All samples had between 17000-20000 droplets indicating high-
quality. The concertation of each RNA species and ratio of gene of interest/reference 
gene concentration were calculated using QuantaSoft for each sample. Each DNA sample 
was run in three technical replicates, the average ratio across technical replicates for each 
sample was calculated manually. Each cDNA sample’s average ratio was used to 
compare ethanol-exposed to control samples using a paired sample Paired Samples t-Test 
with littermates paired. Averages were normalized to 1.00 relative expression level for 
control group.  
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 Results  
4.4.1 Differentially Expressed Genes 
To describe which transcripts were significantly differentially expressed in the 
PND 70 mouse hippocampus following PND 4,7 ethanol exposure, a fold-change cut-off 
of >1.2 or <-1.2 as well as an ANOVA p-value<0.05 were used to determine statistical 
significance. These cut-offs are relatively standard in PAE research in the Singh 
laboratory and others; they are intended to be permissive enough to capture the subtle 
effects of ethanol without excessive false positives. There were 317 transcripts meeting 
these criteria, which were visualized using a heat map (Figure 4.1). The distance tree 
shows that the control and ethanol-exposed groups cluster together. The relative 
expression level for each transcript was quite consistent across the three biological 
replicates, indicating a consistent effect of ethanol on the abundance of each (Figure 4.1).  
Of these differentially expressed transcripts, there were 59 annotated genes differentially 
expressed at a fold cut off>1.2 and p<0.05 (Table 4.1). Two thirds of these were 
upregulated, and one third down-regulated in response to ethanol. The largest increase in 
expression was 1.5 fold and the largest decrease was -1.39 fold.  
4.4.2 Ontology of Differentially Expressed Genes 
Known and predicted interactions between proteins encoded by differentially 
expressed genes were assessed using GeneMania. The resulting network illustrates that 
there were relatively few known functional relationships between these genes. The most 
common relationships were co-expression or co-localization (Figure 4.2). Gene ontology 
(GO) analysis was performed to categorize differentially expressed genes, and assess 
their biological impact. The list of 59 differentially expressed genes (fold cut-off>1.5, 
p<0.05) was used for GO analysis using Enrichr (Chen et al., 2013). The top affected 
biological processes include various biosynthetic processes such as dicarboxylic acid, 
kynurenine, and tryptophan metabolism (Table 4.2). “Intrinsic apoptotic signaling 
pathway in response to oxidative stress” was also implicated, which is particularly 
relevant to FASD. The top affected cellular components include various structural 
components such as Z-disc, contractile fiber, and plasma membrane (Table 4.2). The top  
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Figure 4.1 Heirarchical clustering of expression patterns from indiviual 
mircoarrays. 
Differentailly expressed transcripts with fold changes>1.2 and p<0.05 are shown. 
Distance trees show similaries in expression patterns among  genes and among 
experimental groups. Consistencey of expression changes across biological repilcates is 
evident for each gene by the consistencey of the fold (colour) change.  
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Table 4.1 Differentailly expressed genes in response to neonatal ethanol exposure in 
the adult mouse hippocampus†.  
Gene Symbol p-value Fold 
change Tcf7l2 0.032 1.50 
Synpo2 0.047 1.43 
Vipr2 0.043 1.42 
Cypt2 0.012 1.40 
Defb5 0.002 1.39 
Serpinb1b 0.027 1.35 
Gm8994 0.021 1.32 
Gm7168 0.016 1.31 
Olfr119 0.007 1.30 
Vmn2r15 0.049 1.29 
Cfhr2 0.023 1.29 
LOC10003842
2 
0.025 1.28 
Nup210l 0.037 1.27 
Kmo 0.024 1.27 
Tmprss11a 0.049 1.26 
BC094916 0.036 1.26 
Krt8 0.013 1.25 
Olfr539 0.035 1.25 
Slitrk6 0.023 1.24 
Cd209f 0.031 1.24 
Krt39 0.008 1.23 
Olfr121 0.026 1.23 
Gm11362 0.041 1.23 
Hcn4 0.048 1.23 
Olfr1018 0.022 1.23 
Cdnf 0.044 1.23 
Casp3 0.021 1.23 
4933416I08Rik 0.049 1.22 
Vmn2r109 0.022 1.22 
Stac 0.029 1.22 
Vmn1r5 0.042 1.21 
Dnm3os 0.050 1.21 
Olfr648 0.003 1.21 
Olfr1131 0.026 1.21 
4930524N10Ri
k 
0.006 1.21 
Gm4801 0.011 1.21 
Mrgprh 0.007 1.21 
Gm11437 0.026 1.20 
Apol7a 0.010 1.20 
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C330022B21Ri
k 
0.020 -1.20 
1600015I10Rik 0.005 -1.20 
Gm4776 0.024 -1.20 
Olfr455 0.011 -1.20 
Olfr979 0.007 -1.21 
Mafg 0.036 -1.21 
Olfr2 0.022 -1.21 
Gm16551 0.006 -1.22 
4930401B11Ri
k 
0.047 -1.22 
L3mbtl4 0.040 -1.22 
D4Wsu53e 0.005 -1.22 
Olfr281 0.013 -1.24 
D730002M21R
ik 
0.045 -1.25 
BC055004 0.039 -1.25 
Hdx 0.015 -1.25 
Olfr1350 0.002 -1.26 
Crygb 0.011 -1.27 
Tmem79 0.027 -1.29 
Zfa 0.023 -1.31 
Dnahc7a 0.023 -1.39 
†n=3 ethanol-exposed and n=3 control microarrays. p-values deterimed using a one-way 
ANOVA, fold change in expression vs. control group deterimend using Partek RMA 
alorithm. Genes presented passed a fold cut off >1.2 and p<0.05. 
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Figure 4.2 Interaction network of published interactions between differentially 
expressed genes.  
Gene node increases with increased connections, line width decreases with number of 
connections from its node. Co-expression indicates expression levels are similar across 
conditions in a published gene expression study. Co-localization indicates genes 
expressed in the same tissue, or proteins found in the same cellular location. Predicted 
indicates a predicated functional relationship between genes, often protein interactions, 
based on data from other organisms. Examples of Other include phenotype correlations 
from Ensembl or disease information from OMIM. Protein domain indicates the same 
protein domain in each gene.  
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Table 4.2 Gene ontology (GO) analysis of differentially expressed genes†.  
GO term p-value 
   GO biological processes 
Dicarboxylic acid biosynthetic process (GO:0043650) 0.010 
Kynurenine metabolic process (GO:0070189) 0.010 
Genitalia morphogenesis (GO:0035112) 0.011 
Positive regulation of triglyceride biosynthetic process (GO:0010867) 0.011 
Positive regulation of glycoprotein biosynthetic process (GO:0010560) 0.012 
Positive regulation of gluconeogenesis (GO:0045722) 0.013 
Response to auditory stimulus (GO:0010996) 0.013 
Tryptophan metabolic process (GO:0006568) 0.013 
Positive regulation of protein export from nucleus (GO:0046827) 0.013 
Intrinsic apoptotic signaling pathway in response to oxidative stress 
(GO:0008631) 
0.017 
   GO cellular component  
Z disc (GO:0030018) 0.004 
Contractile fiber part (GO:0044449) 0.015 
Dystrophin-associated glycoprotein complex (GO:0016010) 0.020 
Intermediate filament (GO:0005882) 0.021 
Costamere (GO:0043034) 0.025 
Integral component of plasma membrane (GO:0005887) 0.028 
Intrinsic component of plasma membrane (GO:0031226) 0.038 
   GO molecular function 
Intracellular cAMP activated cation channel activity (GO:0005222) 0.008 
Muscle alpha-actinin binding (GO:0051371) 0.009 
armadillo repeat domain binding (GO:0070016) 0.009 
Cyclic nucleotide-gated ion channel activity (GO:0043855) 0.010 
Intracellular cyclic nucleotide activated cation channel activity 
(GO:0005221) 
0.010 
Gamma-catenin binding (GO:0045295) 0.011 
Cyclin-dependent protein serine/threonine kinase inhibitor activity 
(GO:0004861) 
0.011 
Oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor 
(GO:0050664) 
0.014 
14-3-3 protein binding (GO:0071889) 0.016 
Structural constituent of eye lens (GO:0005212) 0.018 
†Top 10 GO processes are shown where number of entries exceeds 20.    
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affected cellular components included various nucleotide-gated ion channels, as well as 
structural components and oxidoreductase activity (Table 4.2).  
4.4.3 Pathways Affected by Differentially Expressed Genes.  
The list of differentially expressed genes was also submitted to three separate 
pathway suites: Ingenuity Pathway Analysis (IPA), Partek Pathway, and Enrichr (Table 
4.3). The genes Casp3 and Tcf7l2 are responsible for implicating many of the genes in 
these pathways; one or both are present in >90% of the identified pathways. Casp3 
encodes Caspase-3 which is involved in apoptosis, Tcf7l2 encodes a transcription factor 
involved in Wnt signalling (D’Amelio et al., 2012). These two genes were also 
responsible for implicating pathways related to cancer and development across each 
software platform (Table 4.3). The top IPA pathway was “Free radical scavenging, gene 
expression, dermatological diseases and conditions” which also contained Tcf7l2 and 
Casp3 (Figure 4.3). The top Partek pathway was “Olfactory transduction”, implicated by 
10 olfactory receptor genes (Table 4.3). 
4.4.4 Gene-Specific Confirmations 
Five differentially expressed genes from the top IPA pathway (Figure 4.3) were 
selected for confirmation via real-time polymerase chain reaction (qPCR). Casp3, Mafg, 
Stac, Tcf7l2, and Vipr2 qPCR confirmations were attempted (Table 4.4). Though Vipr2 
and Tcf7l2 approached statistical significance, none of these genes were confirmed to be 
differentially expressed in ethanol-exposed mice. Since several genes approached 
significance, droplet digital PCR (ddPCR) was employed for each gene using the same 
cDNA samples. Casp3, Tcf7l2, and Vipr2 were confirmed using ddPCR (Table 4.4; 
Figure 4.4).  Mafg and Stac were non-significant (Table 4.4; Figure 4.4). Given this 
success, ddPCR was employed for four more genes, two from the top IPA pathway 
(Tmem79 and Krt8), one with a targeting miRNA (L3mbl4), and one with relevance to 
brain function (Synpo2). Synpo2 and L3mbl4 were confirmed, while Tmem79 and Krt8 
were not (Table 4.4). 
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Table 4.3 Pathways significantly enriched with differentially expressed genes. 
Pathway name Affected genes  p-value 
    IPA network/pathway  
Free Radical Scavenging, Gene 
Expression, Dermatological Diseases 
and Conditions 
Apol7a, Defb4, Dnah7, Hdx, 
Ifi204, Kmo, Krt8, Mafg Tcf7l2, 
Tmem79, Stac, Vipr2  
10E-31 
Cellular Development, Developmental 
Disorder, Hereditary Disorder 
Casp3, Tcf7l2 0.001 
Molecular Transport, RNA Trafficking, 
Cell Death and Survival 
Casp3, Kmo 0.001 
Cell Cycle, Nervous System 
Development and Function, Cell 
Signaling 
Casp3, Tcf7l2 0.001 
Cardiovascular System Development 
and Function, Skeletal and Muscular 
System Development and Function, 
Cell-To-Cell Signaling and Interaction 
Casp3, Hcn4 0.01 
  Partek pathway  
Olfactory Transduction  Olfr2, Olfr121, Olfr281, 
Olfr455, Olfr539, Olfr648, 
Olfr979, Olfr1018, Olfr1131, 
Olfr1350 
0.001 
Colorectal Cancer Casp3, Tcf7l2 0.012 
Amoebiasis Casp3, Serpinb1b 0.03 
  Enrichr KEGG 
Colorectal cancer Casp3, Tcf7l2 0.0012 
cAMP signaling pathway Hcn44, Vipr2 0.011 
Thyroid cancer Tcf7l2 0.025 
Tryptophan metabolism Kmo 0.034 
Pathways in cancer Casp3, Tcf7l2 0.041 
Amyotrophic lateral sclerosis (ALS) Casp3 0.043 
Endometrial cancer Tcf7l2 0.044 
Legionellosis Casp3 0.047 
Basal cell carcinoma Tcf7l2 0.047 
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Figure 4.3 Top IPA network for gene expression changes “Free Radical Scavenging, 
Gene expression, Dermatological Diseases and Conditions”. 
Red nodes represent proteins whose transcripts were increased in ethanol-exposed mice 
vs. controls, green nodes represent those that were decreased in ethanol exposed mice. 
Score determined in IPA was 31 (right-tailed Fisher’s Exact Test). For legend, see 
Appendix B). 
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Table 4.4 mRNA abundance from real-time PCR (qPCR) compared to droplet 
digital PCR (ddPCR)†. 
 Microarray qPCR ddPCR 
Gene Fold 
change 
p-value Fold 
change 
p-value Fold 
change 
p-value 
Casp3 1.23 0.021 -1.07 0.20 2.52 0.040 
Mafg -1.21 0.036 1.08 0.17 1.03 0.30 
Stac 1.22 0.029 -1.04 0.43 -1.15 0.18 
Tcf7l2 1.50 0.032 1.99 0.08 2.18 0.045 
Vipr2 1.42 0.043 3.94 0.07 2.80 0.023 
†Data presented are fold change in ethanol-exposed vs. control groups. Microarray fold 
change and p-values were determined in Partek. qPCR and ddPCR data are presented as 
the mean of n=7 biological replicates per group, p-values determined by Paired Samples 
t-Test. Shaded cells denote a p-value<0.05.  
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Figure 4.4 Droplet digital PCR (ddPCR) confirmations of differential gene 
expression.  
n=14, 7 ethanol-exposed and 7 control mice.  Data are presented as relative quantity 
normalized to control expression level, mean ± standard error. *p<0.05 (Paired Samples 
t-Test). Not shown is Defb4 which was undetected in the samples.  
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The expression patterns of the six confirmed genes in the PND 70 mouse 
hippocampus were assessed using data from the Allen Brain Atlas (Sunkin et al., 2013). 
Casp3 showed high expression in dentate granule neurons and hippocampal pyramidal  
neurons. The other five genes did not show discernable expression patterns in the 
hippocampus.  
4.4.5 Differentially Expressed MicroRNAs  
In addition to the mRNA expression microarray, a microRNA (miRNA) 
expression microarray was also performed. It identified 60 differentially expressed 
miRNAs at p<0.05, fold cut-off>1.2 (Table 4.5). Most (89%) were increased in 
expression in ethanol-exposed mice. There were greater fold-change magnitude values 
compared to mRNAs; ranging from 2.59 to -2.01 fold. Next, interactions between 
miRNAs and mRNAs were assessed. Using IPA Target Filer™ analysis, miRNAs 
predicted to target differentially expressed genes were identified (Table 4.6). Four genes 
(Hcn4, Mafg, L3mbtl4, and Tmem79) targeted by five miRNAs were identified with 
reciprocal changes in fold-change. (Table 4.6). Other interactions where a miRNA and a 
predicted target mRNA had the same direction of change were identified; however, they 
were shown due to unlikely functional relevance.  
4.4.6 Epigenetic Changes at Differentially Expressed Genes 
The differentially expressed genes from Chapter 2 were compared with the 
differentially methylated genes from the DNA and histone methylation lists. There was 
very little overlap between the lists using the genes generated for pathway analysis (i.e. 
p<0.001 for the DNA and histone methylation lists; Figure 4.5). Only one gene 
overlapped between the H3K4me3 RDHM list and gene expression list which is 
significantly less overlap than expected by chance (X2=55.6, p<0.00001). The gene was 
Tcf7l2 which encodes a transcription factor involving in Wnt signaling. It was part of the 
top IPA pathway identified in the gene expression analysis and was confirmed with 
ddPCR. It is also the top differentially expressed gene in terms of fold-change magnitude. 
In order to identify more potentially biologically relevant relationships between gene 
expression and epigenetic changes, the expression and methylation datasets were also   
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Table 4.5 MicroRNAs and pre-microRNAs identified as differentially expressed 
from microarray analysis†. 
Probe Set ID p-value Fold change 
miR-1935 0.0315 2.59 
miR-1946a 0.0160 2.36 
miR-184 0.0185 2.35 
miR-1306 0.0496 2.28 
miR-207 0.0294 2.19 
miR-130b 0.0180 2.19 
miR-1983 0.0284 2.16 
miR-669n 0.0327 2.10 
miR-1946b 0.0174 2.07 
miR-200c 0.0221 1.95 
miR-26a-1 0.0127 1.80 
miR-695 0.0146 1.75 
miR-188-5p 0.0487 1.70 
miR-1894-3p 0.0343 1.67 
mir-302b 0.0174 1.65 
miR-125b 0.0281 1.64 
miR-425 0.0034 1.63 
miR-105_st 0.0177 1.60 
miR-678_st 0.0264 1.57 
miR-671-5p 0.0133 1.52 
miR-505 0.0127 1.48 
miR-452 0.0058 1.48 
miR-511 0.0002 1.46 
miR-1937 0.0036 1.43 
miR-1962 0.0026 1.43 
miR-106b 0.0489 1.43 
miR-2136 0.0265 1.41 
miR-484 0.0468 1.39 
miR-18a 0.0283 1.39 
miR-105 0.0069 1.39 
miR-490 0.0368 1.38 
miR-214 0.0477 1.37 
miR-2135-4 0.0241 1.37 
miR-466b-1 0.0238 1.35 
miR-295 0.0481 1.32 
miR-698 0.0403 1.30 
miR-377 0.0185 1.29 
miR-29b-1 0.0292 1.28 
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miR-540 0.0455 1.28 
miR-700 0.0258 1.26 
miR-505 0.0226 1.25 
miR-187 0.0366 1.24 
miR-704 0.0043 1.24 
miR-709 0.0463 1.23 
miR-297a-6 0.0428 1.23 
miR-3473 0.0157 1.22 
miR-1944 0.0319 1.22 
miR-466g 0.0300 1.22 
miR-450b-3p 0.0165 1.21 
miR-876 0.0463 1.20 
miR-449c 0.0136 1.20 
miR-214 0.0305 -1.21 
miR-1956 0.0298 -1.23 
miR-882 0.0335 -1.25 
miR-290-3p 0.0372 -1.30 
miR-1945 0.0125 -1.39 
miR-297c 0.0149 -1.95 
miR-669 0.0065 -2.01 
†n=3 ethanol-exposed and n=3 control microarrays. p-values deterimed using a one-way 
ANOVA, fold change in expression vs. control group deterimend using Partek RMA 
alorithm. Transcripts presented passed a fold cut off >1.2 and p<0.05. 
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Table 4.6 MicroRNA expression changes with corresponding reciprocal changes in 
expression of predicted target genes†. 
Gene 
Symbol 
p-value Fold 
change 
miRNA ID p-value Fold 
change 
Confidence 
Hcn4 0.048 1.23 miR-185-5p  0.026 -1.26 High 
Mafg 
 
0.036 -1.21 miR-130a-3p 0.018 2.19 High 
miR-200b-3p 0.022 1.95 High 
L3mbtl4 0.040 -1.22 miR-377-3p  0.019 1.29 High 
Tmem79 0.027 -1.29 miR-34a-5p  0.046 1.20 Moderate 
†Fold changes and p-values determined in Partek using the RMA algorithm. 
Relationships were identified using IPA Target Scan™. Fold change and p-values from 
microarrays presented. miRNA targets predicted by Ingenuity Target Scan™, only 
reciprocal changes in miRNA abundance vs. target mRNA abundance shown. Confidence 
is an output of IPA target scan and refers the likelihood of the predicted miRNA-mRNA 
interaction occurring in vivo.  
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Figure 4.5 Distribution of implicated genes shared between experiments at p<0.001. 
Darker shading indicates more genes present at that intersection. Gene expression (GE) 
and miRNA list generated using p<0.05, fold-cut off >1.2; H3K4me3 and H3K27me3 
lists generated using MAT score cut-off p<0.001; DNA methylation (5mC) list generated 
using AMS cut-off p<0.001.  
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Figure 4.6 Distribution of implicated genes shared between experiments at p<0.01. 
Darker shading indicates more genes present at that intersection. Gene expression (GE) 
and miRNA list generated using p<0.05, fold-cut off >1.2; H3K4me3 and H3K27me3 
lists generated using MAT score cut-off p<0.01; DNA methylation (5mC) list generated 
using AMS cut-off p<0.01.  
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Table 4.7 Differentially expressed genes proximal to a change in DNA methylation 
or histone methylation†. 
Gene expression 5mC DMR H3K4me3 
RDHM 
H3K27me3 
RDHM 
Gene Symbol p-
value 
Fold 
change 
AMS 
score 
p-
value 
MAT 
score  
p-
value 
MAT 
score  
p-
value 
Tcf7l2 0.032 1.50 9.87 0.007 -3.12 0.004 1.86 0.003 
  -4.38 0.000
9 
  
Synpo2 0.047 1.43 11.82 0.004 3.10 0.009   
Vipr2 0.043 1.42 10.32 0.002     
Gm8994 0.021 1.32     3.14 0.008   
Olfr119 0.007 1.30   -2.93 0.008   
Vmn2r15 0.049 1.29 
  
  1.44 0.004 
Cfhr2 0.023 1.29 
  
3.09 0.009   
Krt8 0.013 1.25 
  
3.12 0.008   
Slitrk6 0.023 1.24 
  
3.24 0.006   
Krt39 0.008 1.23 
  
3.05 0.009   
Hcn4 0.048 1.23     -2.95 0.007   
Vmn2r109 0.022 1.22 
  
  1.14 0.008 
Dnm3os 0.050 1.21 
  
  1.16 0.007 
Gm4776 0.024 -1.20 
  
-2.91 0.008   
Mafg 0.036 -1.21 9.39 0.009     
-12.67 0.005     
13.42 0.001     
†Differentially 5-methylcytosine (5mC) methylated regions (DMRs) and regions of 
differentially histone modification (RDHMs) in gene promoters are also shown (cut-off 
p<0.01). Positive AMS indicates increased methylation in ethanol exposed mice, while 
positive MAT score indicates reduced methylation in ethanol exposed mice. 
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compared with a p-value<0.01 (Figure 4.6). There were 16 differentially expressed genes 
proximal to a change in DNA or histone methylation at this significance level (Table 
4.7). Gm8994, Olfr119, Cfhr2, Slitrk6, Krt39, Hcn4, Gm4776 and Olfr2 were proximal to 
H3K4me3 changes only; Vmn2r15, Vmn2r109, and Dnm3os were proximal to 
H3K27me3 changes only; Vipr2 and Mafg were proximal to DNA methylation changes 
only; Synpo2 and Krt8 were proximal to H3K4me3 and DNA methylation changes; 
Tcf7l2 was proximal to H3K4me3, H3K27me3, and DNA methylation changes. Four of 
these genes (Krt8, Mafg, Tcf7l2, and Vipr2) were present in the top IPA pathway 
(Chapter 2). No differentially expressed miRNAs were proximal to DNA or histone 
methylation changes. There was significantly more overlap between the gene expression 
and the H3K4me3 gene lists than expected by chance (X2=31.6, p<0.00001) and 
significantly less overlap than expected by between the gene expression and H3K27me3 
lists (X2=48.7, p<0.00001) and between the gene expression and DNA methylation lists 
(X2=42.6, p<0.00001). 
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 Discussion  
Analysis of the function and interactions of the 59 differentially expressed genes 
identified in this experiment revealed that diverse cellular processes are affected by 
neonatal ethanol exposure. Most (60%) of the affected genes are co-expressed and many 
(22%) are co-localized. None of the gene protein products directly interact, nor transcribe 
one another.  
 GO analysis implicated the differentially expressed genes in various biosynthetic 
processes including dicarboxylic acid, kynurenine, and tryptophan metabolism (Table 
4.2). The differentially expressed gene Kmo (Kynurenine 3-monooxygenase) is 
responsible for identifying these processes. It encodes an enzyme involved in metabolism 
of L-tryptophan to the dicarboxylic acid L-3-hydroxykynurenine, part of the synthesis of 
quinolinic acid. This is part of the cytokine-mediated inflammation response (Dantzer et 
al., 2011). L-3-hydroxykynurenine is also a source of free radicals, and a neurotoxin; it is 
an NMDA receptor antagonist, which acts in much the same neurotoxic manner as 
ethanol during synaptogenesis (Lugo-Huitrón et al., 2013). Its upregulation may indicate 
a residual inflammatory response after ethanol exposure. Fetal ethanol exposure leads to 
various neuroimmune changes, including microglia activation and production of pro-
inflammatory molecules, leading to altered neuronal survival (Drew and Kane, 2014).  
Several other classes of genes were differentially expressed. Upregulation of 
Synpo2 (synaptopodin 2) in ethanol-exposed mice was also confirmed (Figure 4.4). 
Synaptopodins are a class of proteins that are highly expressed in telencephalic dendrites. 
The precise function of synaptopodins is unknown; they found at dendritic spines and 
post-synaptic densities (Deller et al., 2003; Mundel et al., 1997).  Synpo2 dysregulation 
may underlie some of their characteristic learning and memory impairment in PND 4,7 
ethanol-exposed mice (Kleiber et al., 2014a). Olfactory receptors represent 19% (11/59) 
of the differentially expressed genes. Olfactory receptors are implicated in several FASD 
studies, and may be involved in its etiology. 
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4.5.1 Olfactory Receptor Genes  
The top Partek Pathway was “Olfactory Transduction” (Table 4.3). There were 11 
olfactory receptor (Olfr) genes differentially expressed, five down regulated and 6 
upregulated representing 19% of the identified genes (Figure 4.2) Olfactory receptors 
(ORs) are G-protein-coupled receptors that function in the main olfactory epithelium 
(MOE). They sense external olfactory cues, and through signal transduction pathways, 
send this information to the brain. ORs are ectopically expressed in the brain and other 
tissues, but their function remains unclear (Kang and Koo, 2012). The ectopically 
expressed ORs are evolutionarily constrained between mice, rats and humans, suggesting 
they serve conserved functions (De la Cruz et al., 2008). Generation of antibodies to 
study these proteins has been difficult, thus very little is known about their cellular 
localization (Kang and Koo, 2012). Evidence suggests that they are important for 
mediating cell-cell communication; in skin, ORs mediate communication between 
keratinocytes and trigeminal neurons (Sondersorg et al., 2014). During mouse 
embryogenesis, ORs may act as recognition molecules providing a complex addressing 
system facilitating cell-cell recognition, migration, and tissue assembly during 
embryogenesis (Dreyer, 1998). ORs may also have a role in repair. In the rat brain, ORs 
were upregulated in dorsal root ganglia following nerve injury (Gong et al., 2015). 
Induction of oxidative stress in cultured rat Schwann cells induced upregulation of 14 
ORs (Gong et al., 2015). Several human neurodegenerative diseases are also associated 
with changes in OR expression, including Alzheimer’s disease, Progressive Supranuclear 
Palsy, Parkinson’s disease, and Creutzfeldt-Jakob disease (Ansoleaga et al., 2013; 
Garcia-Esparcia et al., 2013). These data suggest that ORs may play an important role in 
the development of the brain, and its response to external stress.  
Dysregulation of Olfr genes is common in FASD studies. In previous work from 
our laboratory using the PND 4,7 model, seven Olfr genes were differentially expressed 
at P60, though none of the same genes as in this study (Kleiber et al., 2014a). In a study 
examining the hippocampus of P28 mice exposed to ethanol from G0.5-8.5, 30% (7/23) 
of differentially expressed genes were olfactory receptors (Marjonen et al., 2015). This 
study also found reduction in volume of olfactory bulb and hippocampus. Another study 
examining the effect of ethanol on whole-embryo culture found changes in DNA 
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methylation of several olfactory receptor genes (Liu et al., 2009). Interestingly, impaired 
olfaction is an outcome of fetal ethanol exposure (Muralidharan et al., 2013). 
Dysregulation of Olfr genes in the brain in response to ethanol may represent a conserved 
response. If ORs facilitate cell-cell communication in the brain, their dysregulation may 
be related to the known detrimental effect of ethanol on synaptic pruning/development 
(Olney et al., 2002). Further, if ORs indeed have a role in response to stresses, their 
dysregulation may be a result of ethanol-induced effects such as oxidative stress 
(Brocardo et al., 2011). 
4.5.2 Implication of Free Radical Scavenging Pathway 
Ingenuity pathway analysis (IPA) identified the top affected gene expression 
network as “Free Radical Scavenging, Gene Expression, Dermatological Diseases and 
Conditions” (Figure 4.3). This gene network is responsible for coordinating the 
transcriptional free radical scavenging response. NFE2L2 homodimers and 
NFE2L2/MAFG heterodimers control the expression of genes with antioxidant response 
elements (ARE) in their promoters (Nguyen et al., 2009). Such genes are involved in 
response to inflammation resulting from elevated free radical levels. Other proteins in 
this network have roles in oxidative stress such as GPX, KEAP1, and apolipoproteins. 
This network also includes many apoptosis-related proteins including BNIP3L, AATF, 
and HSD2D as well as proteins important in the brain such as MAOA, CLCN3. 
Dysregulation of this pathway could impact these critical processes, all of which are 
relevant to FASD etiology.  
Microarray analysis identified 13 genes which were differentially regulated in this 
top IPA network. Four of these changes were confirmed by ddPCR: Casp3, Krt8, Tcf7l2 
and Vipr2 (Figure 4.4); Casp3 (Caspase-3) is a hub of this network. Caspase-3 has a key 
role in the execution phase of cellular apoptosis, and is inducible by oxidative stress 
(Ueda et al., 1998). It is involved in many response pathways and processes, and is 
responsible for implicating many of the pathways in this analysis (Table 4.3). Its 
activation by ethanol is part of the apoptotic cascade that happens in the fetal brain during 
development (Goodlett et al., 2005). TCF7L2 regulates insulin secretion, acting as a 
transcription factor in the Wnt pathway. Wnt signaling is key in brain development and 
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synaptogenesis as well as adult functions such as synaptic modeling and neuronal 
maintenance (Oliva et al., 2013). It is a key developmental regulator, and as such is 
responsible for implicating many of the pathways in this analysis (Table 4.3). VIPR2 is a 
G-protein coupled receptor for a small neuropeptide, pituitary adenylate cyclase 
activating polypeptide (PACAP). PACAP acts as a hypothalamic hormone, a 
neurotransmitter and a neurotrophic factor (Shioda, 2000). Vipr2 showed methylation 
differences in a study of children with ADHD (Wilmot et al., 2015). Downregulation of 
L3mbtl4 which is a putative polycomb group protein was also confirmed. These proteins 
maintain repressive chromatin states by modification of histone modifications.  
Other genes in this network have been implicated in FASD-relevant processes. 
Defb5 is a defensin, a family of proteins involved in inflammatory response and 
antimicrobial defense which are produced by microglia and astrocytes (Hao et al., 2001). 
Our laboratory found Defb15, Defb30 upregulated in PND 70 mice given continuous 
access to ethanol during pregnancy (Kleiber et al., 2012). A model of gestational ethanol 
exposure also affected defensin expression (Muralidharan et al., 2013). Upregulation of 
defensins may indicate stressors, such as oxidative stress occurring in hippocampus. 
Again, KMO is involved in inflammatory response. The role of keratins in the brain is 
unclear; however, several keratin genes and keratin-associated protein (KRTAP) have 
been implicated in FASD models. Krtap was downregulated in previous work from our 
laboratory (Chater-Diehl et al., 2016) and in P28 mice exposed to ethanol during GD 0.5-
8.5, (Marjonen et al., 2015). The abundance of another keratin protein (KRT72) was 
reduced in whole-mouse-embryo culture in ethanol (Mason et al., 2012).  
The implication of this pathway, and other evidence presented suggests an altered 
free-radical-scavenging response in the hippocampus. Oxidative stress is a well 
characterized component of FASD etiology. Ethanol acts directly on mitochondria to 
produce superoxide, hydroxide, and nitric oxide radicals (Wu and Cederbaum, 2003). 
Metabolism of ethanol by CYP2E1 produces oxidized products and ultimately hydroxide 
radical generation (Mansouri et al., 2001). Catalase also produces acetaldehyde from 
alcohol in the brain, further increasing the formation of ROS (Shaw, 1989). Oxidative 
damage can lead to blood-brain barrier impairment, inflammation, and increased 
apoptosis (Haorah et al., 2008). Interestingly, these are also key features of FASD 
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etiology. Indeed, oxidative damage is observed in many rodent models of FASD, 
including lipid peroxidation, protein oxidation, and DNA damage (Brocardo et al., 2011). 
Lipid peroxidation is not often present in young animals, but accumulates over time into 
adulthood (Dembele et al., 2006). In a Drosophila model of developmental ethanol 
exposure, changes in expression of antioxidant genes contributed to oxidative stress in 
adult flies (Logan-Garbisch et al., 2014). Further, this increased oxidative stress was a 
primary cause of developmental delay associated with ethanol exposure (Logan-Garbisch 
et al., 2014). Oxidative damage to DNA, protein, membranes, and other cellular 
components is a key cause of ethanol-induced damage and cell-death in the brain (Guerri, 
1998).  
Alteration of oxidative stress gene expression has also been reported in FASD 
models. Oxidative stress response genes such as c-Fos have been reported to be 
differentially expressed in response to ethanol (Incerti et al., 2010; Poggi et al., 2003). 
Fetal ethanol exposure reduces the expression of antioxidant enzymes in the brain 
(Drever et al., 2012). The direct role of oxidative stress in FASD phenotypes has been 
supported by the amelioration of phenotypes with antioxidant treatment (Patten et al., 
2013; Wu and Cederbaum, 2003) 
4.5.3 Low Expression Levels of Differentially Expressed Genes  
Expression localization data from the Allen Brain Atlas revealed that only one of 
the six differentially expressed genes (Casp3) was expressed at high levels in dentate 
granule neurons and hippocampal pyramidal neurons. Caspase-3 is a crucial protein in 
many neuronal processes. The other five genes show non-neuron-specific expression 
patterns, or are expressed at too low a level to be detected. Each of these genes was 
upregulated in response to ethanol. The upregulation of a gene normally expressed at 
very low levels could have a substantial impact on the hippocampus.  
The low levels of expression, and relatively low fold-changes of these genes made 
them very difficult to confirm with qPCR. Droplet digital PCR proved to be better able to 
quantify these changes (Figure 4.4). The relative expression in each of the confirmed 
genes did not differ from the qPCR data; however, the variation was reduced, resulting in 
significant differences in expression.  
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All of the genes in this study have a relatively low expression fold change, the 
maximum magnitude being 1.5 fold. A low fold change does not necessarily imply 
irrelevance to phenotype. A small 1.2 fold increase in the expression of many genes in a 
pathway can potentially have a greater impact than a 20 fold change in a single gene 
(Barabási and Oltvai, 2004; Subramanian et al., 2005). The previous studies from our 
laboratory also found low (less than 2 fold) changes in expression in response to PAE 
(Kleiber et al., 2014b; Laufer et al., 2013). Examining a specific brain region did not 
change this fold change pattern, suggesting that ethanol exerts subtle effects on gene 
expression across the brain. Similarly, the number of differentially expressed genes was 
similar to our previous work.  
4.5.4 Notable Changes in MicroRNA Expression 
There were 60 pre- and mature miRNAs differentially expressed in PND 70 
hippocampus after ethanol exposure. Five of these were identified in our laboratory 
previously: miR-184 and miR-466b were identified in P60 mice exposure to ethanol 
during late (G14,16) gestation  while miR-184, miR-704, miR-297a, and miR-669 were 
identified in PND 7 mice exposed to PND 4,7 ethanol injections (Mantha et al., 2014). 
There were no miRNAs in common with the CPD model. Though the functions of many 
of the differentially expressed miRNAs remain unknown, several are involved in brain 
development and other FASD-relevant processes. MiR-207 and mir449c are involved in 
embryonic neurogenesis (Choi et al., 2008; Maiorano and Mallamaci, 2009). Mir-200c 
and miR-130b are involved in neural progenitor cell proliferation (Gong et al., 2013; 
Peng et al., 2012). MiR-214 and miR-207 are involved in promoting apoptosis (Liao et 
al., 2010; Tan et al., 2014). MiR-130b is involved in regulation of peroxisomes (Pan et 
al., 2015). Two are also involved in inflammatory response in the brain; miR-125b 
promotes microglia activation (Parisi et al., 2016) and miR-200c promotes astrocyte 
activation (Mor et al., 2011).  
 Using IPA Target Scan™, five of the differentially expressed miRNAs were 
found to have differentially expressed predicted miRNA targets (Table 4.6). 
Confirmation of differential expression of Mafg, L3mbtl4, and Tmem79 was attempted, 
only downregulation of L3mbtl4 was confirmed (Figure 4.4). L3mbtl4 encodes a tumour 
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suppressor protein has been shown to be mutated often in breast cancers (Addou-Klouche 
et al., 2010). Interestingly, its targeting miRNA, miR-377 also functions as a tumour 
suppressor renal cell carcinoma by targeting Ets1 (Wang et al., 2015). Tumor suppressors 
have complex and unclear roles in the nervous system; however, their downregulation 
can trigger apoptosis and abnormal neurodevelopmental trajectories (Baker and 
McKinnon, 2004). Altered regulation of L3mbtl4 and its targeting miRNA miR-377 may 
be associated with apoptosis present in the PND 4,7 model. Alternatively, they may be a 
“footprint” of earlier ethanol exposure remaining into adulthood. Tmem97 encodes a 
membrane protein involved in regulating cellular cholesterol levels. It was differentially 
methylated in the DNA methylation analysis, and was present in several top IPA 
pathways (Chapter 3). Due to its relevance to lipid metabolism, and downregulation of a 
putative targeting miRNA, confirmation of Tmem97 upregulation was attempted using 
ddPCR; it was not confirmed however.  
4.5.5 Few Co-occurring Gene Expression and Methylation 
Changes 
Identification of genes across experiments was one of the primary goals of this 
project during its conception. Genes which are differentially expressed and differentially 
methylated are better candidates for participating in FASD etiology. Such genes would be 
implicated by multiple independent explements. Further, differential methylation of these 
genes would provide an explanation for their differential expression. There were 16 
differentially expressed genes that had changes in at least one methylation. Four of these 
(Krt8, Mafg, Tcf7l2, and Vipr2) were present in the top IPA pathway and were assessed 
using ddPCR. Krt8, Tcf7l2, and Vipr2 were confirmed using this technique. Synpo2 was 
also confirmed with ddPCR. Synpo2 and Krt8 were proximal to H3K4me3 and DNA 
methylation changes (Table 4.7).  
There were very few differentially expressed genes that had changes in any 
methylation. A chi-squared analysis was performed to determine if there was more or less 
overlap between each of the three methylation gene lists and the gene expression gene list 
than expected by chance. Interestingly, there was more overlap than expected between 
the H3K4me3 gene list and the gene expression list (X2=31.6, p<0.00001); significantly 
fewer between the H3K27me3 list gene and the gene expression list (X2=48.7, 
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p<0.00001) and a significantly fewer between the DNA methylation gene list and the 
gene expression list (X2=42.6, p<0.00001). This suggests that the differentially expressed 
genes are enriched for H3K4me3 changes, and depleted for H3K27me3 and DNA 
methylation changes. H3K4me3 may be more relevant to the gene expression changes 
observed here. In Chapter 5, the possible origin and implications of methylation changes 
without corresponding gene expression changes are discussed.  
4.5.6 Tcf7l2 as an FASD Candidate Gene 
Tcf7l2 is notable since it was the only differentially expressed gene proximal to an 
epigenetic methylation change with p<0.001 (Figure 4.5) and the only differentially 
expressed gene proximal to all three assessed epigenetic methylation changes with 
p<0.01 (Figure 4.6). The proximal H3K4me3 and H3K27me3 RDHMs and 5mC DMR 
were in the predicted direction with respect to increased gene expression (Table 4.7). The 
agreement between these changes suggest Tcf7l2 they may play a functional role in its 
upregulation. It is also the top differentially expressed gene in terms of fold-change 
magnitude (1.5 fold). Together, these findings make it the single most compiling 
candidate gene in this thesis.  
Tcf7l2 encodes a transcription factor involved in Wnt signaling. Extracelluar Wnt 
signalling proteins bind to frizzled receptors, triggering axin to bind to the β-catenin 
destruction complex, inhibiting and promoting β-catenin accumulation. β-catenin enters 
the nucleus and binds to TCF7L2 which can then bind to target genes promoting their 
expression (Araoka et al., 2010). In the liver, these target genes are involved in insulin 
secretion. In the brain, Tcf7l2 and Wnt signalling are necessary for oligodendrocyte 
differentiation. TCF7L2 promotes the regulation of key oligodendrocyte-specific genes 
during their development. It also regulates neuronal lipids, promoting myelination and 
cholesterol biosynthesis gene transcription (Zhao et al., 2016). Tcf7l2 is expressed in 
oligodendrocytes of the hippocampus during mouse fetal development (Weaver et al., 
2012). TCF7L2 is also negatively responsive to oxidative stress; oxidative stress 
signaling diverts β-catenin depleting active TCF7L2 (Gloyn et al., 2009). These 
interactions implicate TCF7L2 in the top IPA pathway, and its relation to lipid 
metabolism overlap with peroxisome genes.  
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Polymorphisms in this gene are the strongest genetic risk factors for type 2 
diabetes (Gloyn et al., 2009). Specific polymorphisms are associated with impaired 
insulin secretion, glucose production, and glucose tolerance (Lyssenko et al., 2007). The 
mechanisms by which these variants influence glucose homeostasis and diabetes are 
believed to be through the gene’s role in adipogenesis, myogenesis, glucose and 
pancreatic islet development (Takamoto et al., 2014). The link between hypoglycemia 
and FASD is not clear, though some studies have found increased incidence in FASD 
individuals (Tanaka et al., 1982). Tcf7l2 has not been previously implicated in FASD 
prior to this study. The status of this gene in the top gene expression and methylation 
pathways, its overlap with epigenetic changes, indicate that it should be considered as a 
candidate gene in FASD and investigated further. Given its role in myelination during 
development, its alteration may underlie ethanol-induced synaptic changes in the 
hippocampus, contributing to learning and memory impairment.  
4.5.7 Conclusion 
This chapter describes gene and miRNA expression changes in the adult 
hippocampus in response to neonatal ethanol exposure. The affected genes were enriched 
for olfactory receptors and oxidative stress response genes. Delineating the possible role 
of these genes in FASD etiology is challenging. Exposure of mice to ethanol on PND 4 & 
7 results in widespread apoptotic cell death. The surviving cells adapt and alter their 
developmental trajectories. It is the gene expression changes in these cells that are 
detected in this study. These gene expression changes may represent 
adaptations/alterations in the surviving cells, or they may simply reflect the differential 
cell population created by early apoptotic cell death (Kleiber et al., 2014b). The changes 
in gene expression identified here provide insight into the state of the hippocampal 
transcriptome long after ethanol exposure. The conditions responsible for establishing 
these changes (early ethanol exposure) are well understood. It is unknown what cellular 
and gene expression changes occur between ethanol exposure and the transcriptional 
timepoint observed here. Other studies can provide insight into these changes, but given 
the heterogeneity of ethanol response, it is difficult to make inferences about specific 
genes between studies. Tcf7l2 emerged as a strong candidate gene, being upregulated, 
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present in the top IPA pathway, proximal to DNA, H3K4me3, and H3K27me3 changes. 
Tcf7l2 is critical in the regulation of glucose homeostasis, and may be involved in 
metabolic changes in the brain following PAE. Beyond this gene, few examples of 
differential gene expression cooccurring with epigenetic methylation changes were 
found. In the final chapter the possible mechanistic hypotheses and future experiments 
necessary to test them will be explored. 
Footnote  
 A modified version of this chapter has been published (Chater-Diehl et al., 2016).   
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 Discussion 
 Overview  
The research presented in this thesis describes changes in histone modification 
(Chapter 2), DNA methylation (Chapter 3), and gene expression (Chapter 4) in 
hippocampus of adult mice exposed to ethanol during development. The results show that 
different but related genes show changes in epigenetic marks and expression. These 
include changes in apoptotic, synaptic, and oxidative stress genes. In this chapter, the 
results from Chapters 2 to 4 are synthesized, revealing important trends. Free radical 
scavenging pathways were implicated in each analysis, particularity the gene expression 
and combined methylation analyses. The meaning and possible origins of these changes 
are explored, generating hypotheses for additional work. Addition caveats and 
considerations for future work are considered.  
 Implications for Biological Processes  
A common approach in genetics is to study a perturbation of a system to better 
understand its function. Ethanol exposure during synaptogenesis alters hippocampal 
developmental trajectory by removing cells via apoptosis (Ikonomidou, 2000), impairing 
neurogenesis (Bonthius and West, 1991; Gil-Mohapel et al., 2010) reducing both synaptic 
efficacy (Bellinger et al., 1999), and dendritic spine density (Abel et al., 1983). Such 
alterations provide insight into neurodevelopmental trajectories, and identify sensitive 
timepoints. The results of this thesis support a role for molecular changes in these 
processes. GO and pathway analysis from each chapter implicated differential 
expression/methylation of synaptic and apoptotic genes. Differential expression of the 
synaptic gene Synpo2, and the apoptosis regulator Casp3 highlights the alteration of 
neurodevelopmental genes. Similarly, ethanol can be considered an epigenetic disruptor, 
and its effects viewed as a challenge to the epigenome during development (Fowler et al., 
2012). The results of this thesis show that epigenetic disruption using ethanol results in 
changes in histone and DNA methylation in adulthood. Examining earlier timepoints in 
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mice would further the understanding of establishment and maintenance of such 
epigenetic changes after environmental perturbation (see section 5.6 below).  
 Free Radical Scavenging Pathway  
The histone modification, DNA methylation, and gene expression analyses 
identified free radical scavenging pathways. The top IPA gene expression pathway was 
related to the gene expression response to increased free radicals. Peroxisome biogenesis 
was the top Partek pathway for the combined methylation analysis and the penultimate 
pathway for DNA methylation. Many lipid-related pathways were implicated across 
analyses also, further implicating peroxisomes. Few individual ROS genes were 
identified by multiple experiments. Nevertheless, the implication of differentially 
regulated free-radical scavenging pathways suggests an altered free-radical scavenging 
response lasting into adulthood. This thesis reports a novel interface of free-radical 
scavenging and epigenetic mechanisms, two key processes in FASD etiology.  
There are three main possibilities for the origin of these expression and epigenetic 
changes (Figure 5.1). First, these changes were established as a direct response to ethanol 
during exposure and are maintained to adulthood. Second, these changes were indirectly 
caused by ethanol as a compensation or amelioration response to ethanol-induced 
oxidative stress. Third, these changes presented later in life in response to long-term 
accumulation of oxidative damage. The second explanation is most likely, or perhaps a 
combination of the three. As discussed, ethanol is known to induce ROS as one of its 
primary effects on the brain. The genes involved in the response to this stress include 
those differentially methylated/expressed in this thesis. Cells may have altered the 
epigenetic regulation of these genes to cope with oxidative stress and its effects. The 
hypothesis that these changes are established early should be tested with future 
experiments to distinguish between these possible explanations. 
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Figure 5.1 Potential origins of observed epigenetic and gene expression hippocampal 
profile in response to neonatal ethanol exposure. 
It is well established that in the brain, ethanol leads to increased ROS, leading to 
oxidative damage, which contributes to altered behaviour (i.e. FASD phenotypes). The 
epigenetic and gene expression changes identified here (represented by a Circos plot of 
all the changes identified) may have arisen from: a) the direct action of ethanol during the 
exposure period, which may then act to perpetuate ethanol-induced oxidative damage; b) 
an early response to ethanol-induced oxidative cellular damage, acting to ameliorate or 
compensate for this damage; c) a later response to accumulating oxidative damage over 
the early life of the mouse, prior to 70 days of age.  
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 Diagnostic and Therapeutic Potential  
Biomarkers can serve several roles; an ideal biomarker should be part of the 
causal pathway of the disease. It should also be well understood, and not related to any 
unknown factors that are also related to the exposure. If this is the case, it can reduce the 
validity of the relation between biomarker and disease (Mayeux, 2004). There are two 
main types of biomarkers: biomarkers of exposure which are used to make predictions, 
and biomarkers of disease which are used for diagnosis (Mayeux, 2004). Biomarkers of 
disease in FASD are very challenging since so little is known about its etiology. One can 
imagine a mark that correlates with the severity of neurodevelopmental challenges, but 
unless a mechanism is understood, its validity would be suspect. In theory, histone 
modifications and DNA methylation should have good utility as biomarkers of fetal 
alcohol exposure. Certain marks at certain genes may indicate how much fetal alcohol 
exposure has occurred. Importantly, this quantity can be inferred from patient reports and 
gauged against the molecular changes. These types of markers would be independent of 
the behavioural outcome however, which is known to vary greatly even with the same 
exposure. 
The data from this thesis implicate Tcf7l2 as a candidate gene for FASD. Tcf7l2 
showed differential expression, histone methylation, and DNA methylation. Tcf7l2 
encodes a transcription factor in the Wnt signaling pathway. It controls oligodendrocyte 
differentiation during development, lipid metabolism gene expression, and is the gene 
most associated with type II diabetes (Oliva et al., 2013). Disruption of myelination via 
altered Tcf7l2 expression has the potential to affect synaptic function in the hippocampus 
and underlie FASD-related learning and memory impairment. Further investigation of 
this gene may lead to understanding of FASD etiology, and may serve as a diagnostic 
target.  
Changes in H3K4me3 and H4K27me3 occurred at numerous Pcdh genes. Pcdh 
genes encode protocadherins, cell-cell signaling molecules involved in synaptogenesis 
via providing individual neuron identity (Thu et al., 2014). Altered epigenetic regulation 
of these genes by ethanol could account for some of the abnormalities in synaptic 
structure in FASD (Sadrian et al., 2012). Recent work from our laboratory and others has 
implicated differential DNA methylation of Pcdh genes in children with FASD (Laufer et 
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al., 2015; Portales-Casamar et al., 2016). Differential histone medication at these genes 
may contribute to an epigenetic signature that will better differentiate affected from 
unaffected individuals. Employing multiple components makes biomarkers more 
discerning (Mayeux, 2004).  
The implication of oxidative stress pathways, but few single genes does not 
provide many diagnostic targets. It does however raise the possibility of therapeutics 
targeting these pathways. Peroxisomes are already the target of therapeutic research in 
neurological disorders and FASD. Use of peroxisome proliferator-activated receptor 
(PPAR) agonists is being explored as a possible treatment for FASD (Drew et al., 2015; 
Kane et al., 2011). Upregulation of peroxisome biogenesis is shown in these studies to 
prevent many of the detrimental effects of ethanol. Finding therapeutic interventions that 
work after ethanol exposure is challenging, but important as it is far more relevant to 
clinical applications. Altered epigenetic methylation of peroxisome genes in this thesis 
underscores their importance in FASD etiology.  
 Limitations and Caveats  
Each of the technologies used in this thesis have inherent strengths and 
weaknesses. The use of a promoter microarray focused the study on these regions 
exclusively, which was more economical and allowed for simplified bioinformatic 
analysis. However, by examining only promoters, changes in other relevant regions such 
as enhancers could not be examined. In addition, the DNA capture methods used have 
inherent biases. For example, MeDIP used in the DNA methylation experiment is most 
sensitive in regions with low CpG density (Nair et al., 2011). Use of a different technique 
such as MBD-capture or bisulfite sequencing would likely identify completely different 
DMRs. ChIP is currently the only viable option to study histone modification changes. 
The histone modification experiment was inherently limited by characterizing only two 
modifications out of the 100 or more present in mammalian chromatin. The specific 
histone modifications assessed in this thesis were chosen for their presence in promoters 
and known close association with gene expression levels. Nevertheless, it is possible that 
other more salient changes to other modifications occurred in this model. The results of 
this this thesis are also affected by the intrinsic limitations of mice as a model. Though 
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mice permit studies not feasible in humans, they are also imperfect models of human 
disease. In mouse models of FASD specifically, more ethanol per unit body mass must be 
administered to reach similar BAC levels to humans, since mice metabolize ethanol much 
faster (Patten et al., 2014). In order to target the third trimester equivalent, ethanol must 
be injected directly into neonates, bypassing maternal metabolism and the placenta. In 
terms of the molecular changes identified, mice and humans have similar but distinct 
genomes, transcriptomes, brain architecture etc. Variation at each of these levels may 
limit the applicability of specific findings to human FASD. For example, the CpG 
identified as differentially methylated in Chapter 3 is not present in the human genome. 
Finally, the experiments of this thesis use a relatively low sample size. Minimal 
biological replicates were used thesis to reduce microarray costs and allow for multiple 
epigenetic marks to be assessed. Low sample size may have limited the power of these 
studies, preventing the possible identification of meaning genes. An increased number of 
microarrays in each experiment would increase statistical power and potentially identify 
more/different genes.  
 Considerations for Future Experiments  
The changes in gene expression and epigenetics identified in this thesis represent 
a component of a much larger field. Expansion of these results to other models and 
techniques can test their importance in FASD. Several trade-offs were made in this 
research. Further, questions were generated which could not be addressed in this thesis. 
As such, there are several improvements and extensions of this research to address for the 
future. They are as follows:  
1. Additional endpoints in younger mice.  The hypothesis that changes in 
oxidative stress gene modification and expression can be tested. The hippocampus 
of younger mice should be assessed for changes in similar free radical pathways, 
ideally at multiple timepoints from PND 7 to PND 70. This would test whether 
changes persist from early initiation, or accumulate over time.  
2. Investigation of candidate genes in other models: Before the candidate genes 
identified in this thesis (Tcf7l2, Pcdh) can be explored in a clinical setting, they 
must be further verified in human studies and animal models. For instance, the 
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functional significance of Tcf7l2 should be assessed by determining if protein 
expression level change in response to ethanol. Functional characterization, such 
as developmental knock-out studies, would also strengthen the implication of 
these genes in FASD etiology.  
3. Cell type heterogeneity. The DNA, RNA, and chromatin samples used in this 
thesis were extracted from the whole hippocampus. All of the analysis presented 
represents a mix of the cell types of the region. Bioinformatics techniques to 
address this heterogeneity, or repetition using cell-type specific techniques may 
provide further precision and specificity.  
4. Histone modification techniques. While two histone modifications were 
assessed from the same chromatin sample, determining modification patterns on 
individual nucleosomes was not possible. Emerging histone analysis techniques 
allow characterization of all modifications to each nucleosome (Shema et al., 
2016).  
5. Limitations to oxidative damage assays. Only DNA was available to assess 
oxidative damage in the experimental mice. As such, more informative and long-
lasting markers such as lipid, DNA, and protein peroxidation were not assessed. 
Use of these assays in the future in this model may validate the oxidative gene 
expression changes identified here.  
 Conclusions  
A number of conclusions are evident from the results of this thesis. The gene 
expression, histone modification and DNA methylation analyses provide insight when 
analyzed separately and together. They show that:  
1. Neonatal ethanol exposure results in long-term changes to gene expression, 
histone modification, and DNA methylation in the mouse hippocampus.  
2. In the gene expression experiment, expression of free radical scavenging and 
olfactory genes were altered. 
3. Numerous epigenetic changes occurred across the entire genome; however, 
changes were enriched a specific gene types. 
a. H3H4me3 & H3K27me3 changes occurred at: 
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i. Protocadherins and other synaptic genes & 
ii. Imprinted genes  
b. DNA methylation changes occurred at:  
i. Peroxisome biogenesis genes.  
4. The combined analysis of each dataset revealed further enrichment of free-radical 
scavenging processes.  
The results of this thesis provide a compressive dataset on the epigenomic impact 
of early ethanol exposure. The data provide insight into the actions of ethanol at the 
molecular level in the hippocampus. The implication of processes observed in other 
FASD models suggests that similar mechanisms are at work. Failure to identify any one 
gene consistently supports the heterogeneity the response to ethanol exposure. Oxidative 
stress pathways are a key component of FASD etiology, and may be a target for 
therapeutic interventions. Since the epigenome is mutable and regulates many cellular 
processes it may be an ideal target for such interventions. The results presented also 
provide insight into basic biologically principles. Chromatin provides both dynamic 
transcriptional control, and maintenance of long-term repression. Environmental 
perturbation during brain development was associated with long-lasting changes to 
chromatin modifications. The fact that a single event during development can have 
lasting molecular consequences underscores the importance of the environment in 
shaping human health.   
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Appendices 
 
Appendix A Animal ethical approval. 
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Appendix B Ingenuity Pathway Analysis (IPA) legend. 
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Appendix C Linear relationship between number of genes and number of regions of 
differential histone medication (RDHMs) per chromosome. 
Numbers indicate the chromosome associated with each data point. R2 value calculated in 
Microsoft Excel. 
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Appendix D Affected genes in pathways identified from each software suite in 
proximity to H3K4me3 changes†. 
Pathway name  Genes in pathway and list p-value  
    IPA network/pathway  
Carbohydrate 
Metabolism, Molecular 
Transport, Small 
Molecule Biochemistry 
Sfrp1, Akt2, Hoxa7, Six3, Tusc2, Socs7, Tspan8, 
Ctsl, Ddx4, Meis1, Cox4i1, Agt, Mmp2, Brf1, 
Actn3, Dbh, Pax6, Sox18, Rho, Lipe, Ddit3, 
Nck2, Tcf7l2, Ralgds, Trpv6, Gyk, Fgf1, Slfn4, 
Ptprn, Ptprj, Emx2, Rb1, Arntl, Gprc6a, Iigp1, 
Flt4, Phox2b, Eef2k, Grk6, Tmem119, 
Cyp24a1, Pdcd4, Prl3d2, Col6a2, Fgfr1, 
Lamb2 
10E-63 
Hematological System 
Development and 
Function, Tissue 
Morphology, Cell Death 
and Survival 
Ptpre, Vamp2, Bst2, Ntrk1, Cd27, Thpo, Flii, 
Jak3, Tln1, Nedd4, Rnf31, Rbck1, Ebf1, 
Cyp3a16, Col15a1, Rnasel, Myd88, Sh3bp2, 
Gata3, Arrb1, Sigirr, Ptpn5, Notch4, Drd5, 
Snap23, Scfd1, Mapk8ip1, Sct, Smpd3, Mir22, 
Efs, Fas 
10E-49 
Humoral Immune 
Response, Protein 
Synthesis, Cellular 
Function and 
Maintenance 
Tbc1d17, Rbp3, Tef, Gng4, Crip1, Chil1, Pbx2, 
Pcp4, Cryba1, Nlrp4f, Rad21, Ncs1, Zp1, 
Muc1, Eci1, Polk, Tia1, Cenpp, Slain1, Senp7, 
Rnps1, Tra2a, Crybb3, Id3, Snn, Ifi30 
10E-31 
 
Endocrine System 
Disorders, 
Gastrointestinal Disease, 
Immunological Disease 
Pou3f3, Pip5k1c, Psd2, Tapbpl, Ecsit, Acat3, 
H2-DMa, Rhcg, Gas7, Gja5, Lpin2, Acsl6, 
Parp14, Abca8b, Fcgr1, H2-Eb1, Ctsw, Dock5, 
Mst1, Trex1, Prpf8, Psme2, Capn5, Arhgef10, 
Spdef, Homer2, Gpr146 
10E-25 
Endocrine System 
Development and 
Function, Lipid 
Metabolism, Small 
Molecule Biochemistry 
Hoxd3, Hsd17b3, Gdf10, Abcc4, Rps29, Rgs16, 
Glra1, Ttyh1, Ankrd6, Ndufa7, Ccdc74a, Ogfr, 
Ttll7, Dnmt3a, Col4a3bp, Krtdap, Atp6v1f, 
Sptb, Cox6c, Rps10, Rps15, Mat2a, Ncoa7, 
Fgf18, Smarcc1, Taf10, Spen 
10E-24 
Cellular Development, 
Cellular Growth and 
Proliferation, Cancer 
Gprasp1, Pcdha2, Mid1, Arpc4, Pcdha3, 
Pcdha4, Pcdha10, Ryr1, Bai1, Kctd20, Odf3b, 
Gpr123, Ap1m1, Jph1, Jakmip1, Mir138-2, 
Cfc1, Lpar3, Nuak2, Inf2, Sema4c, Asic1, Stip1, 
Cnot6l, Mrgpra3, Faim2, Foxm1, Ltbp4, 
Serpina5, Akap1 
10E-24 
Cell Morphology, 
Connective Tissue 
Development and 
Function, Cellular 
Development 
Ptbp1, Eno1, Naip1, Hes5, Creb3, Syn1, Tnk2, 
Noxa1, Slc14a1, Crip2, Urod, Cnn2, Gtf3c2, 
Bcr, Fsd1l, Mlh1, Ptp4a3, Ptk7, Mzb1, Pcca, 
Scpep1, Dhrs7, Rbm3, Shisa5, Hdlbp, Rgs12, 
Idh3g, Slc38a9 
10E-23 
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Energy Production, Lipid 
Metabolism, Small 
Molecule Biochemistry 
Ndufa8, Chtf18, Akt1s1, Csnk2b, Rasl10b, 
1100001G20Rik, Akr1c21, Slc4a4, Tmem176a, 
Tmem176b, Omp, Arpp21, Scd4, C1qtnf5, 
Gpr17, Recql4, Tc2n, Rai1, Slc16a1, Macrod1, 
Slco2b1, Trrap, Cacng3, Hap1, Ube2v1 
10E-22 
Endocrine System 
Development and 
Function, Carbohydrate 
Metabolism, Molecular 
Transport 
Insrr, Mras, Itpr3, Amn, Aars, Irak,1bp1, 
Trpm5, Pycr1, Hgfac, Cbx4, Sertad1, Tmod1, 
Oog1, Slc38a4, Fgf15, Dmtn, Ssbp2, Ank1, 
Ero1lb, Fbxl17, Fermt3, Ctbp2, Rph3al 
10E-20 
Cellular Growth and 
Proliferation, Cell 
Morphology, Cellular 
Assembly and 
Organization 
Rassf1, Vmn2r85, Gm11937, Ndst1, Agtpbp1, 
Mcf2l, Acaa1a, Hhatl, Nlrp6, Myadml2, 
Serpina12, Mtus1, Gprin1, Krtap19-3, Mbp, 
Cmip, Paqr7, Zfp106, Pcyox1, Neu2, Cyp2s1, 
Cirbp, Pde4c, Gne, Vars, Ip6k2 
10E-20 
Embryonic Development, 
Organismal 
Development, Gene 
Expression 
Plekhf1, Chrd, G530011O06Rik, Gcm2, 
Vmn1r44, Serpinf2, Mical2, Shank2, Lrrfip1, 
Prrxl1, Isl2, Tsta3, Mmp15, Grik5, Slc22a22, 
Sv2b, Cit, Rnase2a, Zfp521, Auts2, Lbx1, Pax9, 
Osr2, Btrc 
10E-18 
Cellular Movement, 
Immune Cell Trafficking, 
Hematological System 
Development and 
Function 
Pde2a, Rnf19a, Hmmr, Rtcb, Tst, Serpinb9e, 
Rbfox1, Dsc3, Kctd10, Rab19, Alyref, Neu1, 
Slc35d3, Lims2, Snph, Nkx2-3, Cdhr5, H13, 
Hnrnpk, Eif1 
10E-17 
Lipid Metabolism, 
Molecular Transport, 
Small Molecule 
Biochemistry 
Grik3, Matn1, Cmtm6, Mir7-1, St6galnac4, 
Krt31, Apbb1, Gfap, Rbpjl, H2-Ke6, Matn4, 
Mknk2, Erv3, Acsl4, Nr2e3, Olfm1, Prl7d1, 
Pnoc, Rsl1d1, Chrna9, Pdlim4, Ncor1 
10E-14 
     IPA canonical  
Regulation of cellular 
mechanics by calpain 
protease  
Ptk2, Capn5, Rb1, Mras, Ln1, Capn9 0.0039 
Fatty acid β-oxidation  Acaa1, Acsl6, Acsl4, Eci1, Hsd17b8 0.0044 
Amyotrophic lateral 
sclerosis signaling  
Capn5, Naip, Grik5, Gdnf, Grik3, Capn9, 
Rnf19a, Ssr4 
0.0088 
Bladder cancer signaling  Rb1, Fgf18, Mmp15, Mras, Mmp2, Rassf1, 
Fgf1, Fgf19 
0.013 
Thyroid cancer signaling  Gdnf, Ntrk1, Mras, Rxrb, Tcf7l2 0.014 
Giloma invasiveness 
signaling  
Ptk2, Timp1, Hmmr, Mras, Mmp2, Timp2 0.016 
Non-small cell lung 
cancer signalling  
Rb1, Akt2, Itpr3, Mras, Rxrb, Rassf1 0.029 
Sphingomyelin 
metabolism  
Smpd4, Smpd3 0.032 
Estrogen biosynthesis  Hsd17b3, Cyp3a5, Hsd17b8, Cyp2s1 0.035 
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Spliceosomal cycle  U2af2 0.038 
FGF signaling  Akt2, Fgf18, Fgfr1, Creb3, Map2k3, Fgf1, 
Fgf19 
0.040 
TREM1 signaling  Sigirr, Nod2, Akt2, Nlrp6, Myd88 0.045 
FAK signaling  Ptk2, Capn5, Akt2, Hmmr, Mras, Tln1, Capn9 0.048 
     Partek Pathway  
Pathways in cancer Akt2, Amn, Bcr, Ctbp2, Fas, Fgf1, Fgf15, 
Fgf18, Fgfr1, Flt3, Lamb2, Mlh1, Mmp2, Ntrk1, 
Ptk2, Ralgds, Rassf1, Rb1, Rxrb, Tcf7l2 
0.034 
Fatty acid metabolism  Acaa1a, Acsl4, Acsl6, Fas, Scd4 0.035 
Sphingolipid metabolism  Cers1, Neu1, Neu2, Smpd3, Smpd4 0.040 
    Enrichr KEGG 
MAPK Signaling 
pathway  
Fas, Map2k3, Ntrk1, Fgf1, Cacng3, Ecsit, 
Mknk2, Fgf18, Ddit3, Arrb1, Fgfr1, Mras, 
Ptpn5, Akt2, Mapk8ip1 
0.041 
Sphingolipid metabolism Neu1, Neu2, Smpd3, Smpd4 0.046 
†p-values provided for each pathway are shown (right-tailed Fishers exact test). 
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Appendix E Genes bearing both H3K4me3 and H3K27me3 changes†. 
Gene name H3K4- 
me3 
MAT 
score 
H3K4me3 
p-value 
Distance 
from TSS 
H3K27- 
me3 
MAT 
score 
H3K27- 
me3 p-
value 
Distance 
from 
TSS 
Reciprocal 
E030025P04Rik 4.33 0.000375 -2489 3.14 0.000375 -2489  
Elfn2 -5.24 0.0000936 41237 1.90 0.00246 5169 R 
Fbrsl1 -4.35 0.000281 -2406 1.12 0.00815 23673 R 
    3.21 0.000375 8911  
Fbxl16 -4.56 0.0000936 6620 12.76 0.000753 6620 R 
Flii 6.23 0.0000936 -577 4.42 0.000187 577  
Gareml 5.05 0.0000936 -2491 3.06 0.000385 -2491  
Grik3 -5.15 0.0000936 4162 -13.08 0.000667 4162  
H2-DMa -4.08 0.0002809 13252 -14.26 0.000475 13252  
Hoxa7 -6.18 0.0000936 -2823 -19.74 0.000093
6 
-2823  
Mief2 6.22 0.0000936 -579 4.42 0.000187 -579  
Mir5100 6.22 0.0000936 -844 4.42 0.000187 -844  
Myadml2 0.998 0.0002809 1056 -13.03 0.000655 1056 R 
Ndor1 -6.04 0.0000936 4744 -12.76 0.000749 4744  
Pcdha4-g -4.11 0.0002809 486398 -12.45 0.001311 540697  
    -14.11 0.000468 781334  
    -10.87 0.003558 722971  
    1.07 0.00899 365221 R 
    2.02 0.001966 400019 R 
    -11.29 0.002528 -3178  
Pcdhga1 -11.16 0.0000936 72130 -14.11 0.000468 72130  
 -8.17 0.0000936 13767 -10.87 0.003558 13767  
Pcdhga2 -11.16 0.0000936 64970 -14.11 0.000468 64970  
 -8.17 0.0000936 6607 -10.87 0.003558 6607  
Pcdhga3 -
11.1605 
0.0000936 59740 -14.11 0.000468 59740 
 
 
 -8.17 0.0000936 1377 -10.87 0.003558 1377  
Pcdhga4 -11.16 0.0000936 48675 -14.11 0.000468 48675  
Pcdhga5 -11.16 0.0000936 39574 -14.11 0.000468 39574  
Pcdhga6 -11.16 0.0000936 26846 -14.11 0.000468 26846  
Pcdhga7 -11.16 0.0000936 19241 -14.11 0.000468 19241  
Pcdhga8 -11.16 0.0000936 8369 -14.11 0.000468 8369  
Pcdhga9 -11.16 0.0000936 -2841 -14.11 0.000468 -2841  
Pcdhgb1 -11.16 0.0000936 53617 -14.11 0.000468 53617  
Pcdhgb2 -11.16 0.0000936 44216 -14.11 0.000468 44216  
Pcdhgb4 -11.16 0.0000936 13521 -14.11 0.000468 13521  
Pcdhgb5 -11.16 0.0000936 2921 -14.11 0.000468 2921  
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Pebp4 4.30 0.0003747 -2474 4.13 0.000187 -2474  
Pycr1 -4.16 0.0002809 -3591 -13.03 0.000655 -3591  
Rai1 4.28 0.0003745 -2491 1.14 0.007491 10315  
    3.51 0.000375 76874  
Rassf1 -5.00 0.0000936 3765 -13.01 0.000655 3765  
Tmem203 -6.04 0.0000936 -4768 -12.76 0.000749 -4768  
Tusc2 -5.00 0.0000936 -4887 -13.01 0.000655 -4887  
†The degree of enrichment (MAT score) and p-value for each RDHM is shown for each 
gene (two-way ANOVA). The distance from the region of differential histone 
methylation (RDHM) to the transcriptional start site (TSS) of the gene in base pairs is 
also shown. Negative distance indicates that the RDHM is upstream of the TSS. The 
reciprocal column is marked if the two methylations have a reciprocal relationship, i.e. 
one is increased and the other decreased indicating the same predicted effect on gene 
expression. 
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Appendix F Linear relationship between number of genes and number of 
differentially methylated regions (DMRs) per chromosome. 
Numbers indicate the chromosome associated with each data point. R2 value calculated in 
Microsoft Excel. 
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Appendix G Affected genes in pathways significantly enriched with genes proximal 
to differentially methylated regions (DMRs). 
Network name  Affected genes  p-value 
   IPA 
Cellular 
Movement, Cell 
Death and Survival, 
Cellular 
Development 
Acadvl, Adcyap1, Bai1, Banp, Bmp7, Camk2n1, 
Cc2d1a, Ccl17, Cd151, Cd1d, Cd38, Cd3e, Cd70, 
Cdc25c, Cdh15, Cenpa, Csf1r, Csk, Ctsb, Ctsh, 
Cyld, Cyp11b2, Cyp27b1, Ddx5, Dhx58, Dll4, 
Dusp4, E2f3, Egr2, Fat1, Fbln2, Fgf1, Flna, 
Gas2l1, Gata1, Gins2, Gjb1, Golt1b, Grn, Hdac11, 
Hgs, Hipk2, Hist1h2ab, Hspa1a/hspa1b, Id2, Il13, 
Il13ra2, Il17rd, Il21r, Itga5, Kat2a, Lsp1, Mcl1, 
Mir-135, Mir-143, Mir-146, Mir-26, Myd88, 
Ndfip2, Neurog3, Nos2, Nppc, Ntn1, Numbl, P2ry2, 
Pcdha5, Pgf, Plcd1, Pole, Polr2a, Ptger4, Rbl2, 
Rbp1, Recql, Relb, S100a6, S100a9, Sirpa, Slc9a8, 
Snupn, Socs2, Spn, Stra6, Tac1, Tacc2, Tardbp, 
Tff1, Thbs4, Thpo, Timp3, Tnfsf4, Tnk2, Tp73, 
Trak1, Trib3, Trps1, Tshz3, Uba7, Ung, Vdr, Vegfa, 
Vkorc1l1, Wnk2 
10E-130 
Cell Cycle, Cellular 
Development, 
Cellular Growth 
and Proliferation 
Antxr1, Atp5b, Bcl2l12, Bclaf1, Bik, Capn3, 
Ccdc33, Cchcr1, Cdc25c, Ctsd, Cul4a, Cxxc1, 
Ddx5, Egr2, Eif4a2, Elf4, Foxl2, Foxp4, Fzd4, 
Gemin5, Gpa33, Hist4h4, Hopx, Ifitm2, Kctd13, 
Lnx2, Lpin1, Lsm2, Mettl1, Mir-135, Mir-150, Mir-
188, Mir-26, Mir-324, Mir-338, Mir-486, Naca, 
Nav2, Ndufb5, Ndufs8, Nos1, Npas1, Numbl, Pax6, 
Pla2r1, Poldip2, Ptpru, Rap2b, Rbm3, Sf3a1, 
Slc39a3, Snapc1, Tagln2, Tal1, Thpo, Tmem97, 
Unc45a  
 
10E-50 
Inflammatory 
Response, Cellular 
Movement, 
Immune Cell 
Trafficking 
Acaa1, Acss2, Ambp, Aoah, Ap1g2, Aplp1, Bcan, 
C9orf9, Carhsp1, Cd151, Cd177, Clasp1, Clstn1, 
Colq, Csnk2a2, Ctsb, Derl2, Dgkz, Dlec1, Dlg4, 
Efnb3, Epha2, Esrrg, Fam53c, Fat1, Fgf1, Fgf4, 
Fmn2, Gcc1, Hs6st1, Htr6, Igfbp2, Il17rd, Iscu, 
Itga5, Itm2c, Kcnip1, Kcnj12, Lamc1, Mir-146, 
Mir-196, Nos2, Nrn1, Pdlim4, Prmt2, Ptger4, 
Rab21, Scamp3, Slc1a2, Smtn, Ssh3, Tac1, Timp3, 
Tnni3, Tspan4, Usp2, Vamp4,  
 
10E-50 
Organismal 
Development, 
Tissue 
Development, 
Actc1, Arf5, Atl1, Atl2, Cct6a, Cdo1, Ceacam1, 
Chac1, Cnn2, Ddx5, Dlgap5, Dll1, Dpep1, Eif3i, 
Enpp4, Exosc6, Gtf2h1, Hsd17b2, Igf2bp2, Il11ra, 
Impa2, Iqgap2, Krt80, Lamp2, Lef1, Lrch4, 
10E-43 
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Embryonic 
Development 
Lypd6b, Mecr, Mrap, Msl3, Nfx1, Nipal2, Nmb, 
Nop2, Nup50, Onecut1, Otx2, Oxtr, Pik3ap1, Pir, 
Polr1d, Polr2a, Polr2h, Ptch2, Samm50, Sema3f, 
Tmem17, Tmem64, Tmem97, Trpv4, Tspan17, 
Umodl1,  
 
Cell Death and 
Survival, Cellular 
Development, 
Cellular Growth 
and Proliferation 
Aatk, Abcb10, Agrn, Arl16, Bre, C1qtnf4, C4orf19, 
Cdc25c, Chpf, Dapk2, Dmrt3, Dpp7, Ebna1bp2, 
Emilin2, Fam167a, Fgf1, Fhdc1, Galnt6, Gata5, 
Glp2r, Il20rb, L3mbtl3, Lad1, Mfi2, Mis12, 
Mybbp1a, Myd88, Nfatc3, Nr1d2, Nr1h4, Nudt11, 
Pgam1, Rab17, Rhbdl2, Rpp25, Scn1b, Scx, 
Sema5b, Sema7a, Sos2, Stx12, Sytl2, Tjap1, Tmcc3, 
Tnfrsf21, Trib3,  
 
10E-35 
  Partek pathway 
Hematopoietic cell 
lineage 
Cd1d1, Cd3e, Cd38, Csf1r, Gm2002, Gm13305, 
Il11ra1, Il11ra2, Itga5, Thpo 
0.0003 
Peroxisome Acaa1a, Hao2, Mpv17l, Mvk, Nos2, Peci, Pex26, 
Pxmp2, Slc25a17 
0.0006 
Jak-STAT 
signaling pathway 
Gm2002, Gm13305, Il11ra1, Il11ra2, Il12rb1, Il13, 
Il13ra2, Il20rb, Il21r, Socs2, Sos2 
0.0006 
Lysosome  Abcb9, Ap1g2, Ap1s1, Arsg, Ctsb, Ctsd, Ctsh, 
Lamp2, Tcirg1 
0.003 
Taurine and 
hypotaurine 
metabolism 
Cdo1, Ggt6 0.009 
   Enrichr KEGG 
Peroxisome Slc25a17, Mvk, Nos2, Pxmp, Mpv17l, Hao2, Pex26 0.024 
Lysosome Ap1g2, Lamp2, Ap1s1, Ctsh, Arsg, Abcb, Tcirg1, 
Ctsd, Ctsb 
0.026 
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Appendix H Affected genes in pathways significantly enriched with genes proximal 
to differentially methylated regions (DMRs) or regions of differential histone 
modification (RDHMs). 
Pathway name Genes in list p-value 
   IPA 
Embryonic 
Development, 
Organismal 
Development, Cellular 
Development 
Apbb1, Aplp1, App, Bmp7, Brf1, Ceacam1, 
Cox4I1, Dbh, Ddx4, Ddx5, Derl2, Dis3, E2F3, 
Eef2K, Eif5B, Fgf1, Fgf4, Fgfr1, Gnaz, 
Gprc6A, Gyk, Hoxb9, Hoxd3, Hoxd9, Hoxd10, 
Hs6St1, Htr3A, Id3, Itga5, Itm2B, Itm2C, 
Lamb2, Mecr, Meis1, Ncs1, Nr1H4, Nrg1, 
Ntn1, Numbl, Otx2, Pax6, Pdcd4, Pgf, Phf1, 
Phox2B, Ppargc1B, Rb1, Rbl2, Rbp1, Rho, 
S100A6, Six3, Slc14A1, Socs7, Suv420H1, 
Tcf7L2, Tusc2 
10E-64 
Cardiac Hypertrophy, 
Cardiovascular 
Disease, 
Developmental 
Disorder 
Acss2, Actc1, Adcyap1, Antxr1, Cc2D1A, 
Cd53, Cd5L, Cdo1, Cxxc1, Cyp24A1, 
Cyp27B1, Dleu2, Flt3, Flt4, Foxl2, Gdnf, 
Hoxa7, Igf1, Inhba, Jph4, Lh, Lingo1, Mb, 
Nos1, Nos2, Nrgn, Polr2A, Ptger4, Ptpre, 
Ptprj, Ptprn, Ralgds, Relb, Retnlb, Serpinh1, 
Sfrp1, Sfxn1, Slc39A14, Slc8A1, Socs2, Syn1, 
Tkt, Tmem119, Tnk2, Tnni3, Trpv6, Tspan2, 
Tspan17, Ttyh1, Vdr, Zbtb20 
10E-56 
Humoral Immune 
Response, Protein 
Synthesis, 
Hematological System 
Development and 
Function 
Abcc4, Abcg2, Arhgef10, Bcl3, Bik, Bst2, 
Cabin1, Ccl17, Cd27, Cd38, Cd70, Dhx58, 
Dll4, Dnmt3A, Drd5, Ebf1, Efs, Gas7, Gata3, 
Glra1, Grn, Ifit3, Il25, Il13Ra2, Il20Rb, Il21R, 
Jak3, Lef1, Mafk, Mapk8Ip1, Mat2A, Myd88, 
Nod2, Notch4, Ntrk1, Pou3F1, Rxrb, Smarcc1, 
Tardbp, Tcirg1, Tmem97, Tnfrsf21, Trex1, 
Uba7, Ung 
10E-49 
Cellular Development, 
Cellular Growth and 
Proliferation, 
Hematological System 
Development and 
Function 
Adcy7, Ager, Asap1, Cd3E, Csf1R, Csk, Cyld, 
Dgkz, Dmtn, Dok3, Dusp4, Egr2, Epha2, 
Esrrg, Fas, Flii, Il13, Lamc1, Lamp2, Lpin1, 
Map2K3, Mcf2L, Mcl1, Mif, Pik3Ap1, Plec, 
Prmt2, Ptk2, Rbck1, Rnf31, Scfd1, Sh2B2, 
Sh3Bp2, Sigirr, Sirpa, Smpd3, Snap23, Stra6, 
Thpo, Tnfsf4, Vegfa 
10E-41 
Skeletal and Muscular 
Disorders, 
Developmental 
Disorder, Hereditary 
Disorder 
Abca7, Acot11, Actc1, Actn3, Ankrd6, Arntl, 
Atp1B2, Bhmt, Capn3, Cd151, Cd177, Fat1, 
Flna, Igf2Bp2, Impa2, Inf2, Kcnk3, Ldb3, Lipe, 
Lpar3, Lrch1, Ncoa7, Nphs1, Nr1D2, P2Ry2, 
Pnpla2, Rgs19, Slc35D3, Sox18, Srpk3, 
Tmem40, Tst, Tsta3 
10E-30 
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Hematological System 
Development and 
Function, Tissue 
Morphology, Cell-To-
Cell Signaling and 
Interaction 
Acsl6, Arsg, Ccl17, Cip1, Cryba1, Crybb3, 
Dusp4, Ebna1Bp2, Gtf2H4, Homer2, Il12Rb1, 
Kat2A, Lad1, Map2K3, Mst1, Mvk, Ndfip2, 
Nedd4, Nrn1, Pbx2, Pla2R1, Polr1D, Rasa2, 
Rgs16, Rnps1, Ska1, Slain1, Socs2, Tia1, 
Usp2, Vdr, Zfhx3 
10E-26 
Endocrine System 
Development and 
Function, Molecular 
Transport, Protein 
Synthesis 
Aatk, Ank1, Atp5B, Cbx4, Ctsd, Ero1Lb, 
Fbxl17, Fem1B, Foxp4, Gpr17, Hipk2, 
Hsd17B3, Igf1, Insrr, Ip6K1, Itpr3, Kctd10, 
Lims2, Lpin1, Mfi2, Mrap, Mrpl47, Mybbp1A, 
Ntrk1, Pnpla2, Rbm39, Rnasel, Rph3Al, 
Sertad1, Socs2, Sptb, St6, Galnac4, Taf10, 
Timp2 
10E-24 
Cell Death and 
Survival, 
Antimicrobial 
Response, 
Inflammatory 
Response 
Agl, Bcr, Cc2D1A, Ccl17, Cd70, Cd300E, 
Ceacam1, Clstn1, Dhx58, Dll1, Dock5, Dsc3, 
Ebf1, Glp2R, Hes5, Ifi47, Ifit3, Iigp1, 
Irak1Bp1, Lrrfip1, 42801, Mettl1, Mzb1, 
Parp14, Sigirr, Slc39A14, Sox1, Spn 
10E-23 
Cell-To-Cell 
Signaling and 
Interaction, 
Hematological System 
Development and 
Function, Immune 
Cell Trafficking 
Ap1S1, Apol6, Bcan, C1Qtnf5, Calb2, Capn5, 
Dpp7, Egr2, Emx2, Fermt3, Gata3, Gdnf, 
Gins2, Gja5, Gpr146, Hapln2, Il12Rb1, 
Kcnk9, Mras, Nfatc3, Nr1H4, Orai1, Pam16, 
Pip5K1C, Pou3F3, Prpf8, Psd2, Rhcg, Socs2, 
Tac1, Tapbpl, Tc2N, Tcirg1 
10E-21 
Embryonic 
Development, 
Organismal 
Development, Cell-
To-Cell Signaling and 
Interaction 
Arpp21, Atp2B3, Cacng3, Casz1, Cdadc1, 
Cnot6L, Dapk2, Dhrs7, Dll1, Eif1, Epha2, 
Fam32A, Flna, Fmn2, Fzd4, Fzr1, Gdf10, 
Hes5, Hmmr, Hnrnpk, Macf1, Macrod1, 
Mapk8Ip1, Mesp1, Myo1F, Neu1, Nup50, 
Pde2A, S100A9, Scn1B, Snn, Spen, Tff1 
10E-20 
Cell-To-Cell 
Signaling and 
Interaction, 
Reproductive System 
Development and 
Function, Tissue 
Development 
Abcb10, Acsl4, Adam3, Appl2, Ccl6, Chrna9, 
Clasp1, Cmtm6, Cyth3, E330034G19Rik, Erv3, 
Fscn3, Hoxc10, Krt31, Lpin1, Lpin2, Map2K3, 
Mbnl3, Mtus1, Muc1, Neu2, Nlrp4F, Pcyox1, 
Pde4C, Rbp3, Rsl1D1, Tia1, Tmem64, Tpst2, 
Tspan4, Usp2, Wee2, Zp1 
10E-20 
Cell Death and 
Survival, Lipid 
Metabolism, Small 
Molecule 
Biochemistry 
Acadvl, Als2Cr12, Ap1b1, Asb2, Cenpp, 
Chtf18, Csf1r, Ctsd, Epha2, Faim2, Gng4, 
Gpr160, Inhba, Mlh1, Ndst1, Omp, Plscr3, 
Pole, Ppargc1b, Rai1, Rasl10b, Recql4, Rhof, 
Scd4, Senp7, Stip1, Tac1, Timp3, Tmem176a, 
Tmem176b, Ublcp1 
10E-20 
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Cell Cycle, DNA 
Replication, 
Recombination, and 
Repair, Cellular 
Development 
Arl6ip6, Asic1, Banp, Bclaf1, Camk2n1, Colq, 
Cyp2s1, Dhx40, Dnal4, Emilin2, Eno1, Fscb, 
Ip6k2, Ldlrad3, Matn1, Matn4, Naf1, Nr2e3, 
Olfm1, Pcdha2, Pcdha3, Pdlim4, Pgam1, 
Ptp4A3, Qrich1, Sema3F, Serpina12, Slc16a1, 
Smtn, Snrk, Trrap 
10E-19 
Embryonic 
Development, 
Organismal 
Development, Cell 
Morphology 
Ap1m1, Auts2, Ccdc74a, Cenpa, Col4a3bp, 
Cst12, Disp2, Dmrt3, Dmrta2, Dmrtc1b, 
Dnm1, Dock9, Emb, Fgfr1, Foxm1, Fsd1l, 
Gata1, Gzmc, Hsd17b2, Id2, Ifitm2, Inhba, 
Klrg1, Krtdap, Mical2, Nav2, Ogfr, Ptbp1, 
Ptk7, Rab19, Sult1e1, Sv2b, Sytl2, Tbx4 
10E-19 
Cell Death and 
Survival, Cancer, 
Cellular Development 
Anapc4, Astn2, Atp5k, Carhsp1, Cd38, Cnn2, 
Creb3, Crip2, Dpep1, Elf4, Fbln2, Gtf2h1, 
Gtf3c2, Hdlbp, Idh3G, Ifi30, Lsp1, Mlh1, 
Mpv17l, Noxa1, Pcca, Prdx4, Ptp4a3, Ptpru, 
Rap2b, Rbm3, Rgs12, Scpep1, Stip1, Tacc2, 
Tinagl1, Urod 
10E-19 
Cell-To-Cell 
Signaling and 
Interaction, Nervous 
System Development 
and Function, 
Behavior 
Adam11, Arpc4, Atp5B, Bai1, Bcl3, Bhmt, 
Cant1, Cirbp, Cit, Cmip, Ctsw, Dlg4, Dusp4, 
Emilin1, Gemin5, Gne, Gpr123, Grik5, Iqsec2, 
Nuak2, Pcdha4, Sema4c, Sf3a1, Shank2, Sik1, 
Slc1a2, Slc4a4, Spdef, Stx1b, Svs2, Tbc1d17, 
Vamp2 
10E-18 
Lipid Metabolism, 
Small Molecule 
Biochemistry, 
Molecular Transport 
1100001G20Rik, Acadvl, Apoc1, B3gnt6, Ctsd, 
Eci1, Fgf18, Lbx1, Matk, Mir705, Ncor1, 
Nthl1, Paqr7, Prl7dg1, Rbpjl, Rnf19a, Sardh, 
Sfxn4, Socs2, Sycp3, Tef, Tmem159 
10E-18 
Cell Morphology, Cell 
Death and Survival, 
Nervous System 
Development and 
Function 
Agtpbp1, Aoah, Atp6v1f, Cct6a, Chrd, Cox6c, 
Evc, Fyttd1, Gfap, Hhatl, Hoxb3, Htr6, Jph1, 
Mbp, Ndufa7, Ndufa8, Ndufb5, Ndufs8, Psme2, 
Rassf1, Rgs16, Rpl10a, Rps10, Rps15, Rps29, 
Ryr1, Sct, Tln1, Tnpo3, Ttll7, Vars 
10E-16 
Cell-To-Cell 
Signaling and 
Interaction, Nervous 
System Development 
and Function, Cellular 
Development 
Aars, Agap1, Agrn, Akap1, Ccdc109b, Cdhr5, 
Ebf2, Gprasp1, Gprin1, Ifitm5, Jakmip1, 
Mfap4, Mid1, Odf3b, Otx2, Pde1b, Polk, 
Pycr1, Rab17, Rad21, Rbfox1, Retnlb, Sephs1, 
Shisa5, Ssbp2, Thbs4, Tra2a 
10E-16 
Lipid Metabolism, 
Small Molecule 
Biochemistry, 
Vitamin and Mineral 
Metabolism 
Aspa, B3gnt3, Bcl6b, Cd151, Fhl5, Hgfac, 
Hgs, Krtap19-3, Muc4, Myadml2, Neurog3, 
Nlrp6, Npas1, Nptx2, Nr1h4, Oaz1, Onecut1, 
Pxmp2, Slc38a4, Slco2b1, Spic, Tagln2, 
Tmprss4, Trpm5, Trps1, Ube2v1 
10E-15 
Tissue Morphology, 
Embryonic 
Akt1s1, Arrb1, Bmp7, Btrc, Cdh15, Csnk1a1, 
Csnk2a2, Csnk2b, Ctbp2, Ctnnd2, Ctsh, Ecsit, 
10E-15 
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Development, 
Organismal 
Development 
Ggt6, Glis2, Iqgap2, Kctd20, Lef1, Mmp15, 
Naca, Nkx2-3, Nppc, Ptch2, Rab18, Scnn1b, 
Slc26a11, Smad1, Timp3, Tmem17 
Nervous System 
Development and 
Function, Cellular 
Development, Tissue 
Morphology 
Amn, Dnajc6, G530011O06Rik, Gcm2, Grik3, 
Hao2, Inpp5j, Isl2, Kcnip1, Lhx5, Mctp2, 
Pcp4, Plekhf1, Pnoc, Prrxl1, Rbm47, Sall3, 
Scarf1, Slc22a6, Slc22a22, Slc47a1 
10E-14 
   Partek Pathway 
Peroxisome  Acaa1a, Acsl4, Acsl6, Agt, Hao2, Mpv17, 
Mpv17l, Mpv17l2, Mvk, Nos2, Peci, Pex26, 
Pxmp2, Slc25a17 
0.008 
Hematopoietic cell 
lineage  
Cd1d1, Cd3e, Cd38, Csf1r, Fcgr1, Flt3, 
Gm2002, Gm13305, H2-Eb1, Il11ra1, Il11ra2, 
Itga5, Thpo 
0.01 
Notch signalling 
pathway  
Ctbp2, Dll1, Dll4, Hes5, Kat2a, Notch4, 
Numbl, Rbpjl 
0.032 
ABC transporters  Abca6, Abca7, Abca8b, Abcb9, Abcb10, Abcc4, 
Abcc10, Abcg2 
0.036 
  Enrichr KEGG 
Notch signaling 
pathway 
Rbpjl, Dll4, Kat2A, Numbl, Ctbp2, Notch4, 
Dll1, Hes5 
0.040 
Bladder cancer Rb1, Rassf1, Dapk2, Mmp2, E2F3, Vegfa, 
Tymp 
0.048 
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